@article{Abdullah2018,
  title = {Long-{{Term Association}} of {{Low-Density Lipoprotein Cholesterol}} with {{Cardiovascular Mortality}} in {{Individuals}} at {{Low}} 10-{{Year Risk}} of {{Atherosclerotic Cardiovascular Disease}}: {{Results}} from the {{Cooper Center Longitudinal Study}}},
  author = {Abdullah, Shuaib M. and Defina, Laura F. and Leonard, David and Barlow, Carolyn E. and Radford, Nina B. and Willis, Benjamin L. and Rohatgi, Anand and McGuire, Darren K. and De Lemos, James A. and Grundy, Scott M. and Berry, Jarett D. and Khera, Amit},
  date = {2018-11-20},
  journaltitle = {Circulation},
  volume = {138},
  number = {21},
  eprint = {30571575},
  eprinttype = {pmid},
  pages = {2315--2325},
  publisher = {{Lippincott Williams and Wilkins}},
  issn = {15244539},
  doi = {10.1161/CIRCULATIONAHA.118.034273},
  url = {https://pubmed.ncbi.nlm.nih.gov/30571575/},
  urldate = {2021-04-02},
  abstract = {Background: The associations of low-density lipoprotein cholesterol (LDL-C) with cardiovascular disease (CVD) and coronary heart disease mortality in an exclusively low estimated 10-year risk group are not well delineated. We sought to determine the long-term associations of various LDL-C and non-high-density lipoprotein cholesterol (HDL-C) thresholds and CVD and coronary heart disease mortality in a large, low 10-year risk cohort. Methods: The study sample included participants of the CCLS (Cooper Center Longitudinal Study) without a history of CVD or diabetes mellitus and defined as low risk ({$<$}7.5\%) for 10-year atherosclerotic CVD events at baseline based on Pooled Cohort Risk Assessment Equations. The associations of fasting LDL-C and non-HDL-C with CVD mortality were tested with Cox proportional hazards models. Results: In 36 375 participants (72\% men, median age 42) followed for a median of 26.8 years, 1086 CVD and 598 coronary heart disease deaths occurred. Compared with LDL-C {$<$}100 mg/dL, LDL-C categories 100 to 129 mg/dL, 130 to 159 mg/dL, 160 to 189.9 mg/dL, and â‰¥190 mg/dL were associated with a significantly higher risk of CVD death, with hazard ratios of 1.4 (95\% CI, 1.1-1.7), 1.3 (95\% CI, 1.1-1.6), 1.9 (95\% CI, 1.5-2.4), and 1.7 (95\% CI, 1.3-2.3), and mean reductions in years free of CVD death of 1.8, 1.1, 4.3, and 3.9, respectively. After adjustment for atherosclerotic CVD risk factors, LDL-C categories 160 to 189 mg/dL and â‰¥190 mg/dL remained independently associated with CVD mortality, with hazard ratios of 1.7 (95\% CI, 1.4-2.2) and 1.5 (95\% CI, 1.2-2.1), respectively. In multivariable-adjusted models using non-HDL-C {$<$}130 mg/dL as the reference, non-HDL-C 160 to 189 mg/dL, 190 to 219 mg/dL, and â‰¥220 mg/dL were significantly associated with CVD death, with hazard ratios of 1.3 (95\% CI, 1.1-1.6), 1.8 (95\% CI, 1.4-2.2), and 1.5 (95\% CI, 1.2-2.0), respectively. Restricting the cohort to those with 10-year risk {$<$}5\% did not diminish the associations of LDL-C and non-HDL-C with CVD mortality. Conclusions: In a low 10-year risk cohort with long-term follow-up, LDL-C and non-HDL-C â‰¥160 mg/dL were independently associated with a 50\% to 80\% increased relative risk of CVD mortality. These findings may have implications for future cholesterol treatment paradigms.},
  keywords = {ðŸ”´,long-term follow-up,low-density lipoprotein,primary prevention},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Abdullah et al_2018_Long-Term Association of Low-Density Lipoprotein Cholesterol with.pdf}
}

@article{Ahmadi2011,
  title = {Post-Traumatic Stress Disorder, Coronary Atherosclerosis, and Mortality},
  author = {Ahmadi, Naser and Hajsadeghi, Fereshteh and Mirshkarlo, Hormoz B. and Budoff, Matthew and Yehuda, Rachel and Ebrahimi, Ramin},
  date = {2011-07-01},
  journaltitle = {American Journal of Cardiology},
  volume = {108},
  number = {1},
  eprint = {21530936},
  eprinttype = {pmid},
  pages = {29--33},
  publisher = {{Am J Cardiol}},
  issn = {00029149},
  doi = {10.1016/j.amjcard.2011.02.340},
  url = {https://pubmed.ncbi.nlm.nih.gov/21530936/},
  urldate = {2021-03-17},
  abstract = {Post-traumatic stress disorder (PTSD) is associated with increased risk of multiple medical problems including myocardial infarction. However, a direct link between PTSD and atherosclerotic coronary artery disease (CAD) has not been made. Coronary artery calcium (CAC) score is an excellent method to detect atherosclerosis. This study investigated the association of PTSD to atherosclerotic CAD and mortality. Six hundred thirty-seven veterans without known CAD (61 Â± 9 years of age, 12.2\% women) underwent CAC scanning for clinical indications and their psychological health status (PTSD vs non-PTSD) was evaluated. In subjects with PTSD, CAC was more prevalent than in the non-PTSD cohort (76.1\% vs 59\%, p = 0.001) and their CAC scores were significantly higher in each Framingham risk score category compared to the non-PTSD group. Multivariable generalized linear regression analysis identified PTSD as an independent predictor of presence and extent of atherosclerotic CAD (p {$<$}0.01). During a mean follow-up of 42 months, the death rate was higher in the PTSD compared to the non-PTSD group (15, 17.1\%, vs 57, 10.4\%, p = 0.003). Multivariable survival regression analyses revealed a significant linkage between PTSD and mortality and between CAC and mortality. After adjustment for risk factors, relative risk (RR) of death was 1.48 (95\% confidence interval [CI] 1.03 to 2.91, p = 0.01) in subjects with PTSD and CAC score {$>$}0 compared to subjects without PTSD and CAC score equal to 0. With a CAC score equal to 0, risk of death was not different between subjects with and without PTSD (RR 1.04, 95\% CI 0.67 to 6.82, p = 0.4). Risk of death in each CAC category was higher in subjects with PTSD compared to matched subjects without PTSD (RRs 1.23 for CAC scores 1 to 100, 1.51 for CAC scores 101 to 400, and 1.81 for CAC scores {$<$}400, p {$<$}0.05 for all comparisons). In conclusion, PTSD is associated with presence and severity of coronary atherosclerosis and predicts mortality independent of age, gender, and conventional risk factors. Â© 2011 Elsevier Inc. All rights reserved.},
  isbn = {0002-9149},
  keywords = {ðŸ”´,Calcium / metabolism,California / epidemiology,Comparative Study,Confidence Intervals,Coronary Artery Disease / etiology,Coronary Artery Disease / metabolism,Coronary Artery Disease / mortality*,Coronary Vessels / metabolism,doi:10.1016/j.amjcard.2011.02.340,Female,Fereshteh Hajsadeghi,Follow-Up Studies,Humans,Male,MEDLINE,Middle Aged,Naser Ahmadi,National Center for Biotechnology Information,National Institutes of Health,National Library of Medicine,NCBI,NIH,NLM,Odds Ratio,pmid:21530936,Post-Traumatic / complications,Post-Traumatic / metabolism,Post-Traumatic / mortality*,PubMed Abstract,Ramin Ebrahimi,Retrospective Studies,Risk Factors,Stress Disorders,Survival Rate / trends,United States / epidemiology}
}

@article{Al-Kawaz2018,
  title = {Comparative {{Risks}} of {{Ischemic Stroke}} in {{Atrial Flutter}} versus {{Atrial Fibrillation}}},
  author = {Al-Kawaz, Mais and Omran, Setareh S and Parikh, Neal S and Elkind, Mitchell S.V. and Soliman, Elsayed Z and Kamel, Hooman},
  date = {2018},
  journaltitle = {Journal of Stroke and Cerebrovascular Diseases},
  volume = {27},
  number = {4},
  eprint = {29223550},
  eprinttype = {pmid},
  pages = {839--844},
  issn = {15328511},
  doi = {10.1016/j.jstrokecerebrovasdis.2017.10.025},
  url = {https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.10.025},
  urldate = {2022-11-22},
  abstract = {Introduction: The aim of this study was to compare the risk of ischemic stroke in patients who have atrial fibrillation and patients who have atrial flutter. Methods: Using inpatient and outpatient Medicare claims data from 2008 to 2014 for a 5\% sample of all beneficiaries 66 years of age or older, we identified patients diagnosed with atrial fibrillation and those diagnosed with atrial flutter. The primary outcome was ischemic stroke. In the primary analysis, patients with atrial flutter were censored upon converting to fibrillation; in a secondary analysis, they were not. Survival statistics were used to compare incidence of stroke in patients with flutter and patients with fibrillation. Cox proportional hazards analysis was used to compare the associations of flutter and fibrillation with ischemic stroke after adjustment for demographics and risk factors. Results: We identified 14,953 patients with flutter and 318,138 with fibrillation. During a mean follow-up period of 2.8 (Â±2.3) years, we identified 18,900 ischemic strokes. The annual incidence of ischemic stroke in patients with flutter was 1.38\% (95\% confidence interval [CI] 1.22\%-1.57\%) compared with 2.02\% (95\% CI 1.99\%-2.05\%) in patients with fibrillation. After adjustment for demographics and stroke risk factors, flutter was associated with a lower risk of stroke compared with fibrillation (hazard ratio.69; 95\% CI.60-.79, P {$<$}.05). Within 1 year, 65.7\% (95\% CI 64.9\%-66.4\%) of patients with flutter converted to fibrillation but remained at a lower risk of ischemic stroke (hazard ratio.85; 95\% CI.78-.92). Conclusions: Patients with atrial flutter faced a lower risk of ischemic stroke than patients with atrial fibrillation.},
  keywords = {ðŸ”´,arrhythmia,atrial fibrillation,atrial flutter,Stroke},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Al-Kawaz et al_2018_Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial.pdf}
}

@article{Almas2015,
  title = {Severity of Depression, Anxious Distress and the Risk of Cardiovascular Disease in a {{Swedish}} Population-Based Cohort},
  author = {Almas, Aysha and Forsell, Yvonne and Iqbal, Romaina and Janszky, Imre and Moller, Jette},
  editor = {Hashimoto, Kenji},
  date = {2015-10-15},
  journaltitle = {PLoS ONE},
  volume = {10},
  number = {10},
  eprint = {26469703},
  eprinttype = {pmid},
  pages = {e0140742},
  issn = {19326203},
  doi = {10.1371/journal.pone.0140742},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/26469703},
  urldate = {2018-12-25},
  abstract = {BACKGROUND Depression is known to be associated with cardiovascular diseases (CVD). This population-based cohort study aimed to determine the association between depression of varying severity and risk for CVD and to study the effect of concomitant anxious distress on this association. METHODS We utilized data from a longitudinal cohort study of mental health, work and relations among adults (20-64 years), with a total of 10,443 individuals. Depression and anxious distress were assessed using psychiatric rating scales and defined according to DSM-5. Outcomes were register-based and self-reported cardiovascular diseases. FINDINGS Overall increased odds ratios of 1.5 to 2.6 were seen for the different severity levels of depression, with the highest adjusted OR for moderate depression (OR 2.1 (95\% CI 1.3, 3.5). Similar odds ratios were seen for sub-groups of CVD: ischemic/hypertensive heart disease and stroke, 2.4 (95\% CI 1.4, 3.9) and OR 2.1 (95\%CI 1.2, 3.8) respectively. Depression with anxious distress as a specifier of severity showed OR of 2.1 (95\% CI 1.5, 2.9) for CVD. CONCLUSION This study found that severity level of depression seems to be of significance for increased risk of CVD among depressed persons, although not in a dose-response manner which might be obscured due to treatment of depression. Further, we found a higher risk of CVD among depressed individuals with symptoms of anxious distress.},
  isbn = {1932-6203},
  keywords = {ðŸ”´}
}

@article{Alzahrani2018,
  title = {Association {{Between Family History}} and {{Early-Onset Atrial Fibrillation Across Racial}} and {{Ethnic Groups}}},
  author = {Alzahrani, Zain and Ornelas-Loredo, Aylin and Darbar, Sara D. and Farooqui, Abdullah and Mol, Denise and Chalazan, Brandon and Villagrana, N. Elizabeth and McCauley, Mark and Lazar, Sorin and Wissner, Erik and Bhan, Adarsh and Konda, Sreenivas and Darbar, Dawood},
  date = {2018-09-21},
  journaltitle = {JAMA Network Open},
  shortjournal = {JAMA Network Open},
  volume = {1},
  number = {5},
  pages = {e182497},
  issn = {2574-3805},
  doi = {10.1001/jamanetworkopen.2018.2497},
  url = {https://doi.org/10.1001/jamanetworkopen.2018.2497},
  urldate = {2023-11-01},
  abstract = {There is a genetic predisposition to early-onset atrial fibrillation (EOAF) in European American individuals. However, the role of family history in the pathogenesis of EOAF in racial and ethnic minorities remains unclear.To determine whether probands with EOAF across racial and ethnic groups have a higher rate of AF in first-degree family members than racially and ethnically matched control patients with nonâ€“early-onset AF (non-EOAF).In this cohort study, patients prospectively enrolled in a clinical and genetic biorepository were administered baseline questionnaires that included questions about family history of AF. Early-onset AF was defined as AF occurring in probands aged 60 years or younger in the absence of structural heart disease. All other forms were categorized as non-EOAF. Recruitment took place from July 2015 to December 2017. Analysis was performed in January 2018.Primary analysis of reported family history of AF in first-degree relatives with sensitivity analysis restricted to those in whom a family history was confirmed by medical record review and electrocardiogram.Of 664 patients enrolled (mean [SD] age, 62 [12] years; 407 [61\%] male), 267 (40\%) were European American; 258 (39\%), African American; and 139 (21\%), Hispanic/Latino. There was a family history of AF in 36 probands with EOAF (49\%) compared with 128 patients with non-EOAF (22\%) (difference, 27\%; 95\% CI, 14\%-40\%; P\,\&lt;\,.001). On multivariable analysis, the adjusted odds of a proband with EOAF who was of African descent (odds ratio [OR], 2.69; 95\% CI, 1.06-6.91; P\,\&lt;\,.001) or Hispanic descent (OR, 9.25; 95\% CI, 2.37-36.23; P\,=\,.002) having a first-degree relative with AF were greater than those of European descent (OR, 2.51; 95\% CI, 1.29-4.87; P\,=\,.006). Overall, probands with EOAF were more likely to have a first-degree relative with AF compared with patients with non-EOAF (adjusted OR, 3.02; 95\% CI, 1.82-4.95; P\,\&lt;\,.001) across the 3 racial and ethnic groups. Atrial fibrillation in a first-degree family member was confirmed in 32\% of probands with EOAF vs 11\% of those with non-EOAF (difference, 21\%; 95\% CI, 11\%-33\%; P\,\&lt;\,.001). Furthermore, African American (28\% vs 5\%; difference, 23\%; 95\% CI, 4\%-43\%; P\,=\,.001), European American (35\% vs 20\%; difference, 15\%; 95\% CI, 1\%-30\%; P\,=\,.03), and Hispanic/Latino (30\% vs 5\%; difference, 25\%; 95\% CI, 4\%-54\%; P\,=\,.02) probands with EOAF were more likely to have a first-degree relative with confirmed AF vs racially and ethnically matched control patients with non-EOAF. The positive and negative predictive values for a family history of confirmed AF were both 89\%.Probands of African or Hispanic/Latino descent with EOAF were more likely to have a first-degree relative with AF when compared with European American individuals. These findings support genetic predisposition to EOAF across all 3 races.},
  keywords = {âœ”ï¸},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Alzahrani et al_2018_Association Between Family History and Early-Onset Atrial Fibrillation Across.pdf;/Users/asshah4/projects/zotero/storage/D5I2PJ7A/2703137.html}
}

@article{Andrade2014,
  title = {The Clinical Profile and Pathophysiology of Atrial Fibrillation: Relationships among Clinical Features, Epidemiology, and Mechanisms.},
  author = {Andrade, Jason and Khairy, Paul and Dobrev, Dobromir and Nattel, Stanley},
  date = {2014-04-25},
  journaltitle = {Circulation research},
  volume = {114},
  number = {9},
  eprint = {24763464},
  eprinttype = {pmid},
  pages = {1453--68},
  issn = {1524-4571},
  doi = {10.1161/CIRCRESAHA.114.303211},
  abstract = {Atrial fibrillation (AF) is the most common arrhythmia (estimated lifetime risk, 22\%-26\%). The aim of this article is to review the clinical epidemiological features of AF and to relate them to underlying mechanisms. Long-established risk factors for AF include aging, male sex, hypertension, valve disease, left ventricular dysfunction, obesity, and alcohol consumption. Emerging risk factors include prehypertension, increased pulse pressure, obstructive sleep apnea, high-level physical training, diastolic dysfunction, predisposing gene variants, hypertrophic cardiomyopathy, and congenital heart disease. Potential risk factors are coronary artery disease, kidney disease, systemic inflammation, pericardial fat, and tobacco use. AF has substantial population health consequences, including impaired quality of life, increased hospitalization rates, stroke occurrence, and increased medical costs. The pathophysiology of AF centers around 4 general types of disturbances that promote ectopic firing and reentrant mechanisms, and include the following: (1) ion channel dysfunction, (2) Ca(2+)-handling abnormalities, (3) structural remodeling, and (4) autonomic neural dysregulation. Aging, hypertension, valve disease, heart failure, myocardial infarction, obesity, smoking, diabetes mellitus, thyroid dysfunction, and endurance exercise training all cause structural remodeling. Heart failure and prior atrial infarction also cause Ca(2+)-handling abnormalities that lead to focal ectopic firing via delayed afterdepolarizations/triggered activity. Neural dysregulation is central to atrial arrhythmogenesis associated with endurance exercise training and occlusive coronary artery disease. Monogenic causes of AF typically promote the arrhythmia via ion channel dysfunction, but the mechanisms of the more common polygenic risk factors are still poorly understood and under intense investigation. Better recognition of the clinical epidemiology of AF, as well as an improved appreciation of the underlying mechanisms, is needed to develop improved methods for AF prevention and management.},
  keywords = {ðŸ”´}
}

@article{Andrade2023,
  title = {Progression of {{Atrial Fibrillation}} after {{Cryoablation}} or {{Drug Therapy}}},
  author = {Andrade, Jason G. and Deyell, Marc W. and Macle, Laurent and Wells, George A. and Bennett, Matthew and Essebag, Vidal and Champagne, Jean and Roux, Jean-Francois and Yung, Derek and Skanes, Allan and Khaykin, Yaariv and Morillo, Carlos and Jolly, Umjeet and Novak, Paul and Lockwood, Evan and Amit, Guy and Angaran, Paul and Sapp, John and Wardell, Stephan and Lauck, Sandra and Cadrin-Tourigny, Julia and KochhÃ¤user, Simon and Verma, Atul},
  date = {2023-01-12},
  journaltitle = {New England Journal of Medicine},
  volume = {388},
  number = {2},
  pages = {105--116},
  publisher = {{Massachusetts Medical Society}},
  issn = {0028-4793},
  doi = {10.1056/NEJMoa2212540},
  url = {https://doi.org/10.1056/NEJMoa2212540},
  urldate = {2023-06-11},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Andrade et al_2023_Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.pdf}
}

@article{Armour1999,
  title = {Myocardial Ischaemia and the Cardiac Nervous System.},
  author = {Armour, J Andrew},
  date = {1999-12},
  journaltitle = {European heart journal},
  volume = {16},
  number = {12},
  eprint = {8681998},
  eprinttype = {pmid},
  pages = {1751--2},
  issn = {0195-668X},
  url = {https://academic.oup.com/cardiovascres/article-abstract/41/1/41/317013},
  urldate = {2018-09-27},
  abstract = {The intrinsic cardiac nervous system has been classically considered to contain only parasympathetic efferent postganglionic neurones which receive inputs from medullary parasympathetic efferent preganglionic neurones. In such a view, intrinsic cardiac ganglia act as simple relay stations of parasympathetic efferent neuronal input to the heart, the major autonomic control of the heart purported to reside solely in the brainstem and spinal cord. Data collected over the past two decades indicate that processing occurs within the mammalian intrinsic cardiac nervous system which involves afferent neurones, local circuit neurones (interconnecting neurones) as well as both sympathetic and parasympathetic efferent postganglionic neurones. As such, intrinsic cardiac ganglionic interactions represent the organ component of the hierarchy of intrathoracic nested feedback control loops which provide rapid and appropriate reflex coordination of efferent autonomic neuronal outflow to the heart. In such a concept, the intrinsic cardiac nervous system acts as a distributive processor, integrating parasympathetic and sympathetic efferent centrifugal information to the heart in addition to centripetal information arising from cardiac sensory neurites. A number of neurochemicals have been shown to influence the interneuronal interactions which occur within the intrathoracic cardiac nervous system. For instance, pharmacological interventions that modify b-adrenergic or angiotensin II receptors affect cardiomyocyte function not only directly, but indirectly by influencing the capacity of intrathoracic neurones to regulate cardiomyocytes. Thus, current pharmacological management of heart disease may influence cardiomyocyte function directly as well as indirectly secondary to modifying the cardiac nervous system. This review presents a brief summary of developing concepts about the role of the cardiac nervous system in regulating the normal heart. In addition, it provides some tentative ideas concerning the importance of this nervous system in cardiac disease states with a view to stimulating further interest in neural control of the heart so that appropriate neurocardiological strategies can be devised for the management of heart disease.},
  keywords = {ðŸ”´,dorsal root ganglion afferent,intrinsic cardiac nervous system,local circuit neurone,myocardial ischemia,neurone,nodose ganglion afferent,parasympathetic efferent neurone,sympathetic efferent neurone},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Armour_1999_Myocardial ischaemia and the cardiac nervous system.pdf}
}

@article{Asbun2006,
  title = {The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy},
  author = {Asbun, Juan and Villarreal, Francisco J.},
  date = {2006-02-21},
  journaltitle = {Journal of the American College of Cardiology},
  volume = {47},
  number = {4},
  pages = {693--700},
  publisher = {{Journal of the American College of Cardiology}},
  issn = {07351097},
  doi = {10.1016/j.jacc.2005.09.050},
  abstract = {Diabetes has emerged as a major threat to worldwide health. The increasing incidence of diabetes in young individuals is particularly worrisome given that the disease is likely to evolve over a period of years. In 1972, the existence of a diabetic cardiomyopathy was proposed based on the experience with four adult diabetic patients who suffered from congestive heart failure in the absence of discernible coronary artery disease, valvular or congenital heart disease, hypertension, or alcoholism. The exact mechanisms underlying the disease are unknown; however, an important component of the pathological alterations observed in these hearts includes the accumulation of extracellular matrix (ECM) proteins, in particular collagens. The excess deposition of ECM in the heart mirrors what occurs in other organs such as the kidney and peritoneum of diabetics. Mechanisms responsible for these alterations may include the excess production, reduced degradation, and/or chemical modification of ECM proteins. These effects may be the result of direct or indirect actions of high glucose concentrations. This article reviews our state of knowledge on the effects that diabetes-like conditions exert on the cells responsible for ECM production as well as relevant experimental and clinical data. Â© 2006 by the American College of Cardiology Foundation.},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Asbun_Villarreal_2006_The pathogenesis of myocardial fibrosis in the setting of diabetic.pdf}
}

@article{Bauer2006c,
  title = {Deceleration Capacity of Heart Rate as a Predictor of Mortality after Myocardial Infarction: Cohort Study},
  author = {Bauer, Axel and Kantelhardt, Jan W. and Barthel, Petra and Schneider, Raphael and MÃ¤kikallio, Timo and Ulm, Kurt and Hnatkova, Katerina and SchÃ¶mig, Albert and Huikuri, Heikki and Bunde, Armin and Malik, Marek and Schmidt, Georg},
  date = {2006-05-20},
  journaltitle = {Lancet},
  volume = {367},
  number = {9523},
  pages = {1674--1681},
  issn = {01406736},
  doi = {10.1016/S0140-6736(06)68735-7},
  abstract = {Background: Decreased vagal activity after myocardial infarction results in reduced heart-rate variability and increased risk of death. To distinguish between vagal and sympathetic factors that affect heart-rate variability, we used a signal-processing algorithm to separately characterise deceleration and acceleration of heart rate. We postulated that diminished deceleration-related modulation of heart rate is an important prognostic marker. Our prospective hypotheses were that deceleration capacity is a better predictor of risk than left-ventricular ejection fraction (LVEF) and standard deviation of normal-to-normal intervals (SDNN). Methods: We quantified heart rate deceleration capacity by assessing 24-h Holter recordings from a post-infarction cohort in Munich (n=1455). We blindly validated the prognostic power of deceleration capacity in post-infarction populations in London, UK (n=656), and Oulu, Finland (n=600). We tested our hypotheses by assessment of the area under the receiver-operator characteristics curve (AUC). Findings: During a median follow-up of 24 months, 70 people died in the Munich cohort and 66 in the London cohort. The Oulu cohort was followed-up for 38 months and 77 people died. In the London cohort, mean AUC of deceleration capacity was 0Â·80 (SD 0Â·03) compared with 0Â·67 (0Â·04) for LVEF and 0Â·69 (0Â·04) for SDNN. In the Oulu cohort, mean AUC of deceleration capacity was 0Â·74 (0Â·03) compared with 0Â·60 (0Â·04) for LVEF and 0Â·64 (0Â·03) for SDNN (p{$<$}0Â·0001 for all comparisons). Stratification by dichotomised deceleration capacity was especially powerful in patients with preserved LVEF (p{$<$}0Â·0001 in all cohorts). Interpretation: Impaired heart rate deceleration capacity is a powerful predictor of mortality after myocardial infarction and is more accurate than LVEF and the conventional measures of heart-rate variability. Â© 2006 Elsevier Ltd. All rights reserved.},
  keywords = {ðŸ”´}
}

@article{Bazan2013,
  title = {Obstructive Sleep Apnea in Patients with Typical Atrial Flutter: Prevalence and Impact on Arrhythmia Control Outcome},
  shorttitle = {Obstructive Sleep Apnea in Patients with Typical Atrial Flutter},
  author = {Bazan, Victor and Grau, Nuria and Valles, Ermengol and Felez, Miquel and Sanjuas, Carles and Cainzos-Achirica, Miguel and Benito, BegoÃ±a and Jauregui-Abularach, Miguel and Gea, Joaquim and Bruguera-Cortada, Jordi and Marti-Almor, Julio},
  date = {2013-05},
  journaltitle = {Chest},
  shortjournal = {Chest},
  volume = {143},
  number = {5},
  eprint = {23117936},
  eprinttype = {pmid},
  pages = {1277--1283},
  issn = {1931-3543},
  doi = {10.1378/chest.12-0697},
  abstract = {BACKGROUND: The clinical yield of cavotricuspid isthmus (CTI) radiofrequency ablation of atrial flutter (AF) is limited by a high incidence of atrial fibrillation (AFib) in the long term. Among other acknowledged variables, the association of obstructive sleep apnea (OSA) could favor incomplete arrhythmia control in this setting. We assessed the impact of CPAP in reducing the occurrence of AFib after CTI ablation. METHODS: Consecutive patients with AF who were undergoing CTI ablation were screened for OSA. Relationship of the following variables with the occurrence of AFib during follow-up (12 months) was investigated: CPAP initiation, hypertension, BMI, underlying structural heart disease, left atrial diameter, and AFib documentation prior to ablation. RESULTS: We prospectively included 56 patients (mean age: 66 (Â± 11) years; 12 female patients), of whom 46 (82\%) had OSA and 25 (45\%) had severe OSA. Twenty-one patients (38\%) had AFib during follow-up after CTI ablation. Both freedom from AFib prior to ablation and CPAP initiation in those patients without previously documented AFib at inclusion were associated with a reduction of AFib episodes during follow-up (P = .019 and P = .025, respectively). Inversely, CPAP was not protective from AFib recurrence when this arrhythmia was documented prior to ablation (P = .25). CONCLUSIONS: OSA is a prevalent condition in patients with AF. Treatment with CPAP is associated with a lower incidence of newly diagnosed AFib after CTI ablation. Screening for OSA in patients with AF appears to be a reasonable clinical strategy.},
  langid = {english},
  keywords = {ðŸ”´,Aged,Atrial Fibrillation,Atrial Flutter,Body Mass Index,Catheter Ablation,Continuous Positive Airway Pressure,Female,Follow-Up Studies,Humans,Hypertension,Incidence,Logistic Models,Male,Middle Aged,Multivariate Analysis,Prevalence,Prospective Studies,{Sleep Apnea, Obstructive},Treatment Outcome}
}

@article{Beck1988,
  title = {Psychometric Properties of the {{Beck Depression Inventory}}: {{Twenty-five}} Years of Evaluation},
  author = {Beck, Aaron T. and Steer, Robert A. and Carbin, Margery G.},
  date = {1988-01-01},
  journaltitle = {Clinical Psychology Review},
  volume = {8},
  number = {1},
  eprint = {19042030},
  eprinttype = {pmid},
  pages = {77--100},
  publisher = {{Pergamon}},
  issn = {02727358},
  doi = {10.1016/0272-7358(88)90050-5},
  url = {https://www.sciencedirect.com/science/article/pii/0272735888900505?via%3Dihub},
  urldate = {2018-05-19},
  abstract = {Research studies focusing on the psychometric properties of the Beck Depression Inventory (BDI) with psychiatric and nonpsychiatric samples were reviewed for the years 1961 through June, 1986. A meta-analysis of the BDI's internal consistency estimates yielded a mean coefficient alpha of 0.86 for psychiatric patients and 0.81 for nonpsychiatric subjects. The concurrent validitus of the BDI with respect to clinical ratings and the Hamilton Psychiatric Rating Scale for Depression (HRSD) were also high. The mean correlations of the BDI samples with clinical ratings and the HRSD were 0. 72 and 0.73, respectively, for psychiatric patients. With nonpsychiatric subjects, the mean correlations of the BDI with clinical ratings and the HRSD were 0.60 and 0.74, respectively. Recent evidence indicates that the BDI discriminates subtypes of depression and differentiates depression from anxiety. Â© 1988.},
  isbn = {0272-7358},
  keywords = {ðŸ”´}
}

@article{Benjamin2018c,
  title = {Heart Disease and Stroke Statistics - 2018 Update: {{A}} Report from the {{American Heart Association}}},
  author = {Benjamin, Emelia J. and Virani, Salim S. and Callaway, Clifton W. and Chamberlain, Alanna M. and Chang, Alexander R. and Cheng, Susan and Chiuve, Stephanie E. and Cushman, Mary and Delling, Francesca N. and Deo, Rajat and De Ferranti, Sarah D. and Ferguson, Jane F. and Fornage, Myriam and Gillespie, Cathleen and Isasi, Carmen R. and JimÃ©nez, Monik C. and Jordan, Lori Chaffin and Judd, Suzanne E. and Lackland, Daniel and Lichtman, Judith H. and Lisabeth, Lynda and Liu, Simin and Longenecker, Chris T. and Lutsey, Pamela L. and MacKey, Jason S. and Matchar, David B. and Matsushita, Kunihiro and Mussolino, Michael E. and Nasir, Khurram and O'Flaherty, Martin and Palaniappan, Latha P. and Pandey, Ambarish and Pandey, Dilip K. and Reeves, Mathew J. and Ritchey, Matthew D. and Rodriguez, Carlos J. and Roth, Gregory A. and Rosamond, Wayne D. and Sampson, Uchechukwu K.A. and Satou, Gary M. and Shah, Svati H. and Spartano, Nicole L. and Tirschwell, David L. and Tsao, Connie W. and Voeks, Jenifer H. and Willey, Joshua Z. and Wilkins, John T. and Wu, Jason H.Y. and Alger, Heather M. and Wong, Sally S. and Muntner, Paul},
  date = {2018-03-01},
  journaltitle = {Circulation},
  volume = {137},
  number = {12},
  eprint = {29386200},
  eprinttype = {pmid},
  pages = {E67-E492},
  publisher = {{Lippincott Williams and Wilkins}},
  issn = {15244539},
  doi = {10.1161/CIR.0000000000000558},
  abstract = {Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together in a single document the most up-to-date statistics related to heart disease, stroke, and the cardiovascular risk factors listed in the AHA's My Life Check - Life's Simple 7 (Figure 1 ), which include core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure [BP], and glucose control) that contribute to cardiovascular health. The Statistical Update represents a critical resource for the lay public, policy makers, media professionals, clinicians, healthcare administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions. Cardiovascular disease (CVD) and stroke produce immense health and economic burdens in the United States and globally. The Update also presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease [CHD], heart failure [HF], valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs). Since 2007, the annual versions of the Statistical Update have been cited {$>$}20 000 times in the literature. From January to July 2017 alone, the 2017 Statistical Update was accessed {$>$}106 500 times. Each annual version of the Statistical Update undergoes revisions to include the newest nationally representative data, add additional relevant published scientific findings, remove older information, add new sections or chapters, and increase the number of ways to access and use the assembled information. This year-long process, which begins as soon as the previous Statistical Update is published, is performed by the AHA Statistics Committee faculty volunteers and staff and government agency partners. This year's edition includes new data on the monitoring and benefits of cardiovascular health in the population, new metrics to assess and monitor healthy diets, new information on stroke in young adults, an enhanced focus on underserved and minority populations, a substantively expanded focus on the global burden of CVD, and further evidence-based approaches to changing behaviors, implementation strategies, and implications of the AHA's 2020 Impact Goals. Below are a few highlights from this year's Update.},
  keywords = {ðŸ”´,AHA scientific statements,Cardiovascular diseases,Epidemiology,Risk factors,Statistics,Stroke}
}

@article{Benjamin2023,
  title = {Transforming {{Atrial Fibrillation Research}} to {{Integrate Social Determinants}} of {{Health}}: {{A National Heart}}, {{Lung}}, and {{Blood Institute Workshop Report}}},
  shorttitle = {Transforming {{Atrial Fibrillation Research}} to {{Integrate Social Determinants}} of {{Health}}},
  author = {Benjamin, Emelia J. and Thomas, Kevin L. and Go, Alan S. and Desvigne-Nickens, Patrice and Albert, Christine M. and Alonso, Alvaro and Chamberlain, Alanna M. and Essien, Utibe R. and Hernandez, Inmaculada and Hills, Mellanie True and Kershaw, Kiarri N. and Levy, Phillip D. and Magnani, Jared W. and Matlock, Daniel D. and Oâ€™Brien, Emily C. and Rodriguez, Carlos J. and Russo, Andrea M. and Soliman, Elsayed Z. and Cooper, Lawton S. and Al-Khatib, Sana M.},
  date = {2023-02-01},
  journaltitle = {JAMA Cardiology},
  shortjournal = {JAMA Cardiology},
  volume = {8},
  number = {2},
  pages = {182--191},
  issn = {2380-6583},
  doi = {10.1001/jamacardio.2022.4091},
  url = {https://doi.org/10.1001/jamacardio.2022.4091},
  urldate = {2023-11-20},
  abstract = {Only modest attention has been paid to the contributions of social determinants of health to atrial fibrillation (AF) risk factors, diagnosis, symptoms, management, and outcomes. The diagnosis of AF provides unique challenges exacerbated by the arrhythmiaâ€™s often paroxysmal nature and individualsâ€™ disparate access to health care and technologies that facilitate detection. Social determinants of health affect access to care and management decisions for AF, increasing the likelihood of adverse outcomes among individuals who experience systemic disadvantages. Developing effective approaches to address modifiable social determinants of health requires research to eliminate the substantive inequities in health care delivery and outcomes in AF.The National Heart, Lung, and Blood Institute convened an expert panel to identify major knowledge gaps and research opportunities in the field of social determinants of AF. The workshop addressed the following social determinants: (1) socioeconomic status and access to care; (2) health literacy; (3) race, ethnicity, and racism; (4) sex and gender; (5) shared decision-making in systemically disadvantaged populations; and (6) place, including rurality, neighborhood, and community. Many individuals with AF have multiple adverse social determinants, which may cluster in the individual and in systemically disadvantaged places (eg, rural locations, urban neighborhoods). Cumulative disadvantages may accumulate over the life course and contribute to inequities in the diagnosis, management, and outcomes in AF.Workshop participants identified multiple critical research questions and approaches to catalyze social determinants of health research that address the distinctive aspects of AF. The long-term aspiration of this work is to eradicate the substantive inequities in AF diagnosis, management, and outcomes across populations.},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/projects/zotero/storage/XXUWXQBN/2799379.html}
}

@article{Berkman2003,
  title = {Effects of {{Treating Depression}} and {{Low Perceived Social Support}} on {{Clinical Events}} after {{Myocardial Infarction}}: {{The Enhancing Recovery}} in {{Coronary Heart Disease Patients}} ({{ENRICHD}}) {{Randomized Trial}}},
  author = {Berkman, Lisa F. and Blumenthal, James and Burg, Matthew and Carney, Robert M. and Catellier, Diane and Cowan, Marie J. and Czajkowski, Susan M. and De Busk, Robert and Hosking, James and Jaffe, Allan and Kaufmann, Peter G. and Mitchell, Pamela and Norman, James and Powell, Lynda H. and Raczynski, James M. and Schneiderman, Neil and {Raczynski}},
  date = {2003-06-18},
  journaltitle = {Journal of the American Medical Association},
  volume = {289},
  number = {23},
  pages = {3106--3116},
  publisher = {{American Medical Association}},
  issn = {00987484},
  doi = {10.1001/jama.289.23.3106},
  abstract = {Context: Depression and low perceived social support (LPSS) after myocardial infarction (MI) are associated with higher morbidity and mortality, but little is known about whether this excess risk can be reduced through treatment. Objective: To determine whether mortality and recurrent infarction are reduced by treatment of depression and LPSS with cognitive behavior therapy (CBT), supplemented with a selective serotonin reuptake inhibitor (SSRI) antidepressant when indicated, in patients enrolled within 28 days after MI. Design, Setting, and Patients: Randomized clinical trial conducted from October 1996 to April 2001 in 2481 MI patients (1084 women, 1397 men) enrolled from 8 clinical centers. Major or minor depression was diagnosed by modified Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria and severity by the 17-item Hamilton Rating Scale for Depression (HRSD); LPSS was determined by the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Social Support Instrument (ESSI). Random allocation was to usual medical care or CBT-based psychosocial intervention. Intervention: Cognitive behavior therapy was initiated at a median of 17 days after the index MI for a median of 11 individual sessions throughout 6 months, plus group therapy when feasible, with SSRIs for patients scoring higher than 24 on the HRSD or having a less than 50\% reduction in Beck Depression Inventory scores after 5 weeks. Main Outcome Measures: Composite primary end point of death or recurrent MI; secondary outcomes included change in HRSD (for depression) or ESSI scores (for LPSS) at 6 months. Results: Improvement in psychosocial outcomes at 6 months favored treatment: mean (SD) change in HRSD score, -10.1 (7.8) in the depression and psychosocial intervention group vs -8.4 (7.7) in the depression and usual care group (P{$<$}.001); mean (SD) change in ESSI score, 5.1 (5.9) in the LPSS and psychosocial intervention group vs 3.4 (6.0) in the LPSS and usual care group (P{$<$}.001). After an average follow-up of 29 months, there was no significant difference in event-free survival between usual care (75.9\%) and psychosocial intervention (75.8\%). There were also no differences in survival between the psychosocial intervention and usual care arms in any of the 3 psychosocial risk groups (depression, LPSS, and depression and LPSS patients). Conclusions: The intervention did not increase event-free survival. The intervention improved depression and social isolation, although the relative improvement in the psychosocial intervention group compared with the usual care group was less than expected due to substantial improvement in usual care patients.},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Berkman et al_2003_Effects of Treating Depression and Low Perceived Social Support on Clinical.pdf}
}

@article{Bigger1992,
  title = {Frequency Domain Measures of Heart Period Variability and Mortality after Myocardial Infarction},
  author = {Bigger, J. T. and Fleiss, J. L. and Steinman, R. C. and Rolnitzky, L. M. and Kleiger, R. E. and Rottman, J. N.},
  date = {1992-01},
  journaltitle = {Circulation},
  volume = {85},
  number = {1},
  eprint = {1728446},
  eprinttype = {pmid},
  pages = {164--171},
  issn = {00097322},
  doi = {10.1161/01.CIR.85.1.164},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/1728446},
  urldate = {2018-11-23},
  abstract = {BACKGROUND We studied 715 patients 2 weeks after myocardial infarction to establish the associations between six frequency domain measures of heart period variability (HPV) and mortality during 4 years of follow-up. METHODS AND RESULTS Each measure of HPV had a significant and at least moderately strong univariate association with all-cause mortality, cardiac death, and arrhythmic death. Power in the lower-frequency bands--ultra low frequency (ULF) and very low frequency (VLF) power--had stronger associations with all three mortality end points than power in the higher-frequency bands--low frequency (LF) and high frequency (HF) power. The 24-hour total power also had a significant and strong association with all three mortality end points. VLF power was the only variable that was more strongly associated with arrhythmic death than with cardiac death or all-cause mortality. In multivariate Cox regression models using a step-up approach to evaluate the independent associations between frequency domain measures of heart period variability and death of all causes, ULF power was selected first (i.e., was the single component with the strongest association). Adding VLF or LF power to the Cox regression model significantly improved the prediction of outcome. With both ULF and VLF power in the Cox regression model, the addition of the other two components, LF and HF power, singly or together, did not significantly improve the prediction of all-cause mortality. We explored the relation between the heart period variability measures and all-cause mortality, cardiac death, and arrhythmic death before and after adjusting for five previously established postinfarction risk predictors: age, New York Heart Association functional class, rales in the coronary care unit, left ventricular ejection fraction, and ventricular arrhythmias detected in a 24-hour Holter ECG recording. CONCLUSIONS After adjustment for the five risk predictors, the association between mortality and total, ULF, and VLF power remained significant and strong, whereas LF and HF power were only moderately strongly associated with mortality. The tendency for VLF power to be more strongly associated with arrhythmic death than with all-cause or cardiac death was still evident after adjusting for the five covariates. Adding measures of HPV to previously known predictors of risk after myocardial infarction identifies small subgroups with a 2.5-year mortality risk of approximately 50\%.},
  isbn = {0735-1097},
  keywords = {ðŸ”´,Electrocardiography,{Nervous system, autonomic},Vagus nerves},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Bigger et al_1992_Frequency domain measures of heart period variability and mortality after.pdf}
}

@article{Blase2010,
  title = {Efficacy of {{HRV-biofeedback}} as Additional Treatment of Depression and {{PTSD}}.},
  author = {Blase, K L and family=Dijke, given=A, prefix=van, useprefix=true and Cluitmans, P J M and Vermetten, E},
  date = {2010},
  journaltitle = {The American Journal of Psychiatriy},
  volume = {58},
  number = {4},
  eprint = {27075221},
  eprinttype = {pmid},
  pages = {292--300},
  issn = {0303-7339},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/27075221},
  urldate = {2018-10-29},
  abstract = {BACKGROUND Heartrate variability biofeedback (HRVB) is a non-invasive treatment in which patients are assumed to self-regulate a physiological dysregulated vagal nerve. Although the therapeutic approach of HRVB is promising in various stress-related disorders, it has only been offered on a regular basis in a few mental health treatment settings. AIM To analyse the efficacy of HRV biofeedback as an additional psychophysiological treatment for depression and PTSD. METHOD Systematic review with search terms HRV, biofeedback, PTSD, depression, panic disorder and anxiety disorder. RESULTS Our search of the literature yielded 789 studies. After critical appraisal using the GRADE method, we selected 6 randomised controlled trials (RCTs) and 4 relevant studies. The RCTs with control groups 'treatment as usual' and muscle relaxation training revealed significant clinical efficacy and better results than codntrol conditions after 4 to 8 weeks training. CONCLUSION Although this systematic review shows the popularity of HRV in literature, it does not indicate that HRVB really has been reviewed systematically. Significant outcomes of this limited number of randomised studies indicate there may be a clinical improvement when HRVB training is integrated into treatment of PTSD and depression, particularly when this integration procedure is combined with psychotherapy. More research needs to be done with larger groups and further efforts are needed to integrate HRVB into treatment of stress-related disorders in psychiatry. Future research also needs to focus on the psychophysiological mechanisms involved.},
  isbn = {0303-7339},
  keywords = {ðŸ”´}
}

@article{Borzecki2008,
  title = {Racial Differences in the Prevalence of Atrial Fibrillation among Males.},
  author = {Borzecki, Ann M and Bridgers, D Keith and Liebschutz, Jane M and Kader, Boris and Kazis, Lewis E and Berlowitz, Dan R},
  date = {2008-02},
  journaltitle = {Journal of the National Medical Association},
  volume = {100},
  number = {2},
  eprint = {18300541},
  eprinttype = {pmid},
  pages = {237--45},
  issn = {0027-9684},
  doi = {10.1016/s0027-9684(15)31212-8},
  abstract = {BACKGROUND Despite being the most common cardiac arrhythmia, little is known about racial differences in atrial fibrillation (AF) prevalence and whether differences persist after accounting for known risk factors. METHODS We identified male respondents to the 1999 Large Health Survey of Veteran Enrollees who had an AF diagnosis in the VA administrative database during the preceding two years. RESULTS Of 664,754 male respondents, 5.3\% had AF. By race, age-adjusted prevalence was 5.7\% in whites, 3.4\% in blacks, 3.0\% in Hispanics, 5.4\% in native Americans/Alaskans, 3.6\% in Asians and 5.2\% in Pacific Islanders (p{$<$}0.001). Of predisposing conditions, whites were more likely to have valvular heart disease, coronary artery disease and congestive heart failure, blacks had the highest hypertension prevalence; Hispanics had the highest diabetes prevalence. Racial differences remained after adjustment for age, body mass index and these comorbidities. White males were significantly more likely to have AF compared to all races but Pacific Islanders [versus blacks, OR=1.84 (95\% CI: 1.71-1.98); versus Hispanics, OR=1.77 (1.60-1.97); vs Native Americans, OR 1.15 [1.04-1.27]; versus Asians, OR=1.41 (1.12-1.77) versus Pacific Islanders, OR=1.16 (0.88-1.53)]. CONCLUSIONS AF prevalence varies by race. White males have the highest AF burden even after adjustment for known risk factors. Recognition of the high AF prevalence, especially among whites, as well as native Americans and Pacific Islanders, should help guide provider practices for screening among older male patients. Further research is necessary to verify and establish reasons for these racial differences.},
  keywords = {ðŸ”´}
}

@article{Boscarino2008,
  title = {A Prospective Study of Ptsd and Early-Age Heart Disease Mortality among Vietnam Veterans: {{Implications}} for Surveillance and Prevention},
  author = {Boscarino, Joseph A},
  date = {2008-07},
  journaltitle = {Psychosomatic Medicine},
  volume = {70},
  number = {6},
  eprint = {18596248},
  eprinttype = {pmid},
  pages = {668--676},
  issn = {00333174},
  doi = {10.1097/PSY.0b013e31817bccaf},
  url = {https://insights.ovid.com/crossref?an=00006842-200807000-00007},
  urldate = {2018-10-27},
  abstract = {OBJECTIVE: To examine prospectively early-age heart disease (HD) among a national random sample of 4328 male Vietnam veterans, who did not have HD at baseline in 1985. Studies have suggested that posttraumatic stress disorder (PTSD) may result in cardiovascular disease. However, many past studies had important methodological limitations to their designs.\textbackslash n\textbackslash nMETHOD: Using Cox regressions, we assessed PTSD, age, race, intelligence, family history, obesity, smoking, alcohol abuse, antisocial personality, and depression in predicting HD mortality at follow-up in December 31, 2000. The men were {$<$}65 years old at follow-up.\textbackslash n\textbackslash nRESULTS: Using two PTSD measures, a Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition (DSM-III) measure (D-PTSD) and one developed by Keane (K-PTSD), we found that among Vietnam theater and era veterans combined (era veterans had no Vietnam service), having PTSD was associated with HD mortality for D-PTSD (hazard ratio (HR) = 2.25, p = .045) and approached significance for K-PTSD (HR = 2.16, p = .066). However, having higher PTSD symptoms on either scale was associated with mortality, with a 5-point increase associated with approximately 20\% increase in mortality risk (all p {$<$} .05). Controlling for lifetime depression only slightly altered the results. The effects for theater veterans alone were stronger (D-PTSD: HR = 2.58, p = .025; K-PTSD: HR = 2.73, p = .022). Among theater veterans, controlling for lifetime depression or combat exposure made little difference.\textbackslash n\textbackslash nCONCLUSION: PTSD was prospectively associated with HD mortality among veterans free of HD at baseline. This study suggests that early-age HD may be an outcome after military service among PTSD-positive veterans.},
  isbn = {1534-7796 (Electronic)\textbackslash r0033-3174 (Linking)},
  keywords = {ðŸ”´,Cardiovascular disease,Depression,Posttraumatic stress disorder,Survival analysis,Veterans}
}

@article{Bosch2009,
  title = {Preadolescents' Somatic and Cognitive-Affective Depressive Symptoms Are Differentially Related to Cardiac Autonomic Function and Cortisol: {{The TRAILS}} Study},
  author = {Bosch, Nienke M. and Riese, HarriÃ«tte and Dietrich, Andrea and Ormel, Johan and Verhulst, Frank C. and Oldehinkel, Albertine J.},
  date = {2009},
  journaltitle = {Psychosomatic Medicine},
  volume = {71},
  number = {9},
  eprint = {19834052},
  eprinttype = {pmid},
  pages = {944--950},
  issn = {00333174},
  doi = {10.1097/PSY.0b013e3181bc756b},
  abstract = {OBJECTIVE: To examine in a nonclinical sample of preadolescents the possibility that somatic and cognitive-affective depressive symptoms are differentially related with the autonomic nervous system (ANS) and the hypothalamic-pituitary-adrenal (HPA) axis. Depression is a well-known risk factor for cardiovascular disease and mortality. Dysregulation of the ANS and the HPA axis have been proposed as underlying mechanisms. Several studies suggest that only a subset of the depression symptoms account for associations with cardiovascular prognosis. METHODS: Self-reported somatic and cognitive-affective depressive symptoms were examined in relationship to heart rate variability (HRV), spontaneous baroreflex sensitivity (BRS), and the cortisol awakening response (CAR) in 2049 preadolescents (mean age = 11.1 years; 50.7\% = girls) from the Tracking Adolescents' Individual Lives Survey (TRAILS). RESULTS: Physiological measurements were not associated with the overall measure of depressive symptoms. Somatic depressive symptoms were negatively related to HRV and BRS, and positively to the CAR; cognitive-affective depressive symptoms were positively related to HRV and BRS, and negatively to the CAR. Associations with the CAR pertained to boys only. CONCLUSIONS: Somatic and cognitive-affective depressive symptoms differ in their association with both cardiac autonomic and HPA axis function in preadolescents. Particularly, somatic depression symptoms may mark cardiac risk.},
  isbn = {6060600980},
  keywords = {ðŸ”´,Autonomic function,Baroreflex,Children,Cortisol,Depressive symptoms,Heart rate},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Bosch et al_2009_Preadolescents' somatic and cognitive-affective depressive symptoms are.pdf}
}

@article{Bourla2018,
  title = {E-{{PTSD}}: An Overview on How New Technologies Can Improve Prediction and Assessment of {{Posttraumatic Stress Disorder}} ({{PTSD}})},
  author = {Bourla, Alexis and Mouchabac, Stephane and El Hage, Wissam and Ferreri, Florian},
  date = {2018-12-03},
  journaltitle = {European Journal of Psychotraumatology},
  volume = {9},
  eprint = {29441154},
  eprinttype = {pmid},
  pages = {1424448},
  issn = {2000-8198},
  doi = {10.1080/20008198.2018.1424448},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/29441154},
  urldate = {2018-12-20},
  abstract = {ABSTRACTBackground: New technologies may profoundly change our way of understanding psychiatric disorders including posttraumatic stress disorder (PTSD). Imaging and biomarkers, along with technological and medical informatics developments, might provide an answer regarding at-risk patientâ€™s identification. Recent advances in the concept of â€˜digital phenotypeâ€™, which refers to the capture of characteristics of a psychiatric disorder by computerized measurement tools, is one paradigmatic example.Objective: The impact of the new technologies on health professionals practice in PTSD care remains to be determined. The recent evolutions could disrupt the clinical practices and practitioners in their beliefs, ethics and representations, going as far as questioning their professional culture. In the present paper, we conducted an extensive search to highlight the articles which reflect the potential of these new technologies.Method: We conducted an overview by querying PubMed database with the terms [PTSD] [Post...},
  isbn = {2000-8066},
  issue = {sup1},
  keywords = {ðŸ”´,Artificial Intelligence,digital phenotype,Ecological Momentary Assessment,heart rate variability,new technologies,Posttraumatic stress disorder,virtual reality}
}

@article{Bun2015,
  title = {Atrial Flutter: More than Just One of a Kind},
  author = {Bun, Sok-Sithikun and Latcu, Decebal Gabriel and Marchlinski, Francis and Saoudi, Nadir},
  date = {2015-09-14},
  journaltitle = {European Heart Journal},
  volume = {36},
  number = {35},
  pages = {2356--2363},
  publisher = {{Eur Heart J}},
  issn = {0195-668X},
  doi = {10.1093/eurheartj/ehv118},
  url = {https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehv118},
  urldate = {2022-11-22},
  abstract = {Since its first description about one century ago, our understanding of atrial flutter (AFL) circuits has considerably evolved. One AFL circuit can have variable electrocardiographic (ECG) manifestations depending on the presence of pre-existing atrial lesions, or impaired atrial substrate. Conversely, different (right sided or even left sided) atrial circuits including different mechanisms (macroreentrant, microreentrant, or focal) can present with a very similar surface ECG manifestation. The development of efficient high-resolution electroanatomical mapping systems has improved our knowledge about AFL mechanisms, as well as facilitated their curative treatment with radiofrequency catheter ablation. This article will review ECG features for typical and atypical flutters, and emphasize the limitations for circuit location from the surface ECG.},
  keywords = {âœ”ï¸,Atypical atrial flutter,Cavotricuspid isthmus dependent,ECG,Typical atrial flutter},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Bun et al_2015_Atrial flutter.pdf}
}

@article{Burg2014,
  title = {Psychological {{Stress}} and {{Induced Ischemic Syndromes}}},
  author = {Burg, Matthew M. and Soufer, Robert},
  date = {2014-03-02},
  journaltitle = {Current Cardiovascular Risk Reports},
  shortjournal = {Curr Cardiovasc Risk Rep},
  volume = {8},
  number = {4},
  pages = {377},
  issn = {1932-9563},
  doi = {10.1007/s12170-014-0377-6},
  url = {https://doi.org/10.1007/s12170-014-0377-6},
  urldate = {2023-08-09},
  abstract = {Myocardial ischemia provoked by mental and emotional stress has been the focus of research for almost 40 years. In this paper, we briefly review the literature on this ischemic phenomenon, followed by a more focused review of research findings that have been disseminated over the past year. We use these reviews to highlight important issues concerning research methods, particularly the methods used to myocardial ischemia provoked by mental and emotional stress, along with outstanding questions that bear on clinical utility and integration.},
  langid = {english},
  keywords = {ðŸ”´,Mental stress,Myocardial ischemia},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Burg_Soufer_2014_Psychological Stress and Induced Ischemic Syndromes.pdf}
}

@article{Calkins2020,
  title = {Important {{Differences Exist Between Atrial Fibrillation}} and {{Atrial Flutter}} in {{Atrial Remodeling}}.},
  author = {Calkins, Hugh},
  date = {2020-07-28},
  journaltitle = {Journal of the American College of Cardiology},
  volume = {76},
  number = {4},
  eprint = {32703508},
  eprinttype = {pmid},
  pages = {389--390},
  issn = {1558-3597},
  doi = {10.1016/j.jacc.2020.06.004},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/32703508},
  urldate = {2022-11-22},
  keywords = {ðŸ”´,atrial fibrillation,catheter ablation,contact force,radiofrequency},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Calkins_2020_Important Differences Exist Between Atrial Fibrillation and Atrial Flutter in.pdf}
}

@incollection{Callans2004,
  title = {Ventricular Tachycardia and Psychiatric Depression in Patients with Coronary Artery Disease},
  booktitle = {The {{American Journal}} of {{Medicine}}},
  author = {Carney, Robert M. and Freedland, Kenneth E. and Rich, Michael W. and Smith, Laurie J. and Jaffe, Allan S.},
  date = {1993-07},
  volume = {95},
  number = {1},
  eprint = {8328494},
  eprinttype = {pmid},
  pages = {23--28},
  issn = {00029343},
  doi = {10.1016/0002-9343(93)90228-H},
  url = {https://linkinghub.elsevier.com/retrieve/pii/000293439390228H},
  urldate = {2022-02-21},
  abstract = {purpose: The purpose of this study was to examine the relationship between psychiatric depression and ventricular arrhythmias in patients with coronary artery disease (CAD). The hypothesis was that depressed patients with CAD would have a higher prevalence of ventricular tachycardia (VT) than nondepressed patients with CAD. patients and methods: One hundred three patients who were found to have significant CAD by elective diagnostic cardiac catheterization were administered a standardized psychiatric interview and underwent 24-hour Holter monitoring. results: Twenty-one patients (20\%) met the criteria for either major or minor depression. There were no significant differences between depressed and nondepressed patients with CAD in severity of CAD or in ventricular function. Five (23.8\%) of the depressed patients and three (3.7\%) of the nondepressed patients exhibited episodes of VT during 24 hours of Holter monitoring (p {$<$}0.008). This difference remained significant even after controlling for relevant covariates. conclusions: We conclude that there is a higher prevalence of VT among patients with CAD and depression than among those CAD patients without depression. This may help to explain the increased risk for cardiac mortality in depressed patients with CAD. Â© 1993.},
  isbn = {978-0-7216-0323-0},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney et al_1993_Ventricular tachycardia and psychiatric depression in patients with coronary.pdf}
}

@article{Camici2006c,
  title = {Cardiac {{Nociception}}},
  author = {Camici, Paolo G and Pagani, Massimo},
  date = {2006-11-28},
  journaltitle = {Circulation},
  volume = {114},
  number = {22},
  pages = {2309--2312},
  issn = {0009-7322},
  doi = {10.1161/CIRCULATIONAHA.106.665042},
  url = {http://www.circulationaha.org},
  urldate = {2020-01-20},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Camici_Pagani_2006_Cardiac Nociception.pdf}
}

@article{Camm1996,
  title = {Epidemiology and {{Mechanism}} of {{Atrial Fibrillation}} and {{Atrial Flutter}}},
  author = {Camm, A.J and Obel, O.A},
  date = {1996-10},
  journaltitle = {The American Journal of Cardiology},
  volume = {78},
  number = {8},
  eprint = {8903269},
  eprinttype = {pmid},
  pages = {3--11},
  issn = {00029149},
  doi = {10.1016/S0002-9149(96)00559-0},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S0002914996005590},
  urldate = {2022-11-22},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Camm_Obel_1996_Epidemiology and Mechanism of Atrial Fibrillation and Atrial Flutter.pdf}
}

@report{Carney1988,
  title = {The Relationship between Heart Rate, Heart Rate Variability and Depression in Patients with Coronary Artery Disease},
  author = {Carney, Robert M. and Rich, Michael W. and TeVelde, Adriaantje and Saini, Jasbir and Clark, Karen and Freedland, Kenneth E.},
  date = {1988},
  journaltitle = {Journal of Psychosomatic Research},
  volume = {32},
  number = {2},
  eprint = {3404497},
  eprinttype = {pmid},
  pages = {159--164},
  issn = {00223999},
  doi = {10.1016/0022-3999(88)90050-5},
  url = {http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3404497},
  abstract = {Seventy-seven patients undergoing elective cardiac catheterization were administered a diagnostic psychiatric interview and their mean heart rates and heart rate variability were determined from the results of a 24 hr ambulatory ECG. The mean heart rate for depressed patients with coronary artery disease (CAD) was significantly higher than for nondepressed CAD patients, independent of the patient's age, smoking status, and beta blocker therapy. Heart rate variability was lower in depressed patients but did not achieve significance. With the exception of smoking, which was more common in depressed patients, there were no significant differences between the depressed and nondepressed patients on any other medical or demographic variable assessed. It is concluded that elevated heart rate may represent increased sympathetic tone in depressed CAD patients, and may help to explain the increased morbidity and mortality reported in these patients. Â© 1988.},
  isbn = {0022-3999},
  keywords = {*Arousal,*Heart Rate,ðŸ”´,Coronary Disease/*psychology,Depressive Disorder/*psychology,Electrocardiography,Female,Humans,Male,Middle Aged,Monitoring,Non-U.S. Gov't,P.H.S.,Physiologic,Prognosis,Research Support,Smoking/psychology,U.S. Gov't},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney et al_1988_The relationship between heart rate, heart rate variability and depression in.pdf}
}

@article{Carney1995,
  title = {Association of Depression with Reduced Heart Rate Variability in Coronary Artery Disease},
  author = {Carney, Robert M. and Saunders, Roger D. and Freedland, Kenneth E. and Stein, Phyllis and Rich, Michael W. and Jaffe, Allan S.},
  date = {1995},
  journaltitle = {The American Journal of Cardiology},
  volume = {76},
  number = {8},
  eprint = {7677077},
  eprinttype = {pmid},
  pages = {562--564},
  issn = {00029149},
  doi = {10.1016/S0002-9149(99)80155-6},
  abstract = {Decreased heart rate (HR) variability is an independent risk factor for mortality in cardiac populations. Clinical depression has also been associated with adverse outcomes in patients with coronary artery disease (CAD). This study tests the hypothesis that depressed patients with CAD have decreased HR variability compared with nondepressed CAD patients. Nineteen patients with angiographically documented CAD and either major or minor depression were compared with a sample of nondepressed CAD patients according to age, sex, and smoking status. All patients underwent 24-hour Holter monitoring, and the standard deviation of all normal-to-normal intervals was used as the primary index of HR variability. HR variability was significantly lower in depressed than nondepressed patients (90 Â± 35 vs 117 Â± 26 ms; p {$<$} 0.01), even after adjusting for relevant covariates. Thus, decreased HR variability may help explain the increased risk for cardiac mortality and morbidity in depressed CAD patients. Â© 1995.},
  isbn = {0002-9149},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney et al_1995_Association of depression with reduced heart rate variability in coronary.pdf}
}

@report{Carney2000,
  title = {Change in Heart Rate and Heart Rate Variability during Treatment for Depression in Patients with Coronary Heart Disease},
  author = {Carney, Robert M. and Freedland, Kenneth E. and Stein, Phyllis K. and Skala, Judith A. and Hoffman, Patricia and Jaffe, Allan S.},
  date = {2000},
  journaltitle = {Psychosomatic Medicine},
  volume = {62},
  number = {5},
  eprint = {11020093},
  eprinttype = {pmid},
  pages = {639--647},
  issn = {00333174},
  doi = {10.1097/00006842-200009000-00007},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/11020093},
  abstract = {OBJECTIVE Major depression is a common problem in patients with coronary heart disease (CHD) and is associated with an increased risk for cardiac morbidity and mortality. It is not known whether treating depression will improve medical prognosis in patients with CHD. Depression is also associated with elevated heart rate and reduced heart rate variability (HRV), which are known risk factors for cardiac morbidity and mortality that may explain the increased risk associated with depression. The purpose of this study was to determine whether treatment for depression with cognitive behavior therapy (CBT) is associated with decreased heart rate or increased HRV. METHODS Thirty depressed patients with stable CHD, classified as either mildly or moderately to severely depressed, received up to 16 sessions of CBT. The 24-hour heart rate and HRV were measured in these patients and in 22 medically comparable nondepressed controls before and after treatment of the depressed patients. RESULTS Average heart rate and daytime rMSSD (reflecting mostly parasympathetic activity) improved significantly in the severely depressed patients, but remained unchanged in the mildly depressed and the control patients. However, only rMSSD improved to a level comparable to the control patients. None of the remaining indices of HRV showed improvement. CONCLUSIONS The results suggest that treating depression with CBT may reduce heart rate and increase short-term HRV. Thus, CBT may have a beneficial effect on a risk factor for mortality in depressed patients with coronary heart disease. A randomized, controlled study is needed to confirm these findings.},
  isbn = {0033-3174},
  keywords = {ðŸ”´,Coronary heart disease,Depression,Heart rate variability},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney et al_2000_Change in heart rate and heart rate variability during treatment for depression.pdf}
}

@article{Carney2001a,
  title = {Depression, Heart Rate Variability, and Acute Myocardial Infarction},
  author = {Carney, Robert M. and Blumenthal, James A. and Stein, Phyllis K. and Watkins, Lana and Catellier, Diane and Berkman, Lisa F. and Czajkowski, Susan M. and O'Connor, Christopher and Stone, Peter H. and Freedland, Kenneth E.},
  date = {2001},
  journaltitle = {Circulation},
  volume = {104},
  number = {17},
  eprint = {11673340},
  eprinttype = {pmid},
  pages = {2024--2028},
  issn = {00097322},
  doi = {10.1161/hc4201.097834},
  url = {http://circ.ahajournals.org/content/104/17/2024},
  urldate = {2018-10-28},
  abstract = {BACKGROUND Clinical depression is associated with an increased risk for mortality in patients with a recent myocardial infarction (MI). Reduced heart rate variability (HRV) has been suggested as a possible explanation for this association. The purpose of this study was to determine if depression is associated with reduced HRV in patients with a recent MI. METHODS AND RESULTS Three hundred eighty acute MI patients with depression and 424 acute MI patients without depression were recruited. All underwent 24-hour ambulatory electrocardiographic monitoring after hospital discharge. In univariate analyses, 4 indices of HRV were significantly lower in patients with depression than in patients without depression. Variables associated with HRV were then compared between patients with and without depression, and potential confounds were identified. These variables (age, sex, diabetes, and present cigarette smoking) were entered into an analysis of covariance model, followed by depression status. In the final model, all but one HRV index (high-frequency power) remained significantly lower in patients with depression than in patients without depression. CONCLUSIONS We conclude that greater autonomic dysfunction, as reflected by decreased HRV, is a plausible mechanism linking depression to increased cardiac mortality in post-MI patients.},
  isbn = {0009-7322},
  keywords = {ðŸ”´,Depression,Heart rate variability,Myocardial infarction},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney et al_2001_Depression, heart rate variability, and acute myocardial infarction.pdf}
}

@inproceedings{Carney2002,
  title = {Depression as a Risk Factor for Cardiac Mortality and Morbidity: {{A}} Review of Potential Mechanisms},
  booktitle = {Journal of {{Psychosomatic Research}}},
  author = {Carney, Robert M. and Freedland, Kenneth E. and Miller, Gregory E. and Jaffe, Allan S.},
  date = {2002},
  volume = {53},
  number = {4},
  eprint = {12377300},
  eprinttype = {pmid},
  pages = {897--902},
  issn = {00223999},
  doi = {10.1016/S0022-3999(02)00311-2},
  abstract = {Depression increases the risk of cardiac mortality and morbidity in patients with coronary heart disease (CHD), but the mechanisms that underlie this association remain unclear. This review considers the evidence for several behavioral and physiological mechanisms that might explain how depression increases the risk for incident coronary disease and for subsequent cardiac morbidity and mortality. The candidate mechanisms include: (1) antidepressant cardiotoxicity; (2) association of depression with cardiac risk factor such as cigarette smoking, hypertension, diabetes, and reduced functional capacity; (3) association of depression with greater coronary disease severity; (4) nonadherence to cardiac prevention and treatment regimens; (5) lower heart rate variability (HRV) reflecting altered cardiac autonomic tone; (6) increased platelet aggregation; and (7) inflammatory processes. Despite recent advances in our understanding of these potential mechanisms, further research is needed to determine how depression increases risk for cardiac morbidity and mortality. Â© 2002 Elsevier Science Inc. All rights reserved.},
  isbn = {0022-3999 (Print)\textbackslash r0022-3999 (Linking)},
  keywords = {ðŸ”´,Coronary heart disease,Depression,Mechanisms},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney et al_2002_Depression as a risk factor for cardiac mortality and morbidity.pdf}
}

@article{Carney2003,
  title = {Effects of Depression on {{QT}} Interval Variability after Myocardial Infarction},
  author = {Carney, Robert M. and Freedland, Kenneth E. and Stein, Phyllis K. and Watkins, Lana L. and Catellier, Diane and Jaffe, Allan S. and Yeragani, Vikram K.},
  date = {2003},
  journaltitle = {Psychosomatic Medicine},
  volume = {65},
  number = {2},
  eprint = {12651984},
  eprinttype = {pmid},
  pages = {177--180},
  issn = {00333174},
  doi = {10.1097/01.PSY.0000033129.21715.4B},
  abstract = {OBJECTIVES: Clinical depression is a risk factor for cardiac mortality in patients with coronary heart disease. High QT interval variability is a risk factor for arrhythmic events, including sudden cardiac death. The purpose of this study was to determine whether depression is associated with increased QT variability in patients recovering from myocardial infarction. METHODS: Twenty patients with major depression recovering from a recent myocardial infarction were matched with 20 nondepressed post-myocardial infarction patients on age and sex, and all underwent 24-hour Holter monitoring. RESULTS: There were no differences between groups on average heart rate, heart rate variability, or other electrocardiographic measures. However, the QT interval showed significantly greater variability in the depressed than in the nondepressed group, especially at midnight and at 6:00 AM. CONCLUSIONS: Depressed post-myocardial infarction patients may be at greater risk for sudden cardiac death as a result of abnormalities in ventricular repolarization. More work is needed to determine the clinical and prognostic significance of QT variability in these patients.},
  isbn = {1534-7796 (Electronic)},
  keywords = {ðŸ”´,Myocardial infarction,Psychiatric depression,QT interval},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney et al_2003_Effects of depression on QT interval variability after myocardial infarction.pdf}
}

@article{Carney2005,
  title = {Depression, the Autonomic Nervous System, and Coronary Heart Disease},
  author = {Carney, Robert M. and Freedland, Kenneth E. and Veith, Richard C.},
  date = {2005-05},
  journaltitle = {Psychosomatic Medicine},
  volume = {67},
  eprint = {15953797},
  eprinttype = {pmid},
  pages = {S29-S33},
  issn = {00333174},
  doi = {10.1097/01.psy.0000162254.61556.d5},
  url = {https://insights.ovid.com/crossref?an=00006842-200505001-00008},
  urldate = {2018-05-19},
  abstract = {Depression is a risk factor for medical morbidity and mortality in patients with coronary heart disease (CHD). Dysregulation of the autonomic nervous system (ANS) may explain why depressed patients are at increased risk. Studies of medically well, depressed psychiatric patients have found elevated levels of plasma catecholamines and other markers of altered ANS function compared with controls. Studies of depressed patients with CHD have also uncovered evidence of ANS dysfunction, including elevated heart rate, low heart rate variability, exaggerated heart rate responses to physical stressors, high variability in ventricular repolarization, and low baroreceptor sensitivity. All of these indicators of ANS dysfunction have been associated with increased risks of mortality and cardiac morbidity in patients with CHD. Further research is needed to determine whether ANS dysfunction mediates the effects of depression on the course and outcome of CHD, and to develop clinical interventions that improve cardiovascular autonomic regulation while relieving depression in patients with CHD.},
  isbn = {1534-7796 (Electronic)\textbackslash r1534-7796 (Linking)},
  issue = {SUPPL. 1},
  keywords = {ðŸ”´,Autonomic nervous system,Coronary disease,Depression,Depressive disorder,Mortality,Myocardial infarction},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney et al_2005_Depression, the autonomic nervous system, and coronary heart disease.pdf}
}

@article{Carney2005a,
  title = {Low {{Heart Rate Variability}} and the {{Effect}} of {{Depression}} on {{Post}}â€“{{Myocardial Infarction Mortality}}},
  author = {Carney, Robert M. and Blumenthal, James A. and Freedland, Kenneth E. and Stein, Phyllis K. and Howells, William B. and Berkman, Lisa F. and Watkins, Lana L. and Czajkowski, Susan M. and Hayano, Junichiro and Domitrovich, Peter P. and Jaffe, Allan S.},
  date = {2005-07-11},
  journaltitle = {Archives of Internal Medicine},
  shortjournal = {Archives of Internal Medicine},
  volume = {165},
  number = {13},
  pages = {1486--1491},
  issn = {0003-9926},
  doi = {10.1001/archinte.165.13.1486},
  url = {https://doi.org/10.1001/archinte.165.13.1486},
  urldate = {2023-09-07},
  abstract = {Depression is associated with an increased risk for mortality after acute myocardial infarction (MI). The purpose of this study was to determine whether low heart rate variability (HRV) mediates the effect of depression on mortality.Twenty-fourâ€“hour ambulatory electrocardiograms were obtained from 311 depressed patients with a recent acute MI who were enrolled in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial and from 367 nondepressed patients who met the ENRICHD medical inclusion criteria. Standard HRV indexes were extracted from the recordings.The log of very low-frequency (LnVLF) power, an index of HRV derived from power spectral analysis of the electrocardiogram signal (0.0033-0.04 Hz [in milliseconds squared]), was lower in the depressed than in the nondepressed patients (P\&lt;.001). There were 47 deaths (6.1\%) during a 30-month follow-up. After adjusting for potential confounders, the depressed patients remained at higher risk for all-cause mortality compared with the nondepressed patients (hazard ratio, 2.8; 95\% confidence interval [CI], 1.4-5.4; P\&lt;.003). When LnVLF power was entered into the model, the hazard ratio for depression dropped to 2.1 (95\% CI, 1.1-4.2; P~=~.03). The proportion of the risk for depression attributable to LnVLF power was 0.27 (95\% CI, 0.23-0.31; P\&lt;.001).Low HRV partially mediates the effect of depression on survival after acute MI. This finding helps to clarify the physiological mechanisms underlying depressionâ€™s role as a risk factor for mortality in patients with coronary heart disease. It also raises the possibility that treatments that improve both depression and HRV might also improve survival in these patients.Arch Intern Med. 2005;165:1486-1491--{$>$}},
  keywords = {ðŸ”´,adult,aged,Ambulatory,article,Circadian Rhythm,clinical trial,comparative study,complications,confidence interval,controlled clinical trial,controlled study,death,depression,Depression,electrocardiography,Electrocardiography,epidemiology,female,Female,follow up,Follow-Up Studies,hazard assessment,heart infarction,Heart Rate,heart rate variability,human,Humans,ischemic heart disease,major clinical study,male,Male,Middle Aged,mortality,Myocardial Infarction,physiology,physiopathology,priority journal,Proportional Hazards Models,Retrospective Studies,risk assessment,risk factor,Risk Factors,Severity of Illness Index,survival,Survival Rate,United States},
  file = {/Users/asshah4/projects/zotero/storage/WD6AG7MX/486638.html}
}

@article{Carney2007,
  title = {Heart Rate Variability and Markers of Inflammation and Coagulation in Depressed Patients with Coronary Heart Disease},
  author = {Carney, Robert M. and Freedland, Kenneth E. and Stein, Phyllis K. and Miller, Gregory E. and Steinmeyer, Brian and Rich, Michael W. and Duntley, Stephen P.},
  date = {2007},
  journaltitle = {Journal of Psychosomatic Research},
  volume = {62},
  number = {4},
  eprint = {17383498},
  eprinttype = {pmid},
  pages = {463--467},
  issn = {17353688},
  doi = {10.1016/j.jpsychores.2006.12.004},
  abstract = {Background: Depression is associated with an increased risk for cardiac morbidity and mortality in patients with coronary heart disease (CHD). Cardiac autonomic nervous system (ANS) dysregulation, proinflammatory processes, and procoagulant processes have been suggested as possible explanations. Methods: Heart rate variability (HRV), an indicator of cardiac autonomic regulation, and markers of inflammation [C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-Î± (TNF-Î±)] and coagulation (fibrinogen) were assessed in 44 depressed patients with CHD. Results: Moderate, negative correlations were found between fibrinogen and four measures of HRV. IL-6 also negatively correlated with one measure of HRV (total power) and was marginally related to two others (very low frequency and low frequency power). Neither CRP nor TNF-Î± was significantly related to any measure of HRV. Conclusions: The finding that fibrinogen and IL-6 are moderately related to HRV suggests a link between these factors in depressed CHD patients. The relationship between ANS function and inflammatory and coagulant processes should be investigated in larger mechanistic studies of depression and cardiac morbidity and mortality. Â© 2007 Elsevier Inc. All rights reserved.},
  isbn = {3142861300},
  keywords = {ðŸ”´,Autonomic nervous system,Coagulation,Depression,Heart disease,Inflammation},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney et al_2007_Heart rate variability and markers of inflammation and coagulation in depressed.pdf}
}

@article{Carney2007a,
  title = {Heart Rate Turbulence, Depression, and Survival after Acute Myocardial Infarction},
  author = {Carney, Robert M. and Howells, William B. and Blumenthal, James A. and Freedland, Kenneth E. and Stein, Phyllis K. and Berkman, Lisa F. and Watkins, Lana L. and Czajkowski, Susan M. and Steinmeyer, Brian and Hayano, Junichiro and Domitrovich, Peter P. and Burg, Matthew M. and Jaffe, Allan S.},
  date = {2007},
  journaltitle = {Psychosomatic Medicine},
  volume = {69},
  number = {1},
  eprint = {17167127},
  eprinttype = {pmid},
  pages = {4--9},
  issn = {00333174},
  doi = {10.1097/01.psy.0000249733.33811.00},
  abstract = {OBJECTIVE Depression is a risk factor for mortality after acute myocardial infarction (AMI), possibly as a result of altered autonomic nervous system (ANS) modulation of heart rate (HR) and rhythm. The purposes of this study were to determine: a) whether depressed patients are more likely to have an abnormal HR response (i.e., abnormal turbulence) to premature ventricular contractions (VPCs), and b) whether abnormal HR turbulence accounts for the effect of depression on increased mortality after AMI. METHODS Ambulatory electrocardiographic data were obtained from 666 (316 depressed, 350 nondepressed) patients with a recent AMI; 498 had VPCs with measurable HR turbulence. Of these, 260 had normal, 152 had equivocal, and 86 had abnormal HR turbulence. Patients were followed for up to 30 (median = 24) months. RESULTS Depressed patients were more likely to have abnormal HR turbulence (risk factor adjusted odds ratio = 1.8; 95\% confidence interval [CI] = 1.0-3.0; p = .03) and have worse survival (odds ratio = 2.4; 95\% CI = 1.2-4.6; p = .02) than nondepressed patients. When HR turbulence was added to the model, the adjusted hazard ratio for depression decreased to 1.9 (95\% CI = 0.9-3.8; p = .08), and to 1.6 (95\% CI = 0.8-3.4; p = .18) when a measure of HR variability (LnVLF) was added. The hazard was found to differ over time with depression posing little risk for mortality in year 1 but greater risk in years 2 and 3 of the follow up. CONCLUSION ANS dysregulation may partially mediate the increased risk for mortality in depressed patients with frequent VPCs after an AMI.},
  isbn = {0033-3174},
  keywords = {ðŸ”´,Acute myocardial infarction,Depression,Heart rate turbulence,Survival},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney et al_2007_Heart rate turbulence, depression, and survival after acute myocardial.pdf}
}

@article{Carney2009a,
  title = {Depression and Heart Rate Variability in Patients with Coronary Heart Disease},
  author = {Carney, Robert M. and Freedland, Kenneth E.},
  date = {2009},
  journaltitle = {Cleveland Clinic Journal of Medicine},
  volume = {76},
  eprint = {19376975},
  eprinttype = {pmid},
  issn = {08911150},
  doi = {10.3949/ccjm.76.s2.03},
  abstract = {Depression is common in patients with coronary heart disease (CHD) and is a risk factor for cardiac morbidity and mortality in these patients. Depression is associated with autonomic nervous system dysfunction, which may at least partially explain this increased risk. Low heart rate variability (HRV), which reflects excessive sympathetic and/or inadequate parasympathetic modulation of heart rate, is a strong predictor of mortality in patients with CHD. Most studies-both in patients with stable CHD and in patients with a recent acute coronary event-have found HRV to be lower in depressed patients than in their nondepressed counterparts. This manuscript provides an overview of this literature and concludes that HRV may account for a substantial part of the risk associated with depression in CHD.},
  isbn = {3143627344},
  issue = {SUPPL.2},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney_Freedland_2009_Depression and heart rate variability in patients with coronary heart disease.pdf}
}

@article{Carney2017,
  title = {Depression and Coronary Heart Disease},
  author = {Carney, Robert M. and Freedland, Kenneth E.},
  date = {2017-03-17},
  journaltitle = {Nature Reviews Cardiology},
  volume = {14},
  number = {3},
  eprint = {20425245},
  eprinttype = {pmid},
  pages = {145--155},
  issn = {17595010},
  doi = {10.1038/nrcardio.2016.181},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/27853162},
  urldate = {2018-10-28},
  abstract = {Depression often coexists with coronary heart disease and increases the risk of poor cardiac prognosis. The physiopathology of depression resembles that of chronic, severe stress. Because little research has evaluated the impact of depression treatment on cardiac events, there is no currently recommended depression-specific treatment to reduce cardiac risk. Â© 2007 Copyright Â© 2007 Elsevier Inc. All rights reserved.},
  isbn = {9780123739476},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Carney_Freedland_2017_Depression and coronary heart disease.pdf}
}

@article{Carreno2017b,
  title = {Vagal {{Nerve Stimulation}} for {{Treatment-Resistant Depression}}},
  author = {Carreno, Flavia R. and Frazer, Alan},
  date = {2017-07-01},
  journaltitle = {Neurotherapeutics},
  volume = {14},
  number = {3},
  pages = {716--727},
  publisher = {{Springer New York LLC}},
  issn = {18787479},
  doi = {10.1007/s13311-017-0537-8},
  abstract = {Major depressive disorder (MDD) is prevalent. Although standards antidepressants are more effective than placebo, up to 35\% of patients do not respond to 4 or more conventional treatments and are considered to have treatment-resistant depression (TRD). Considerable effort has been devoted to trying to find effective treatments for TRD. This review focuses on vagus nerve stimulation (VNS), approved for TRD in 2005 by the Food and Drugs Administration. Stimulation is carried by bipolar electrodes on the left cervical vagus nerve, which are attached to an implanted stimulator generator. The vagus bundle contains about 80\% of afferent fibers terminating in the medulla, from which there are projections to many areas of brain, including the limbic forebrain. Various types of brain imaging studies reveal widespread functional effects in brain after either acute or chronic VNS. Although more randomized control trials of VNS need to be carried out before a definitive conclusion can be reached about its efficacy, the results of open studies, carried out over period of 1 to 2 years, show much more efficacy when compared with results from treatment as usual studies. There is an increase in clinical response to VNS between 3 and 12 months, which is quite different from that seen with standard antidepressant treatment of MDD. Preclinically, VNS affects many of the same brain areas, neurotransmitters (serotonin, norepinephrine) and signal transduction mechanisms (brain-derived neurotrophic factorâ€“tropomyosin receptor kinase B) as those found with traditional antidepressants. Nevertheless, the mechanisms by which VNS benefits patients nonresponsive to conventional antidepressants is unclear, with further research needed to clarify this.},
  keywords = {ðŸ”´,BDNF-TrkB,Monoamines,TRD,VNS}
}

@online{CentersforDiseaseControlandPrevention2018,
  title = {Underlying {{Cause}} of {{Death}}, 1999-2017 {{Results Form}}},
  author = {{Centers for Disease Control and Prevention}},
  date = {2018},
  url = {https://wonder.cdc.gov/controller/datarequest/D76;jsessionid=BDCCDF1C86BC2DCE59ACB4091FF6#Citation},
  urldate = {2022-06-09},
  abstract = {Underlying Cause of Death 1999-2017 on CDC WONDER Online Database, released December, 2018. Data are from the Multiple Cause of Death Files, 1999-2017, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program.},
  organization = {{December, 2018}},
  keywords = {ðŸ”´}
}

@article{Chalazan2021,
  title = {Association of {{Rare Genetic Variants}} and {{Early-Onset Atrial Fibrillation}} in {{Ethnic Minority Individuals}}},
  author = {Chalazan, Brandon and Mol, Denise and Darbar, Faisal A. and Ornelas-Loredo, Aylin and Al-Azzam, Bahaa and Chen, Yining and Tofovic, David and Sridhar, Arvind and Alzahrani, Zain and Ellinor, Patrick and Darbar, Dawood},
  date = {2021-07-01},
  journaltitle = {JAMA Cardiology},
  volume = {6},
  number = {7},
  eprint = {33950154},
  eprinttype = {pmid},
  pages = {811--819},
  publisher = {{American Medical Association}},
  issn = {23806591},
  doi = {10.1001/jamacardio.2021.0994},
  abstract = {Importance: Although rare variants in cardiac ion channels, transcription factors, and myocardial structural proteins are associated with early-onset atrial fibrillation (AF) in White individuals of European descent, it remains unclear whether genetic variation also contributes to the cause of AF in those of minority ethnicity. Objectives: To assess the prevalence of rare and novel pathogenic variants in candidate genes in ethnic minority probands with early-onset AF and determine genotype-phenotype associations. Design, Setting, and Participants: In this cohort, family-based study, probands of African and Hispanic descent with early-onset AF (defined as AF occurring in individuals aged â‰¤66 years) prospectively enrolled in a clinical and genetic biorepository underwent sequencing of 60 candidate genes. Recruitment took place from July 1, 2015, to June 30, 2019. Data were analyzed from February 1 to February 28, 2020. Exposures: Rare and novel variants categorized as pathogenic or likely pathogenic. Main Outcomes and Measures: The prevalence of rare and novel pathogenic variants in African American and Hispanic/Latinx probands with early-onset AF and genotype-phenotype associations. Results: Among 227 probands with early-onset AF, mean (SD) age at onset of AF was 51.0 (9.9) years, 132 probands (58.1\%) were men, 148 (65.2\%) were African American, and 79 (34.8\%) were Hispanic/Latinx. A family history of AF was verified in 24 probands with early-onset AF (10.6\%). Sequencing 60 candidate genes identified 53 (23 rare and 30 novel) variants with 16 of the 227 (7.0\%) probands harboring likely pathogenic (43.8\%) or pathogenic (56.2\%) variants, with most loss-of-function variants in TTN, the gene encoding the sarcomeric protein titin (46.7\%). In 6 families with more than 2 affected members, variants of unknown significance in sodium channel (SCN10A), potassium channel (KCNE5), sarcomeric proteins (MYH6 and TTN), and atrial natriuretic peptide (NPPA) cosegregated with AF. Conclusions and Relevance: In this study, likely pathogenic and pathogenic variants were identified, with most loss-of-function variants in TTN, that increase susceptibility to early-onset AF in African American and Hispanic/Latinx individuals. These findings provide further understanding toward molecular phenotyping of AF and suggest novel mechanism-based therapeutic approaches for this common arrhythmia in ethnic minority groups..},
  keywords = {âœ”ï¸},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Chalazan et al_2021_Association of Rare Genetic Variants and Early-Onset Atrial Fibrillation in.pdf}
}

@article{Chiang2012,
  title = {Distribution and {{Risk Profile}} of {{Paroxysmal}}, {{Persistent}}, and {{Permanent Atrial Fibrillation}} in {{Routine Clinical Practice}}},
  author = {Chiang, Chern-En and Naditch-BrÃ»lÃ©, Lisa and Murin, Jan and Goethals, Marnix and Inoue, Hiroshi and Oâ€™Neill, James and Silva-Cardoso, Jose and Zharinov, Oleg and Gamra, Habib and Alam, Samir and Ponikowski, Piotr and Lewalter, Thorsten and Rosenqvist, MÃ¥rten and Steg, Philippe Gabriel},
  date = {2012-08},
  journaltitle = {Circulation: Arrhythmia and Electrophysiology},
  volume = {5},
  number = {4},
  pages = {632--639},
  issn = {1941-3149},
  doi = {10.1161/CIRCEP.112.970749},
  keywords = {ðŸ”´}
}

@article{Choi2020,
  title = {Monogenic and {{Polygenic Contributions}} to {{Atrial Fibrillation Risk}}},
  author = {Choi, Seung Hoan and Jurgens, Sean J. and Weng, Lu-Chen and Pirruccello, James P. and Roselli, Carolina and Chaffin, Mark and Lee, Christina J.-Y. and Hall, Amelia W. and Khera, Amit V. and Lunetta, Kathryn L. and Lubitz, Steven A. and Ellinor, Patrick T.},
  date = {2020-01-17},
  journaltitle = {Circulation Research},
  volume = {126},
  number = {2},
  pages = {200--209},
  publisher = {{American Heart Association}},
  doi = {10.1161/CIRCRESAHA.119.315686},
  url = {https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.119.315686},
  urldate = {2023-07-27},
  abstract = {Download figureDownload PowerPoint},
  keywords = {ðŸ”´,atrial fibrillation,exome,genetics,population,risk},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Choi et al_2020_Monogenic and Polygenic Contributions to Atrial Fibrillation Risk.pdf}
}

@article{Chugh2001,
  title = {Epidemiology and Natural History of Atrial Fibrillation: Clinical Implications},
  shorttitle = {Epidemiology and Natural History of Atrial Fibrillation},
  author = {Chugh, Sumeet S and Blackshear, Joseph L and Shen, Win-Kuang and Hammill, Stephen C and Gersh, Bernard J},
  date = {2001-02-01},
  journaltitle = {Journal of the American College of Cardiology},
  shortjournal = {Journal of the American College of Cardiology},
  volume = {37},
  number = {2},
  pages = {371--378},
  issn = {0735-1097},
  doi = {10.1016/S0735-1097(00)01107-4},
  url = {https://www.sciencedirect.com/science/article/pii/S0735109700011074},
  urldate = {2023-07-26},
  abstract = {With a substantial impact on morbidity and mortality, the growing â€œepidemicâ€ of atrial fibrillation (AF) intersects with a number of conditions, including aging, thromboembolism, hemorrhage, hypertension and left ventricular dysfunction. Currently, the epidemiology and natural history of AF govern all aspects of its clinical management. The ongoing global investigative efforts toward understanding AF are also driven by epidemiologic findings. New developments, by affecting the natural history of the disease, could eventually alter the nature of decision making in patients with AF. The crucial issue of rate versus rhythm control awaits completion of the AF Follow-up Investigation of Rhythm Management trial. The processes of electrical and structural remodeling that perpetuate AF appear to be reversible. In the era of functional genomics, the molecular basis of this ubiquitous arrhythmia is in the process of being defined. Unraveling the molecular genetics of AF might provide new insights into the structural and electrical phenotypes resulting from genetic mutations and, as such, new approaches to treatment of this arrhythmia at the ion channel and cellular levels. Thus, current adverse trends are superimposed on a background of a rapidly developing knowledge base and potentially exciting new therapeutic options. Consequently, an understanding of the epidemiology and natural history of AF is crucial to the future allocation of resources and the utilization of an expanding range of therapies aimed at reducing the impact of this disease on a changing patient population.},
  langid = {english},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Chugh et al_2001_Epidemiology and natural history of atrial fibrillation.pdf;/Users/asshah4/projects/zotero/storage/BLI37ES9/S0735109700011074.html}
}

@article{Cohen2015,
  title = {State of the Art Review: {{Depression}}, Stress, Anxiety, and Cardiovascular Disease},
  author = {Cohen, Beth E. and Edmondson, Donald and Kronish, Ian M.},
  date = {2015-11},
  journaltitle = {American Journal of Hypertension},
  volume = {28},
  number = {11},
  eprint = {25911639},
  eprinttype = {pmid},
  pages = {1295--1302},
  issn = {19417225},
  doi = {10.1093/ajh/hpv047},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/25911639},
  urldate = {2018-12-25},
  abstract = {The notion that psychological states can influence physical health is hardly new, and perhaps nowhere has the mind-body connection been better studied than in cardiovascular disease (CVD). Recently, large prospective epidemiologic studies and smaller basic science studies have firmly established a connection between CVD and several psychological conditions, including depression, chronic psychological stress, posttraumatic stress disorder (PTSD), and anxiety. In addition, numerous clinical trials have been conducted to attempt to prevent or lessen the impact of these conditions on cardiovascular health. In this article, we review studies connecting depression, stress/PTSD, and anxiety to CVD, focusing on findings from the last 5 years. For each mental health condition, we first examine the epidemiologic evidence establishing a link with CVD. We then describe studies of potential underlying mechanisms and finally discuss treatment trials and directions for future research.},
  isbn = {1007-9327 (Print)\textbackslash r1007-9327 (Linking)},
  keywords = {ðŸ”´,anxiety disorders,blood pressure,cardiovascular disease,coronary heart disease,depression,hypertension,PTSD,stress}
}

@article{Cox2017b,
  title = {The Effect of Anger Expression Style on Cardiovascular Responses to Lateralized Cognitive Stressors},
  author = {Cox, David E. and DeVore, Benjamin B. and Harrison, Patti Kelly and Harrison, David W.},
  date = {2017-12-01},
  journaltitle = {Brain Informatics},
  volume = {4},
  number = {4},
  pages = {231--239},
  publisher = {{Springer Berlin Heidelberg}},
  issn = {21984026},
  doi = {10.1007/s40708-017-0068-4},
  abstract = {To determine the effects of self-reported anger expression style on cerebrally lateralized physiological responses to neuropsychological stressors, changes in systolic blood pressure and heart rate were examined in response to a verbal fluency task and a figural fluency task among individuals reporting either â€œanger inâ€ or â€œanger outâ€ expression styles. Significant group by trial interaction effects was found for systolic blood pressure following administration of verbal fluency [F(1,54) = 5.86, p {$<$} 0.05] and nonverbal fluency stressors [F(1,54) = 13.68, p {$<$} .001]. Similar interactions were seen for systolic heart rate following administration of verbal fluency [F(1,54) = 5.86, p {$<$} .005] and nonverbal fluency stressors [F(1,54) = 13.68, p {$<$} .001]. The corresponding results are discussed in terms of functional cerebral systems and potential implications for physiological models of anger. Given the association between anger and negative physical health outcomes, there is a clear need to better understand the physiological components of anger. The results of this experiment indicate that a repressive â€œanger inâ€ expression style is associated with deregulation of the right frontal region. This same region has been shown to be intimately involved in cardiovascular recovery, glucose metabolism, and blood pressure regulation.},
  keywords = {ðŸ”´,Anger,Brain asymmetry,Cardiovascular response,Hostility,Laterality},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Cox et al_2017_The effect of anger expression style on cardiovascular responses to lateralized.pdf}
}

@article{Crea1990,
  title = {Role of Adenosine in Pathogenesis of Anginal Pain},
  author = {Crea, Filippo and Pupita, Giuseppe and Galassi, Alfredo R and El-Tamimi, Hassan and Kaski, Juan Carlos and Davies, Graham and Maseri, Attilio},
  date = {1990-01},
  journaltitle = {Circulation},
  volume = {81},
  number = {1},
  eprint = {2297824},
  eprinttype = {pmid},
  pages = {164--172},
  issn = {00097322},
  doi = {10.1161/01.CIR.81.1.164},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/2297824},
  urldate = {2019-08-27},
  abstract = {The intravenous infusion of adenosine provokes anginalike chest pain. To establish its origin, an intracoronary infusion of increasing adenosine concentrations was given in 22 patients with stable angina pectoris. During adenosine infusion, 20 patients had chest pain without electrocardiographic signs of ischemia. They all reported that the chest pain was similar to their usual anginal pain. In 10 of the 22 patients adenosine was also infused into the right atrium, but it never produced symptoms at the doses that had provoked chest pain during intracoronary infusion. In seven other patients, the intracoronary adenosine infusion was repeated after intravenous administration of aminophylline, an antagonist of adenosine P1-receptors. Aminophylline decreased the severity of adenosine-induced chest pain (assessed with a visual analog scale) from 42 +/- 22 to 23 +/- 17 mm (p less than 0.002). In the remaining five of the 22 patients, monitoring of blood oxygen saturation in the coronary sinus during intracoronary adenosine administration showed that maximum coronary vasodilation was achieved at doses lower than those responsible for chest pain. A single-blind, placebo-controlled, randomized trial of the effect of aminophylline on exercise-induced chest pain was also performed in 20 other patients with stable angina. Aminophylline, compared with placebo, decreased the severity of chest pain at peak exercise from 67 +/- 21 to 51 +/- 23 mm (p less than 0.02), despite the achievement of a similar degree of ST-segment depression. Finally, the effect of intravenous adenosine was compared in 10 patients with predominantly painful myocardial ischemia and in 10 patients with predominantly silent ischemia.},
  keywords = {ðŸ”´,Adenosine,Aminophylline,Angina,Myocardial ischemia}
}

@article{Curry2018,
  title = {Risk Assessment for Cardiovascular Disease with Nontraditional Risk Factors: {{US}} Preventive Services Task Force Recommendation Statement},
  author = {Curry, Susan J. and Krist, Alex H. and Owens, Douglas K. and Barry, Michael J. and Caughey, Aaron B. and Davidson, Karina W. and Doubeni, Chyke A. and Epling, John W. and Kemper, Alex R. and Kubik, Martha and Landefeld, C. Seth and Mangione, Carol M. and Silverstein, Michael and Simon, Melissa A. and Tseng, Chien Wen and Wong, John B.},
  date = {2018-07-17},
  journaltitle = {JAMA - Journal of the American Medical Association},
  volume = {320},
  number = {3},
  eprint = {29998297},
  eprinttype = {pmid},
  pages = {272--280},
  publisher = {{American Medical Association}},
  issn = {15383598},
  doi = {10.1001/jama.2018.8359},
  url = {https://jamanetwork.com/journals/jama/fullarticle/2687225},
  urldate = {2022-08-12},
  abstract = {IMPORTANCE Cardiovascular disease (CVD) is the most common cause of death among adults in the United States. Treatment to prevent CVD events by modifying risk factors is currently informed by the Framingham Risk Score, the Pooled Cohort Equations, or similar CVD risk assessment models. If current CVD risk assessment models could be improved by adding more risk factors, treatment might be better targeted, thereby maximizing the benefits and minimizing the harms. OBJECTIVE To update the 2009 US Preventive Services Task Force (USPSTF) recommendation on using nontraditional risk factors in coronary heart disease risk assessment. EVIDENCE REVIEW The USPSTF reviewed the evidence on using nontraditional risk factors in CVD risk assessment, focusing on the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, and coronary artery calcium (CAC) score; the health benefits and harms of CVD risk assessment and treatment guided by nontraditional risk factors combined with the Framingham Risk Score or Pooled Cohort Equations compared with using either risk assessment model alone; and whether adding nontraditional risk factors to existing CVD risk assessment models improves measures of calibration, discrimination, and risk reclassification. FINDINGS The USPSTF found adequate evidence that adding the ABI, hsCRP level, and CAC score to existing CVD risk assessment models results in small improvements in discrimination and risk reclassification; however, the clinical meaning of these changes is largely unknown. Evidence on adding the ABI, hsCRP level, and CAC score to the Pooled Cohort Equations is limited. The USPSTF found inadequate evidence to assess whether treatment decisions guided by the ABI, hsCRP level, or CAC score, in addition to risk factors in existing CVD risk assessment models, leads to reduced incidence of CVD events or mortality. The USPSTF found adequate evidence to conceptually bound the harms of early detection and interventions as small. The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of using the ABI, hsCRP level, or CAC score in risk assessment for CVD in asymptomatic adults to prevent CVD events. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ABI, hsCRP level, or CAC score to traditional risk assessment for CVD in asymptomatic adults to prevent CVD events.},
  keywords = {ðŸ”´,cardiovascular diseases,coronary calcium score,framingham risk calculator,risk assessment,united states preventive services task force},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Curry et al_2018_Risk assessment for cardiovascular disease with nontraditional risk factors.pdf}
}

@article{Davydov2007,
  title = {Baroreflex Mechanisms in Major Depression},
  author = {Davydov, Dmitry M. and Shapiro, David and Cook, Ian A. and Goldstein, Iris},
  date = {2007},
  journaltitle = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  volume = {31},
  number = {1},
  eprint = {17011098},
  eprinttype = {pmid},
  pages = {164--177},
  issn = {02785846},
  doi = {10.1016/j.pnpbp.2006.08.015},
  abstract = {Background: Recent studies have shown that depressive disorder is associated with impaired baroreceptor or baroreflex sensitivity, which is proposed to be a predisposing factor for sudden death in patients with manifest cardiac disease. These studies have not evaluated the afferent and efferent components of the cardiac baroreflex loop or other baroreflex mechanisms that regulate target processes (cardiac metabolism and blood pressure variability) related to the impairment. The objective of this study was to gain more insight into autonomic functioning in depressive disorder to more fully examine the potential basis for increased cardiac mortality. Methods: The subjects were 28 women and men with unipolar major depression who were taking antidepressant medications and who were in partial remission and free of cardiovascular or other serious disease, and 28 healthy control subjects matched for sex, age, and ethnicity. The two samples were compared for negative affective dispositions (anger expression, hostility, defensiveness, anxiety), spontaneous (closed-loop) baroreflex activity, heart rate, heart rate variability, systolic blood pressure, and heart rate-systolic blood pressure double product under resting conditions. Results: Depressed patients showed a general disposition to anger suppression coupled with higher hostility and anxiety, and lower defensiveness. The patients showed higher general sympathetic activity (high levels of blood pressure, low-frequency heart rate variability) and lower parasympathetic-related activity (high heart rate and reduced high frequency heart rate variability) with affected cardiac metabolism estimated by the double product. Depressed patients had lower baroreflex sensitivity related to a higher gain of the afferent component of the baroreflex without respective gain adjustment of its efferent component (reflex gain 'de-afferentation'). It was coupled with a compensatory higher number of effective baroreflex reactions (reflex gating 're-afferentation'). Antidepressant agents and depressed mood had additional independent effects on baroreflex sensitivity through the efferent component of the cardiac baroreflex loop. Conclusions: The data indicate that different baroreflex components and mechanisms may be impaired in patients with depression and may contribute to their increased cardiac risk. Â© 2006 Elsevier Inc. All rights reserved.},
  isbn = {0278-5846},
  keywords = {ðŸ”´,Baroreflex effectiveness,Baroreflex sensitivity,Cardiac risk,Depression,Heart rate variability},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Davydov et al_2007_Baroreflex mechanisms in major depression.pdf}
}

@article{Dedovic2015,
  title = {The Cortisol Awakening Response and Major Depression: {{Examining}} the Evidence},
  author = {Dedovic, Katarina and Ngiam, Janice},
  date = {2015-05-14},
  journaltitle = {Neuropsychiatric Disease and Treatment},
  volume = {11},
  pages = {1181--1189},
  publisher = {{Dove Medical Press Ltd.}},
  issn = {11782021},
  doi = {10.2147/NDT.S62289},
  url = {https://pubmed.ncbi.nlm.nih.gov/25999722/},
  urldate = {2021-04-02},
  abstract = {A vast body of literature has revealed that dysregulation of the hypothalamicâ€“pituitaryâ€“adrenal (HPA) stress axis is associated with etiology of major depressive disorder (MDD). There are many ways that the dysregulation of the HPA axis can be assessed: by sampling diurnal basal secretion and/or in response to a stress task, pharmacological challenge, and awakening. Here, we focus on the association between cortisol awakening response (CAR), as one index of HPA axis function, and MDD, given that the nature of this association is particularly unclear. Indeed, in the following selective review, we attempt to reconcile sometimes-divergent evidence of the role of CAR in the pathway to depression. We first examine association of CAR with psychological factors that have been linked with increased vulnerability to develop depression. Then, we summarize the findings regarding the CAR profile in those with current depression, and evaluate evidence for the role of CAR following depression resolution and continued vulnerability. Finally, we showcase longitudinal studies showing the role of CAR in predicting depression onset and recurrence. Overall, the studies reveal an important, but complex, association between CAR and vulnerability to depression.},
  keywords = {ðŸ”´,Daily hassles,Environmental factors,Genetic influence,HPA axis,MDD,SCN},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Dedovic_Ngiam_2015_The cortisol awakening response and major depression.pdf}
}

@article{DeLago2021a,
  title = {Incidence and {{Mortality Trends}} of {{Atrial Fibrillation}}/{{Atrial Flutter}} in the {{United States}} 1990 to 2017},
  author = {DeLago, Augustin J and Essa, Mohammed and Ghajar, Alireza and Hammond-Haley, Matthew and Parvez, Arshi and Nawaz, Isaiah and Shalhoub, Joseph and Marshall, Dominic C and Nazarian, Saman and Calkins, Hugh and Salciccioli, Justin D and Philips, Binu},
  date = {2021},
  journaltitle = {American Journal of Cardiology},
  volume = {148},
  eprint = {33640365},
  eprinttype = {pmid},
  pages = {78--83},
  issn = {18791913},
  doi = {10.1016/j.amjcard.2021.02.014},
  url = {https://doi.org/10.1016/j.amjcard.2021.02.014},
  urldate = {2022-11-22},
  abstract = {Atrial fibrillation (AF) and flutter (AFL) are the most common clinically significant arrhythmias in older adults with an increasing disease burden due to an aging population. However, up-to-date trends in disease burden and regional variation remain unknown. In an observational study utilizing the Global Burden of Disease (GBD) database, age-standardized mortality and incidence rates for AF overall and for each state in the United States (US) from 1990 to 2017 were determined. All analyses were stratified by gender. The relative change in age-standardized incidence rate (ASIR) and age-standardized death rate (ASDR) over the observation period were determined. Trends were analyzed using Joinpoint regression analysis. The mean ASIR per 100,000 population for men was 92 (+/-8) and for women was 62 (+/-5) in the US in 2017. The mean ASDR per 100,000 population for men was 5.8 (+/-0.3) and for women was 4.4 (+/-0.4). There were progressive increases in ASIR and ASDR in all but 1 state. The states with the greatest percentage change in incidence were New Hampshire (+13.5\%) and Idaho (+16.0\%) for men and women, respectively. The greatest change regarding mortality was seen in Mississippi (+26.3\%) for men and Oregon (+53.8\%) for women. In conclusion these findings provide updated evidence of increasing AF and/or AFL incidence and mortality on a national and regional level in the US, with women experiencing greater increases in incidence and mortality rates. This study demonstrates that the public health burden related to AF in the United States is progressively worsening but disproportionately across states and among women.},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/DeLago et al_2021_Incidence and Mortality Trends of Atrial Fibrillation-Atrial Flutter in the.pdf}
}

@article{Denollet2010,
  title = {Anger, {{Suppressed Anger}}, and {{Risk}} of {{Adverse Events}} in {{Patients With Coronary Artery Disease}}},
  author = {Denollet, Johan and Gidron, Yori and Vrints, Christiaan J. and Conraads, Viviane M.},
  date = {2010-06-01},
  journaltitle = {American Journal of Cardiology},
  volume = {105},
  number = {11},
  pages = {1555--1560},
  issn = {00029149},
  doi = {10.1016/j.amjcard.2010.01.015},
  abstract = {Anger is associated with cardiovascular stress reactivity; however, little is known about the effect of suppressed anger in patients with coronary artery disease (CAD). We examined whether patients with CAD who suppress their anger are at risk of adverse events. At baseline, 644 patients with CAD completed measures of anger, anger-in (reluctance to express anger), and Type D personality (tendency to experience distress and to be inhibited). The combination of high anger and anger-in scores was used to identify the presence of suppressed anger. The end points were major adverse cardiac events (a composite of death, myocardial infarction, and revascularization) and cardiac death/myocardial infarction. After an average follow-up of 6.3 years (range 5 to 10), 126 patients (20\%) had experienced a major adverse cardiac event, and 59 (9\%) had experienced cardiac death or myocardial infarction. Anger (p = 0.009) and suppressed anger (p = 0.011) were associated with future major adverse cardiac events, but these associations were no longer significant after adjustment for clinical characteristics. However, suppressed anger remained associated with the more rigorous end point of cardiac death or myocardial infarction (odds ratio 2.87, 95\% confidence interval 1.15 to 7.15, p = 0.024) after controlling for decreased systolic function, poor exercise tolerance, extent of CAD, and revascularization. Anger alone was not independently associated with this end point. Patients with a Type D personality had a fourfold rate of suppressed anger, and an adjustment for a Type D personality attenuated the observed association between suppressed anger and adverse cardiac events. In conclusion, patients with CAD who suppress their anger were at increased risk of adverse cardiac events, and this was accounted for by individual differences in Type D personality. Â© 2010 Elsevier Inc. All rights reserved.},
  keywords = {ðŸ”´}
}

@article{Diamant2021,
  title = {Heart Failure and Atrial Flutter: A Systematic Review of Current Knowledge and Practices},
  author = {Diamant, Michael J. and Andrade, Jason G. and Virani, Sean A. and Jhund, Pardeep S. and Petrie, Mark C. and Hawkins, Nathaniel M.},
  date = {2021-12-10},
  journaltitle = {ESC Heart Failure},
  volume = {8},
  number = {6},
  pages = {4484--4496},
  issn = {2055-5822},
  doi = {10.1002/ehf2.13526},
  url = {https://onlinelibrary.wiley.com/doi/10.1002/ehf2.13526},
  urldate = {2022-11-22},
  abstract = {While the interplay between heart failure (HF) and atrial fibrillation (AF) has been extensively studied, little is known regarding HF and atrial flutter (AFL), which may be managed differently. We reviewed the incidence, prevalence, and predictors of HF in AFL and vice versa, and the outcomes of treatment of AFL in HF. A systematic literature review of PubMed/Medline and EMBASE yielded 65 studies for inclusion and qualitative synthesis. No study described the incidence or prevalence of AFL in unselected patients with HF. Most cohorts enrolled patients with AF/AFL as interchangeable diagnoses, or highly selected patients with tachycardia-induced cardiomyopathy. The prevalence of HF in AFL ranged from 6\% to 56\%. However, the phenotype of HF was never defined by left ventricular ejection fraction (LVEF). No studies reported the predictors, phenotype, and prognostic implications of AFL in HF. There was significant variation in treatments studied, including the proportion that underwent ablation. When systolic dysfunction was tachycardia-mediated, catheter ablation demonstrated LVEF normalization in up to 88\%, as well as reduced cardiovascular mortality. In summary, AFL and HF often coexist but are understudied, with no randomized trial data to inform care. Further research is warranted to define the epidemiology and establish optimal management.},
  keywords = {ðŸ”´,Arrhythmia,Atrial flutter,Catheter ablation,Heart failure,Left ventricular systolic dysfunction,Systematic review},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Diamant et al_2021_Heart failure and atrial flutter.pdf}
}

@article{Dolezel1978,
  title = {Adrenergic Innervation of the Coronary Arteries and the Myocardium.},
  author = {Dolezel, S and GerovÃ¡, M and Gero, J and SlÃ¡dek, T and Vasku, J},
  date = {1978},
  journaltitle = {Acta anatomica},
  volume = {100},
  number = {3},
  eprint = {619505},
  eprinttype = {pmid},
  pages = {306--16},
  issn = {0001-5180},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/619505},
  urldate = {2019-05-28},
  abstract = {The monoaminergic innervation of the coronary vessels and myocardium in the dog was studied by means of the histochemical fluorescence method. The distribution of monoaminergic terminals in the arterial wall depends on the diameter of the artery. In large arteries, the terminals are regularly distributed around the entire circumference, the fibres being situated between the elastic lamellae of the adventitia. The terminals within the media could not be detected. In small arteries, the sympathetic ground plexus aggregates in two parallel strands, the artery being between them. In arterioles, two thick fibres only accompany the vellel. The myocardium is innervated by means of a three-dimensional sympathetic ground plexus distributed between the myocardial cells independently of vessels. No difference in density of innervation was found between the right and left heart. The point-counting method, on the other hand, has revealed that the density of innervation in the left auricle is nearly twice as dense as in the left ventricle. The terminals innervating the myocardium are markedly thinner than the fibres innervating the arteries. Two-dimensional plexuses innervate the epicardium, endocardium and valves.},
  keywords = {ðŸ”´}
}

@article{Dooley2018,
  title = {The Role of Inflammation in Core Features of Depression: {{Insights}} from Paradigms Using Exogenously-Induced Inflammation},
  author = {Dooley, Larissa N. and Kuhlman, Kate R. and Robles, Theodore F. and Eisenberger, Naomi I. and Craske, Michelle G. and Bower, Julienne E.},
  date = {2018-11-01},
  journaltitle = {Neuroscience and Biobehavioral Reviews},
  volume = {94},
  eprint = {30201219},
  eprinttype = {pmid},
  pages = {219--237},
  publisher = {{Elsevier Ltd}},
  issn = {18737528},
  doi = {10.1016/j.neubiorev.2018.09.006},
  url = {/pmc/articles/PMC6192535/?report=abstract},
  urldate = {2020-11-04},
  abstract = {A wealth of evidence has implicated inflammation in the development of depression. Yet, the heterogeneous nature of depression has impeded efforts to understand, prevent, and treat the disease. The purpose of this integrative review is to summarize the connections between inflammation and established core features of depression that exhibit more homogeneity than the syndrome itself: exaggerated reactivity to negative information, altered reward processing, decreased cognitive control, and somatic syndrome. For each core feature, we first provide a brief overview of its relevance to depression and neurobiological underpinnings, and then review evidence investigating a potential role of inflammation. We focus primarily on findings from experimental paradigms of exogenously-induced inflammation. We conclude that inflammation likely plays a role in exaggerated reactivity to negative information, altered reward reactivity, and somatic symptoms. There is less evidence supporting an effect of inflammation on cognitive control as assessed by standard neuropsychological measures. Finally, we discuss implications for future research and recommendationsfor how to test the role of inflammation in the pathogenesis of heterogeneous psychiatric disorders.},
  keywords = {ðŸ”´,Cognitive control,Depression,Endophenotype,Inflammation,Mood,Reward,Somatic},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Dooley et al_2018_The role of inflammation in core features of depression.pdf}
}

@article{Essien2021,
  title = {Social Determinants of Atrial Fibrillation},
  author = {Essien, Utibe R. and Kornej, Jelena and Johnson, Amber E. and Schulson, Lucy B. and Benjamin, Emelia J. and Magnani, Jared W.},
  date = {2021-11},
  journaltitle = {Nature Reviews Cardiology},
  shortjournal = {Nat Rev Cardiol},
  volume = {18},
  number = {11},
  pages = {763--773},
  publisher = {{Nature Publishing Group}},
  issn = {1759-5010},
  doi = {10.1038/s41569-021-00561-0},
  url = {https://www.nature.com/articles/s41569-021-00561-0},
  urldate = {2023-08-01},
  abstract = {Atrial fibrillation affects almost 60 million adults worldwide. Atrial fibrillation is associated with a high risk of cardiovascular morbidity and death as well as with social, psychological and economic burdens on patients and their families. Social determinants â€” such as race and ethnicity, financial resources, social support, access to health care, rurality and residential environment, local language proficiency and health literacy â€” have prominent roles in the evaluation, treatment and management of atrial fibrillation. Addressing the social determinants of health provides a crucial opportunity to reduce the substantial clinical and non-clinical complications associated with atrial fibrillation. In this Review, we summarize the contributions of social determinants to the patient experience and outcomes associated with this common condition. We emphasize the relevance of social determinants and their important intersection with atrial fibrillation treatment and outcomes. In closing, we identify gaps in the literature and propose future directions for the investigation of social determinants and atrial fibrillation.},
  issue = {11},
  langid = {english},
  keywords = {ðŸ”´,Atrial fibrillation,Cardiology,Health care,Risk factors},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Essien et al_2021_Social determinants of atrial fibrillation.pdf}
}

@book{First2004,
  title = {The {{Structured Clinical Interview}} for {{DSM-IV Axis I Disorders}} ({{SCID-I}}) and the {{Structured Clinical Interview}} for {{DSM-IV Axis II Disorders}} ({{SCID-II}})},
  author = {family=First, given=MB, given-i=MB and Gibbon, M},
  editor = {family=Hilsenroth, given=MJ, given-i=MJ and family=Segal, given=DL, given-i=DL},
  date = {2004},
  publisher = {{John Wiley \& Sons, Inc.}},
  abstract = {In this chapter, the authors examine the Structured Clinical Interview for Diagnostic and Statistical Manual-Fourth Edition Axis I Disorders (SCID-I) and the SCID-II. The main topics discussed in this chapter include the following: (1) test description; (2) theoretical basis; (3) test development; (4) psychometric characteristics; (5) cross-cultural factors; (6) accommodations for populations with disabilities; (7) computerization; (8) current research status; (9) use in clinical or organizational practice; and (10) future developments. (PsycINFO Database Record (c) 2019 APA, all rights reserved)},
  pagetotal = {134-143},
  keywords = {ðŸ”´}
}

@article{Ford1998,
  title = {Depression Is a Risk Factor for Coronary Artery Disease in Men: {{The}} Precursors Study},
  author = {Ford, Daniel E. and Mead, Lucy A. and Chang, Patricia P. and Cooper-Patrick, Lisa and Wang, Nae Yuh and Klag, Michael J.},
  date = {1998-07-13},
  journaltitle = {Archives of Internal Medicine},
  volume = {158},
  number = {13},
  eprint = {9665350},
  eprinttype = {pmid},
  pages = {1422--1426},
  publisher = {{American Medical Association}},
  issn = {00039926},
  doi = {10.1001/archinte.158.13.1422},
  url = {http://archinte.jamanetwork.com/article.aspx?doi=10.1001/archinte.158.13.1422},
  urldate = {2018-10-28},
  abstract = {BACKGROUND: Several studies have found that depression is an independent predictor of poor outcome after the onset of clinical coronary artery disease. There are few data concerning depression as a risk factor for the development of coronary artery disease. OBJECTIVE: To determine if clinical depression is an independent risk factor for incident coronary artery disease. PATIENTS AND METHODS: The Johns Hopkins Precursors Study is a prospective, observational study of 1190 male medical students who were enrolled between 1948 and 1964 and who continued to be followed up. In medical school and through the follow-up period, information was collected on family history, health behaviors, and clinical depression. Cardiovascular disease end points have been assessed with reviews of annual questionnaires, National Death Index searches, medical records, death certificates, and autopsy reports. RESULTS: The cumulative incidence of clinical depression in the medical students at 40 years of follow-up was 12\%. Men who developed clinical depression drank more coffee than those who did not but did not differ in terms of baseline blood pressure, serum cholesterol levels, smoking status, physical activity, obesity, or family history of coronary artery disease. In multivariate analysis, the men who reported clinical depression were at significantly greater risk for subsequent coronary heart disease (relative risk [RR], 2.12; 95\% confidence interval [CI], 1.24-3.63) and myocardial infarction (RR, 2.12; 95\% CI, 1.11-4.06). The increased risk associated with clinical depression was present even for myocardial infarctions occurring 10 years after the onset of the first depressive episode (RR, 2.1; 95\% CI, 1.1-4.0). CONCLUSION: Clinical depression appears to be an independent risk factor for incident coronary artery disease for several decades after the onset of the clinical depression.},
  isbn = {0003-9926},
  keywords = {ðŸ”´,cardiovascular diseases,coronary heart disease risk,depressive disorders,endogenous depression},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Ford et al_1998_Depression is a risk factor for coronary artery disease in men.pdf}
}

@article{Foy2018,
  title = {Relation of {{Obesity}} to {{New-Onset Atrial Fibrillation}} and {{Atrial Flutter}} in {{Adults}}},
  author = {Foy, Andrew J and Mandrola, John and Liu, Guodong and Naccarelli, Gerald V},
  date = {2018},
  journaltitle = {American Journal of Cardiology},
  volume = {121},
  number = {9},
  eprint = {29501206},
  eprinttype = {pmid},
  pages = {1072--1075},
  issn = {18791913},
  doi = {10.1016/j.amjcard.2018.01.019},
  url = {https://doi.org/10.1016/j.amjcard.2018.01.019},
  urldate = {2022-11-22},
  abstract = {Prospective cohort studies involving older adults report an association of obesity and new-onset atrial fibrillation and atrial flutter. To assess this relation, we performed a longitudinal cohort study from January 1, 2006 to December 31, 2013, using a national claims database that tracks all inpatient, outpatient, and pharmacy claims data. The primary end point of new-onset atrial fibrillation was compared between obese and nonobese cohorts. We used logistic regression to determine the strength of association between obesity and new-onset atrial fibrillation controlling for age, gender, hypertension, and diabetes. Overall, 67,278 subjects were included in the cohort, divided evenly between those with and without a diagnosis of obesity. Obese subjects were significantly more likely to have hypertension (29.5\% vs 14.6\%) and diabetes (12.7\% vs 5.2\%) at study onset. Over 8 years of follow-up, we recorded a new diagnosis of atrial fibrillation in 1,511 (2.2\%) subjects. Obesity was strongly associated with a new diagnosis of atrial fibrillation after controlling for age, gender, hypertension, and diabetes (odds ratio 1.4, 95\% confidence interval 1.3 to 1.6). In conclusion, this information contributes to the growing evidence supporting the causal relation between obesity and atrial fibrillation, and emphasizes the need of addressing obesity as part of our therapeutic strategy to prevent atrial fibrillation.},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Foy et al_2018_Relation of Obesity to New-Onset Atrial Fibrillation and Atrial Flutter in.pdf}
}

@article{Friedrich2017b,
  title = {Depression {{Is}} the {{Leading Cause}} of {{Disability Around}} the {{World}}},
  author = {Friedrich, M. J.},
  date = {2017-04-18},
  journaltitle = {JAMA},
  volume = {317},
  number = {15},
  pages = {1517},
  publisher = {{NLM (Medline)}},
  issn = {15383598},
  doi = {10.1001/jama.2017.3826},
  abstract = {The proportion of the global population living with depression is estimated to be 322 million peopleâ€”4.4\% of the worldâ€™s populationâ€”according to a new report, â€œDepression and Other Common Mental Disorders: Global Health Estimates,â€ released by the World Health Organization. The report also includes data on anxiety disorders, which affect more than 260 million peopleâ€”3.6\% of the global population. The prevalence of these common mental disorders is increasing, particularly in low- and middle-income countries, with many people experiencing both depression and anxiety disorders simultaneously.},
  keywords = {ðŸ”´}
}

@article{Garg2020b,
  title = {Associations of Anger, Vital Exhaustion, Anti-Depressant Use, and Poor Social Ties with Incident Atrial Fibrillation: {{The Atherosclerosis Risk}} in {{Communities Study}}},
  author = {Garg, Parveen K and Claxton, Jâ€™Neka S and Soliman, Elsayed Z and Chen, Lin Y and Lewis, TenÃ© T and Mosley, Thomas and Alonso, Alvaro},
  date = {2020-01-13},
  journaltitle = {European Journal of Preventive Cardiology},
  pages = {204748731989716},
  issn = {2047-4873},
  doi = {10.1177/2047487319897163},
  url = {http://journals.sagepub.com/doi/10.1177/2047487319897163},
  urldate = {2020-01-16},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Garg et al_2020_Associations of anger, vital exhaustion, anti-depressant use, and poor social.pdf}
}

@article{Gerber2006,
  title = {Secular Trends in Deaths from Cardiovascular Diseases: {{A}} 25-Year Community Study},
  author = {Gerber, Yariv and Jacobsen, Steven J and Frye, Robert L and Weston, Susan A and Killian, Jill M and Roger, VÃ©ronique L},
  date = {2006},
  journaltitle = {Circulation},
  volume = {113},
  number = {19},
  pages = {2285--2292},
  issn = {00097322},
  doi = {10.1161/CIRCULATIONAHA.105.590463},
  url = {http://www.circulationaha.org},
  urldate = {2019-02-24},
  abstract = {Although age-adjusted cardiovascular disease (CVD) mortality has declined over the past decades, controversies remain about whether this trend was similar across locations of death and disease categories and about the existence of age and sex disparities.},
  keywords = {ðŸ”´,Cardiovascular diseases,Epidemiology,Mortality,Population,Prevention},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Gerber et al_2006_Secular trends in deaths from cardiovascular diseases.pdf}
}

@article{Ghadri2018,
  title = {International {{Expert Consensus Document}} on {{Takotsubo Syndrome}} ({{Part II}}): {{Diagnostic Workup}}, {{Outcome}}, and {{Management}}},
  author = {Ghadri, Jelena Rima and Wittstein, Ilan Shor and Prasad, Abhiram and Sharkey, Scott and Dote, Keigo and Akashi, Yoshihiro John and Cammann, Victoria Lucia and Crea, Filippo and Galiuto, Leonarda and Desmet, Walter and Yoshida, Tetsuro and Manfredini, Roberto and Eitel, Ingo and Kosuge, Masami and Nef, Holger M. and Deshmukh, Abhishek and Lerman, Amir and Bossone, Eduardo and Citro, Rodolfo and Ueyama, Takashi and Corrado, Domenico and Kurisu, Satoshi and Ruschitzka, Frank and Winchester, David and Lyon, Alexander R. and Omerovic, Elmir and Bax, Jeroen J. and Meimoun, Patrick and Tarantini, Guiseppe and Rihal, Charanjit and Hassan, Shams Y. and Migliore, Federico and Horowitz, John D. and Shimokawa, Hiroaki and LÃ¼scher, Thomas Felix and Templin, Christian},
  date = {2018-06-07},
  journaltitle = {European Heart Journal},
  volume = {39},
  number = {22},
  eprint = {29850820},
  eprinttype = {pmid},
  pages = {2047--2062},
  publisher = {{Oxford University Press}},
  issn = {15229645},
  doi = {10.1093/eurheartj/ehy077},
  url = {/pmc/articles/PMC5991205/?report=abstract},
  urldate = {2020-09-20},
  abstract = {The clinical expert consensus statement on takotsubo syndrome (TTS) part II focuses on the diagnostic workup, outcome, and management. The recommendations are based on interpretation of the limited clinical trial data currently available and experience of international TTS experts. It summarizes the diagnostic approach, which may facilitate correct and timely diagnosis. Furthermore, the document covers areas where controversies still exist in risk stratification and management of TTS. Based on available data the document provides recommendations on optimal care of such patients for practising physicians.},
  keywords = {ðŸ”´,Acute heart failure,Broken heart syndrome,Consensus statement,Diagnostic algorithm,Takotsubo syndrome},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Ghadri et al_2018_International Expert Consensus Document on Takotsubo Syndrome (Part II).pdf}
}

@article{Ghelani2022,
  title = {Thirtyâ€{{Year Trends}} in the {{Incidence}} of {{Atrial Fibrillation}}: {{The ARIC Study}}},
  shorttitle = {Thirtyâ€{{Year Trends}} in the {{Incidence}} of {{Atrial Fibrillation}}},
  author = {Ghelani, Kunali P. and Chen, Lin Yee and Norby, Faye L. and Soliman, Elsayed Z. and Koton, Silvia and Alonso, Alvaro},
  date = {2022-04-19},
  journaltitle = {Journal of the American Heart Association},
  volume = {11},
  number = {8},
  pages = {e023583},
  publisher = {{American Heart Association}},
  doi = {10.1161/JAHA.121.023583},
  url = {https://www.ahajournals.org/doi/10.1161/JAHA.121.023583},
  urldate = {2023-08-16},
  abstract = {Background Longâ€term data to study recent trends in the incidence of atrial fibrillation (AF), overall and among sex and race groups, are scarce. We evaluated the 30â€year trends in the incidence of AF in the ARIC (Atherosclerosis Risk in Communities) study cohort and explored race and sex differences in these trends. Methods and Results We included 15~343 men and women aged 45 to 64 years in 1987 to 1989 without AF from 4 US communities in the ARIC cohort. Incident AF was identified based on study ECGs, hospital discharge codes, and death certificates through 2017. We calculated age and periodâ€specific incidence rates (IRs) of AF. We used Poisson regression to calculate IR ratios of AF over time adjusting for age, sex, and race. A total of 3241 AF cases were identified during a mean (SD) followâ€up of 22 years (8.4 years) (599 in Black participants, 2642 in White participants, 1582 in women, and 1659 in men). Overall, the IR of AF in the ARIC cohort was 9.6 per 1000 personâ€years (6.9 in Black participants, 10.5 in White participants, 8.1 in women, and 11.6 in men). Ageâ€specific IR by time period did not show significant changes over time. In a model adjusted for sex, race, and age group, the rate of AF did not change significantly from 1987 to 1991 compared with 2012 to 2017 (IR ratio, 1.10 [95\% CI, 0.88â€“1.36] comparing 2012â€“2017 with 1987â€“1991). Similarly, no evidence of changes over time in AF rates were identified in men and women or White and Black participants separately. Conclusions Even though IRs of AF increase as age increases, our analysis provided evidence suggesting that the overall IRs of AF have not changed over time in a multicenter cohort of Black and White individuals in the United States from 1987 to 2017.},
  keywords = {ðŸ”´,atrial fibrillation,epidemiology,incidence,trends},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Ghelani et al_2022_Thirtyâ€Year Trends in the Incidence of Atrial Fibrillation.pdf}
}

@article{Glassman2002,
  title = {Sertraline Treatment of Major Depression in Patients with Acute {{MI}} or Unstable Angina},
  author = {Glassman, Alexander H. and O'Connor, Christopher M. and Califf, Robert M. and Swedberg, Karl and Schwartz, Peter and Bigger, J. Thomas and Krishnan, K. Ranga Rama and Van Zyl, Louis T. and Swenson, J. Robert and Finkel, Mitchell S. and Landau, Charles and Shapiro, Peter A. and Pepine, Carl J. and Mardekian, Jack and Harrison, Wilma M.},
  date = {2002-08-14},
  journaltitle = {Journal of the American Medical Association},
  volume = {288},
  number = {6},
  eprint = {12169073},
  eprinttype = {pmid},
  pages = {701--709},
  publisher = {{American Medical Association}},
  issn = {00987484},
  doi = {10.1001/jama.288.6.701},
  url = {http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.288.6.701},
  urldate = {2018-10-24},
  abstract = {CONTEXT: Major depressive disorder (MDD) occurs in 15\% to 23\% of patients with acute coronary syndromes and constitutes an independent risk factor for morbidity and mortality. However, no published evidence exists that antidepressant drugs are safe or efficacious in patients with unstable ischemic heart disease. OBJECTIVE: To evaluate the safety and efficacy of sertraline treatment of MDD in patients hospitalized for acute myocardial infarction (MI) or unstable angina and free of other life-threatening medical conditions. DESIGN AND SETTING: Randomized, double-blind, placebo-controlled trial conducted in 40 outpatient cardiology centers and psychiatry clinics in the United States, Europe, Canada, and Australia. Enrollment began in April 1997 and follow-up ended in April 2001. PATIENTS: A total of 369 patients with MDD (64\% male; mean age, 57.1 years; mean 17-item Hamilton Depression [HAM-D] score, 19.6; MI, 74\%; unstable angina, 26\%). INTERVENTION: After a 2-week single-blind placebo run-in, patients were randomly assigned to receive sertraline in flexible dosages of 50 to 200 mg/d (n = 186) or placebo (n = 183) for 24 weeks. MAIN OUTCOME MEASURES: The primary (safety) outcome measure was change from baseline in left ventricular ejection fraction (LVEF); secondary measures included surrogate cardiac measures and cardiovascular adverse events, as well as scores on the HAM-D scale and Clinical Global Impression Improvement scale (CGI-I) in the total randomized sample, in a group with any prior history of MDD, and in a more severe MDD subgroup defined a priori by a HAM-D score of at least 18 and history of 2 or more prior episodes of MDD. RESULTS: Sertraline had no significant effect on mean (SD) LVEF (sertraline: baseline, 54\% [10\%]; week 16, 54\% [11\%]; placebo: baseline, 52\% [13\%]; week 16, 53\% [13\%]), treatment-emergent increase in ventricular premature complex (VPC) runs (sertraline: 13.1\%; placebo: 12.9\%), QTc interval greater than 450 milliseconds at end point (sertraline: 12\%; placebo: 13\%), or other cardiac measures. All comparisons were statistically nonsignificant (P{$>$} or = .05). The incidence of severe cardiovascular adverse events was 14.5\% with sertraline and 22.4\% with placebo. In the total randomized sample, the CGI-I (P =.049), but not the HAM-D (P =.14), favored sertraline. The CGI-I responder rates for sertraline were significantly higher than for placebo in the total sample (67\% vs 53\%; P =.01), in the group with at least 1 prior episode â€¦},
  isbn = {0098-7484},
  keywords = {ðŸ”´,acute,depressive disorders,major depressive disorder,myocardial infarction,sertraline,unstable angina},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Glassman et al_2002_Sertraline treatment of major depression in patients with acute MI or unstable.pdf}
}

@report{Glassmana,
  title = {Heart {{Rate Variability}} in {{Acute Coronary Syndrome Patients With Major Depression}}},
  author = {Glassman, Alexander H. and Bigger, J. Thomas and Gaffney, Michael and Van Zyl, Louis T.},
  date = {2007},
  journaltitle = {Archives of General Psychiatry},
  volume = {64},
  number = {9},
  eprint = {17768267},
  eprinttype = {pmid},
  pages = {1025},
  issn = {0003-990X},
  doi = {10.1001/archpsyc.64.9.1025},
  url = {http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/archpsyc.64.9.1025},
  abstract = {Context: Major depressive disorder (MDD) associated with acute coronary syndrome (ACS) increases the risk of mortality. Decreased heart rate variability (HRV), also a predictor of mortality, is reduced in patients with MDD after ACS, and has been suggested to be a mediator of MDD mortality after ACS. Although selective serotonin reuptake inhibitors may reduce mortality post-ACS, little is known about their effects on HRV. Objective: To examine the influence of both sertraline and improvement in mood on HRV. Methods: The Sertraline Antidepressant Heart Attack Randomized Trial assessed HRV from 24-hour Holter electrocardiogram recordings at baseline in 290 patients and from a second recording in 258 of these patients 16 weeks after randomization to sertraline or placebo. Frequency domain measures of HRV included high-frequency power, low-frequency power, very low-frequency power, ultra low-frequency power, and total power. Depression severity was measured by the Hamilton Rating Scale for Depression. Clinical response was measured with the Clinical Global Impressions Improvement scale. Results: At baseline, prior episodes of MDD were associated with lower HRV. Sertraline significantly increased ultra low-frequency power, while improvement in mood was associated with higher low-frequency power independent of treatment. However, the expected recovery in HRV following ACS was not observed in patients with MDD. Higher ultra low-frequency during sertraline treatment and higher low-frequency power in patients whose mood improved resulted primarily from these measures decreasing in their comparison groups. Conclusions: Heart rate variability recovery is impaired in depressed patients after ACS. Previously reported differences in baseline HRV between patients with and without depression after ACS grew larger in the 16 weeks following a coronary event. Both sertraline treatment and symptomatic recovery from depression were associated with increased HRV compared with placebotreated and nonrecovered post-ACS control groups, respectively, but this results primarily from decreased HRV in the comparison groups.},
  isbn = {0003-990X},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Glassman et al_2007_Heart Rate Variability in Acute Coronary Syndrome Patients With Major Depression.pdf}
}

@article{Goldenberg2019,
  title = {Heart {{Rate Variability}} for {{Risk Assessment}} of {{Myocardial Ischemia}} in {{Patients Without Known Coronary Artery Disease}}: {{The HRV}}â€{{DETECT}} ({{Heart Rate Variability}} for the {{Detection}} of {{Myocardial Ischemia}}) {{Study}}},
  author = {Goldenberg, Ilan and Goldkorn, Ronen and Shlomo, Nir and Einhorn, Michal and Levitan, Jacob and Kuperstein, Raphael and Klempfner, Robert and Johnson, Bruce},
  date = {2019-12-17},
  journaltitle = {Journal of the American Heart Association},
  volume = {8},
  number = {24},
  eprint = {31838969},
  eprinttype = {pmid},
  pages = {e014540},
  issn = {2047-9980},
  doi = {10.1161/JAHA.119.014540},
  url = {https://www.ahajournals.org/doi/suppl/10.1161/JAHA.119.014540},
  urldate = {2019-12-20},
  abstract = {Background Detecting significant coronary artery disease (CAD) in the general population is complex and relies on combined assessment of traditional CAD risk factors and noninvasive testing. We hypothesized that a CAD-specific heart rate variability (HRV) algorithm can be used to improve detection of subclinical or early ischemia in patients without known CAD. Methods and Results Between 2014 and 2018 we prospectively enrolled 1043 patients with low to intermediate pretest probability for CAD who were screened for myocardial ischemia in tertiary medical centers in the United States and Israel. Patients underwent 1-hour Holter testing, with immediate HRV analysis using the HeartTrends DyDx algorithm, followed by exercise stress echocardiography (n=612) or exercise myocardial perfusion imaging (n=431). The threshold for low HRV was identified using receiver operating characteristic analysis based on sensitivity and specificity. The primary end point was the presence of myocardial ischemia detected by exercise stress echocardiography or exercise myocardial perfusion imaging. The mean age of patients was 61 years and 38\% were women. Myocardial ischemia was detected in 66 (6.3\%) patients. After adjustment for CAD risk factors and exercise stress testing results, low HRV was independently associated with a significant 2-fold increased likelihood for myocardial ischemia (odds ratio, 2.00; 95\% CI, 1.41-2.89 [P=0.01]). Adding HRV to traditional CAD risk factors significantly improved the pretest probability for myocardial ischemia. Conclusions Our data from a large prospective international clinical study show that short-term HRV testing can be used as a novel digital-health modality for enhanced risk assessment in low- to intermediate-risk individuals without known CAD. Clinical Trial Registration URL: http://www.ClinicalTrials.gov. Unique identifiers: NCT01657006, NCT02201017).},
  keywords = {ðŸ”´,coronary artery disease,heart rate variability,risk prediction},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Goldenberg et al_2019_Heart Rate Variability for Risk Assessment of Myocardial Ischemia in Patients.pdf}
}

@article{Goldkorn2015b,
  title = {Comparison of the Usefulness of Heart Rate Variability versus Exercise Stress Testing for the Detection of Myocardial Ischemia in Patients without Known Coronary Artery Disease},
  author = {Goldkorn, Ronen and Naimushin, Alexey and Shlomo, Nir and Dan, Ariella and Oieru, Dan and Moalem, Israel and Rozen, Eli and Gur, Ilan and Levitan, Jacob and Rosenmann, David and Mogilewsky, Yakov and Klempfner, Robert and Goldenberg, Ilan},
  date = {2015},
  journaltitle = {American Journal of Cardiology},
  volume = {115},
  number = {11},
  eprint = {25872904},
  eprinttype = {pmid},
  pages = {1518--1522},
  issn = {18791913},
  doi = {10.1016/j.amjcard.2015.02.054},
  abstract = {Heart rate variability (HRV) has been shown to be attenuated in patients with coronary artery disease (CAD) and may, therefore, be possibly used for the early detection of myocardial ischemia. We aimed to evaluate the diagnostic yield of a novel short-term HRV algorithm for the detection of myocardial ischemia in subjects without known CAD. We prospectively enrolled 450 subjects without known CAD who were referred to tertiary medical centers for exercise stress testing (EST) with single-photon emission computed tomography myocardial perfusion imaging (MPI). All subjects underwent 1-hour Holter testing with subsequent HRV analysis before EST with MPI. The diagnostic yield of HRV analysis was compared with EST, using MPI as the gold standard for the noninvasive detection of myocardial ischemia. All subjects had intermediate pretest probability for CAD. Mean age was 62 years, 38\% were women, 51\% had hypertension, and 25\% diabetes mellitus. HRV analysis showed superior sensitivity (77\%) compared with standard EST (27\%). After multivariate adjustment, HRV was independently associated with an 8.4-fold (p {$<$}0.001) increased likelihood for the detection of myocardial ischemia by MPI, whereas EST did not show a statistically significant association with a positive MPI (odds ratio 2.1; p = 0.12). Of subjects who were referred for subsequent coronary angiography, the respective sensitivities of HRV and EST for the detection of significant CAD were 73\% versus 26\%. Our data suggest that HRV can be used as an important noninvasive technique for the detection of myocardial ischemia in subjects without known CAD, providing superior sensitivity to conventional EST in this population.},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Goldkorn et al_2015_Comparison of the usefulness of heart rate variability versus exercise stress.pdf}
}

@article{Granada2000,
  title = {Incidence and Predictors of Atrial Flutter in the General Population},
  author = {Granada, Juan and Uribe, William and Chyou, Po Huang and Maassen, Karen and Vierkant, Robert and Smith, Peter N. and Hayes, John and Eaker, Elaine and Vidaillet, Humberto},
  date = {2000},
  journaltitle = {Journal of the American College of Cardiology},
  volume = {36},
  number = {7},
  eprint = {11127467},
  eprinttype = {pmid},
  pages = {2242--2246},
  publisher = {{J Am Coll Cardiol}},
  issn = {07351097},
  doi = {10.1016/S0735-1097(00)00982-7},
  url = {https://pubmed-ncbi-nlm-nih-gov.proxy.cc.uic.edu/11127467/},
  urldate = {2022-11-22},
  abstract = {OBJECTIVES: The goal of our study was to determine the incidence and predictors of atrial flutter in the general population. BACKGROUND: Although atrial flutter can now be cured, there are no reports on its epidemiology in unselected patients. METHODS: The Marshfield Epidemiological Study Area (MESA), a database that captures nearly all medical care among its 58,820 residents was used to ascertain all new cases of atrial flutter diagnosed from July 1, 1991 to June 30, 1995. To identify predisposing risk factors, we employed an age- and gender-matched case-control study design using eight additional variables. RESULTS: A total of 181 new cases of atrial flutter were diagnosed for an overall incidence of 88/100,000 person-years. Incidence rates ranged from 5/100,000 in those {$<$}50 years old to 587/100,000 in subjects older than 80. Atrial flutter was 2.5 times more common in men (p {$<$} 0.001). The risk of developing atrial flutter increased 3.5 times (p {$<$} 0.001) in subjects with heart failure and 1.9 times (p {$<$} 0.001) for subjects with chronic obstructive pulmonary disease. Among those with atrial flutter 16\% were attributable to heart failure and 12\% to chronic obstructive lung disease. Three subjects (1.7\%) without identifiable predisposing risks were labeled as having 'lone atrial flutter.' CONCLUSIONS: This study, the first population-based investigation of atrial flutter, suggests this curable condition is much more common than previously appreciated. If our findings were applicable to the entire U.S. population, we estimate 200,000 new cases of atrial flutter in this country annually. At highest risk of developing atrial flutter are men, the elderly and individuals with preexisting heart failure or chronic obstructive lung disease. (C) 2000 by the American College of Cardiology.},
  keywords = {ðŸ”´,80 and over,Adult,Aged,Atrial Flutter / epidemiology*,Case-Control Studies,doi:10.1016/s0735-1097(00)00982-7,H Vidaillet,Humans,Incidence,J Granada,MEDLINE,Middle Aged,National Center for Biotechnology Information,National Institutes of Health,National Library of Medicine,NCBI,NIH,NLM,Non-U.S. Gov't,pmid:11127467,PubMed Abstract,Research Support,Risk Factors,W Uribe,Wisconsin / epidemiology},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Granada et al_2000_Incidence and predictors of atrial flutter in the general population.pdf}
}

@article{Grant2015,
  title = {Epidemiology of {{DSM-5 Alcohol Use Disorder}}: {{Results From}} the {{National Epidemiologic Survey}} on {{Alcohol}} and {{Related Conditions III}}},
  shorttitle = {Epidemiology of {{DSM-5 Alcohol Use Disorder}}},
  author = {Grant, Bridget F. and Goldstein, RisÃ« B. and Saha, Tulshi D. and Chou, S. Patricia and Jung, Jeesun and Zhang, Haitao and Pickering, Roger P. and Ruan, W. June and Smith, Sharon M. and Huang, Boji and Hasin, Deborah S.},
  date = {2015-08},
  journaltitle = {JAMA psychiatry},
  shortjournal = {JAMA Psychiatry},
  volume = {72},
  number = {8},
  eprint = {26039070},
  eprinttype = {pmid},
  pages = {757--766},
  issn = {2168-6238},
  doi = {10.1001/jamapsychiatry.2015.0584},
  abstract = {IMPORTANCE: National epidemiologic information from recently collected data on the new DSM-5 classification of alcohol use disorder (AUD) using a reliable, valid, and uniform data source is needed. OBJECTIVE: To present nationally representative findings on the prevalence, correlates, psychiatric comorbidity, associated disability, and treatment of DSM-5 AUD diagnoses overall and according to severity level (mild, moderate, or severe). DESIGN, SETTING, AND PARTICIPANTS: We conducted face-to-face interviews with a representative US noninstitutionalized civilian adult (â‰¥18 years) sample (N\,=\,36\,309) as the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions III (NESARC-III). Data were collected from April 2012 through June 2013 and analyzed in October 2014. MAIN OUTCOMES AND MEASURES: Twelve-month and lifetime prevalences of AUD. RESULTS: Twelve-month and lifetime prevalences of AUD were 13.9\% and 29.1\%, respectively. Prevalence was generally highest for men (17.6\% and 36.0\%, respectively), white (14.0\% and 32.6\%, respectively) and Native American (19.2\% and 43.4\%, respectively), respondents, and younger (26.7\% and 37.0\%, respectively) and previously married (11.4\% and 27.1\%, respectively) or never married (25.0\% and 35.5\%, respectively) adults. Prevalence of 12-month and lifetime severe AUD was greatest among respondents with the lowest income level (1.8\% and 1.5\%, respectively). Significant disability was associated with 12-month and lifetime AUD and increased with the severity of AUD. Only 19.8\% of respondents with lifetime AUD were ever treated. Significant associations were found between 12-month and lifetime AUD and other substance use disorders, major depressive and bipolar I disorders, and antisocial and borderline personality disorders across all levels of AUD severity, with odds ratios ranging from 1.2 (95\% CI, 1.08-1.36) to 6.4 (95\% CI, 5.76-7.22). Associations between AUD and panic disorder, specific phobia, and generalized anxiety disorder were modest (odds ratios ranged from 1.2 (95\% CI, 1.01-1.43) to 1.4 (95\% CI, 1.13-1.67) across most levels of AUD severity. CONCLUSIONS AND RELEVANCE: Alcohol use disorder defined by DSM-5 criteria is a highly prevalent, highly comorbid, disabling disorder that often goes untreated in the United States. The NESARC-III data indicate an urgent need to educate the public and policy makers about AUD and its treatment alternatives, to destigmatize the disorder, and to encourage those who cannot reduce their alcohol consumption on their own, despite substantial harm to themselves and others, to seek treatment.},
  langid = {english},
  pmcid = {PMC5240584},
  keywords = {ðŸ”´,Adolescent,Adult,Age Factors,Aged,Alcoholism,Comorbidity,Diagnostic and Statistical Manual of Mental Disorders,Female,Health Surveys,Humans,Male,Mental Disorders,Middle Aged,Prevalence,Sex Factors,Socioeconomic Factors,United States,Young Adult},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Grant et al_2015_Epidemiology of DSM-5 Alcohol Use Disorder.pdf}
}

@article{Greenberg2015b,
  title = {The Economic Burden of Adults with Major Depressive Disorder in the {{United States}} (2005 and 2010)},
  author = {Greenberg, Paul E. and Fournier, Andree Anne and Sisitsky, Tammy and Pike, Crystal T. and Kessler, Ronald C.},
  date = {2015-02-01},
  journaltitle = {Journal of Clinical Psychiatry},
  volume = {76},
  number = {2},
  eprint = {25742202},
  eprinttype = {pmid},
  pages = {155--162},
  publisher = {{Physicians Postgraduate Press Inc.}},
  issn = {01606689},
  doi = {10.4088/JCP.14m09298},
  abstract = {Background: The economic burden of depression in the United States-including major depressive disorder (MDD), bipolar disorder, and dysthymia-was estimated at \$83.1 billion in 2000. We update these findings using recent data, focusing on MDD alone and accounting for comorbid physical and psychiatric disorders. Method: Using national survey (DSM-IV criteria) and administrative claims data (ICD-9 codes), we estimate the incremental economic burden of individuals with MDD as well as the share of these costs attributable to MDD, with attention to any changes that occurred between 2005 and 2010. Results: The incremental economic burden of individuals with MDD increased by 21.5\% (from \$173.2 billion to \$210.5 billion, inflation-adjusted dollars). The composition of these costs remained stable, with approximately 45\% attributable to direct costs, 5\% to suicide-related costs, and 50\% to workplace costs. Only 38\% of the total costs were due to MDD itself as opposed to comorbid conditions. Conclusions: Comorbid conditions account for the largest portion of the growing economic burden of MDD. Future research should analyze further these comorbidities as well as the relative importance of factors contributing to that growing burden. These include population growth, increase in MDD prevalence, increase in treatment cost per individual with MDD, changes in employment and treatment rates, as well as changes in the composition and quality of MDD treatment services.},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Greenberg et al_2015_The economic burden of adults with major depressive disorder in the United.pdf}
}

@article{Grippo2002,
  title = {Biological Mechanisms in the Relationship between Depression and Heart Disease},
  author = {Grippo, Angela J. and Johnson, Alan Kim},
  date = {2002},
  journaltitle = {Neuroscience and Biobehavioral Reviews},
  volume = {26},
  number = {8},
  eprint = {12667498},
  eprinttype = {pmid},
  pages = {941--962},
  issn = {01497634},
  doi = {10.1016/S0149-7634(03)00003-4},
  abstract = {Psychological depression is shown to be associated with several aspects of coronary artery disease (CAD), including arrhythmias, myocardial infarction, heart failure and sudden death. The physiological mechanisms accounting for this association are unclear. Hypothalamic-pituitary-adrenal dysregulation, diminished heart rate variability, altered blood platelet function and noncompliance with medial treatments have been proposed as mechanisms underlying depression and cardiovascular disease. Recent evidence also suggests that reduced baroreflex sensitivity, impaired immune function, chronic fatigue and the co-morbidity of depression and anxiety may be involved in the relationship between depression and cardiovascular dysregulation. An experimental strategy using animal models for investigating underlying physiological abnormalities in depression is presented. A key to understanding the bidirectional association between depression and heart disease is to determine whether there are common changes in brain systems that are associated with these conditions. Such approaches may hold promise for advancing our understanding of the interaction between this mood disorder and CAD. Â© 2003 Elsevier Science Ltd. All rights reserved.},
  isbn = {0149-7634},
  keywords = {ðŸ”´,Animal models,Anxiety,Autonomic nervous system,Baroreflex,Cardiovascular,Central nervous system,Coronary artery disease,Depression,Fatigue,Heart rate variability,Immune system},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Grippo_Johnson_2002_Biological mechanisms in the relationship between depression and heart disease.pdf}
}

@article{Gudbjartsson2007,
  title = {Variants Conferring Risk of Atrial Fibrillation on Chromosome 4q25},
  author = {Gudbjartsson, Daniel F. and Arnar, David O. and Helgadottir, Anna and Gretarsdottir, Solveig and Holm, Hilma and Sigurdsson, Asgeir and Jonasdottir, Adalbjorg and Baker, Adam and Thorleifsson, Gudmar and Kristjansson, Kristleifur and Palsson, Arnar and Blondal, Thorarinn and Sulem, Patrick and Backman, Valgerdur M. and Hardarson, Gudmundur A. and Palsdottir, Ebba and Helgason, Agnar and Sigurjonsdottir, Runa and Sverrisson, Jon T. and Kostulas, Konstantinos and Ng, Maggie C. Y. and Baum, Larry and So, Wing Yee and Wong, Ka Sing and Chan, Juliana C. N. and Furie, Karen L. and Greenberg, Steven M. and Sale, Michelle and Kelly, Peter and MacRae, Calum A. and Smith, Eric E. and Rosand, Jonathan and Hillert, Jan and Ma, Ronald C. W. and Ellinor, Patrick T. and Thorgeirsson, Gudmundur and Gulcher, Jeffrey R. and Kong, Augustine and Thorsteinsdottir, Unnur and Stefansson, Kari},
  date = {2007-07},
  journaltitle = {Nature},
  volume = {448},
  number = {7151},
  pages = {353--357},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/nature06007},
  url = {https://www.nature.com/articles/nature06007},
  urldate = {2023-08-13},
  abstract = {A genome-wide association scan in populations from Sweden, North America and China has identified two single-letter sequence variants on chromosome 4q25 as risk factors for atrial fibrillation, the most common form of cardiac arrhythmia. Both are adjacent to the PITX2 gene, known to be involved in early heart development. This work identifies PITX2 as a target for diagnostic tests and possibly for therapeutic intervention.},
  issue = {7151},
  langid = {english},
  keywords = {âœ”ï¸,Humanities and Social Sciences,multidisciplinary,Science},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Gudbjartsson et al_2007_Variants conferring risk of atrial fibrillation on chromosome 4q25.pdf}
}

@article{Hachamovitch1998,
  title = {Incremental Prognostic Value of Myocardial Perfusion Single Photon Emission Computed Tomography for the Prediction of Cardiac Death: {{Differential}} Stratification for Risk of Cardiac Death and Myocardial Infarction},
  author = {Hachamovitch, Rory and Berman, Daniel S. and Shaw, Leslee J. and Kiat, Hosen and Cohen, Ishac and Arthur Cabico, J. and Friedman, John and Diamond, George A.},
  date = {1998-02-17},
  journaltitle = {Circulation},
  volume = {97},
  number = {6},
  eprint = {9494023},
  eprinttype = {pmid},
  pages = {535--543},
  publisher = {{Lippincott Williams \& Wilkins}},
  issn = {00097322},
  doi = {10.1161/01.CIR.97.6.535},
  url = {https://www.ahajournals.org/doi/abs/10.1161/01.CIR.97.6.535},
  urldate = {2022-06-10},
  abstract = {Background - The incremental prognostic value of stress single photon emission computed tomography (SPECT) for the prediction of cardiac death as an individual end point and the implications for risk stratification are undefined. Methods and Results - We identified 5183 consecutive patients who underwent stress/rest SPECT and were followed up for the occurrence of cardiac death or myocardial infarction. Over a mean follow up of 642Â±226 days, 119 cardiac deaths and 158 myocardial infarctions occurred (3.0\% cardiac death rate, 2.3\% myocardial infarction rate). Patients with normal scans were at low risk (â‰¤0.5\%/y), and rates of both outcomes increased significantly with worsening scan abnormalities. Patients who underwent exercise stress and had mildly abnormal scans had low rates of cardiac death but higher rates of myocardial infarction (0.7\%/y versus 2.6\%/y; P{$<$}.05). After adjustment for prescan information, scan results provided incremental prognostic value toward the prediction of cardiac death. The identification of patients at intermediate risk of nonfatal myocardial infarction and low risk for cardiac death by SPECT may result in significant cost savings when applied to a clinical testing strategy. Conclusions - Myocardial perfusion SPECT yields incremental prognostic information toward the identification of cardiac death. Patients with mildly abnormal scans after exercise stress are at low risk for cardiac death but intermediate risk for nonfatal myocardial infarction and thus may benefit from a noninvasive strategy and may not require invasive management.},
  keywords = {ðŸ”´,Perfusion,Prognosis,Tomography},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Hachamovitch et al_1998_Incremental prognostic value of myocardial perfusion single photon emission.pdf}
}

@article{Halligan2004,
  title = {The {{Natural History}} of {{Lone Atrial Flutter}}},
  author = {Halligan, Sean C. and Gersh, Bernard J. and Brown, Robert D. and Rosales, A. Gabriela and Munger, Thomas M. and Shen, Win Kuang and Hammill, Stephen C. and Friedman, Paul A.},
  date = {2004},
  journaltitle = {Annals of Internal Medicine},
  volume = {140},
  number = {4},
  eprint = {14970149},
  eprinttype = {pmid},
  pages = {265--269},
  issn = {00034819},
  doi = {10.7326/0003-4819-140-4-200402170-00008},
  abstract = {Background: The natural history of atrial flutter is not well defined. Objective: To report the risk for stroke, conversion to atrial fibrillation, and anticoagulation for lone atrial flutter. Design: Retrospective cohort analysis. Setting: A clinically based longitudinal study of inpatients and outpatients with atrial flutter. Patients: The authors compared the stroke rate in 59 patients with atrial flutter with rates in a sample in which age- and sex-specific ischemic cerebrovascular event rates were determined and in a sample of nonhypertensive patients with lone atrial fibrillation. The risk for developing atrial fibrillation after presenting with atrial flutter is also reported. Measurements: Electrocardiograms and clinical data were collected and reviewed for each study participant. Results: After adjustment for age and sex, patients with atrial flutter had a higher incidence of thromboembolic events than the sample control patients and patients with atrial fibrillation. Atrial fibrillation developed in 56\% of patients with atrial flutter. Conclusions: Lone atrial flutter has a stroke risk at least as high as lone atrial fibrillation and carries a higher risk for subsequent development of atrial fibrillation than in the general population. Anticoagulation should be considered for all patients with atrial flutter who are older than 65 years of age.},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Halligan et al_2004_The Natural History of Lone Atrial Flutter.pdf}
}

@article{Hare2014,
  title = {Depression and Cardiovascular Disease: {{A}} Clinical Review},
  author = {Hare, David L and Toukhsati, Samia R and Johansson, Peter and Jaarsma, Tiny},
  date = {2014-06-01},
  journaltitle = {European Heart Journal},
  volume = {35},
  number = {21},
  eprint = {24282187},
  eprinttype = {pmid},
  pages = {1365--1372},
  issn = {15229645},
  doi = {10.1093/eurheartj/eht462},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/24282187},
  urldate = {2019-10-19},
  abstract = {Cardiovascular disease (CVD) and depression are common. Patients with CVD have more depression than the general population. Persons with depression are more likely to eventually develop CVD and also have a higher mortality rate than the general population. Patients with CVD, who are also depressed, have a worse outcome than those patients who are not depressed. There is a graded relationship: the more severe the depression, the higher the subsequent risk of mortality and other cardiovascular events. It is possible that depression is only a marker for more severe CVD which so far cannot be detected using our currently available investigations. However, given the increased prevalence of depression in patients with CVD, a causal relationship with either CVD causing more depression or depression causing more CVD and a worse prognosis for CVD is probable. There are many possible pathogenetic mechanisms that have been described, which are plausible and that might well be important. However, whether or not there is a causal relationship, depression is the main driver of quality of life and requires prevention, detection, and management in its own right. Depression after an acute cardiac event is commonly an adjustment disorder than can improve spontaneously with comprehensive cardiac management. Additional management strategies for depressed cardiac patients include cardiac rehabilitation and exercise programmes, general support, cognitive behavioural therapy, antidepressant medication, combined approaches, and probably disease management programmes. Â© The Author 2013.},
  keywords = {ðŸ”´,Cardiovascular disease,Depression,Management,Prognosis,Quality of life,Screening}
}

@article{Hayek2015,
  title = {Soluble {{Urokinase Receptor}} and {{Chronic Kidney Disease}}},
  author = {Hayek, Salim S. and Sever, Sanja and Ko, Yi-An and Trachtman, Howard and Awad, Mosaab and Wadhwani, Shikha and Altintas, Mehmet M. and Wei, Changli and Hotton, Anna L. and French, Audrey L. and Sperling, Laurence S. and Lerakis, Stamatios and Quyyumi, Arshed A. and Reiser, Jochen},
  date = {2015-11-12},
  journaltitle = {New England Journal of Medicine},
  shortjournal = {N Engl J Med},
  volume = {373},
  number = {20},
  pages = {1916--1925},
  publisher = {{Massachusetts Medical Society}},
  issn = {0028-4793},
  doi = {10.1056/NEJMoa1506362},
  url = {https://www.nejm.org/doi/10.1056/NEJMoa1506362},
  urldate = {2023-09-07},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Hayek et al_2015_Soluble Urokinase Receptor and Chronic Kidney Disease.pdf}
}

@article{Holmqvist2015,
  title = {Heart Rate Is Associated with Progression of Atrial Fibrillation, Independent of Rhythm},
  author = {Holmqvist, Fredrik and Kim, Sunghee and Steinberg, Benjamin A. and Reiffel, James A. and Mahaffey, Kenneth W. and Gersh, Bernard J. and Fonarow, Gregg C. and Naccarelli, Gerald V. and Chang, Paul and Freeman, James V. and Kowey, Peter R. and Thomas, Laine and Peterson, Eric D. and Piccini, Jonathan P. and {ORBIT-AF Investigators}},
  date = {2015-06},
  journaltitle = {Heart (British Cardiac Society)},
  shortjournal = {Heart},
  volume = {101},
  number = {11},
  eprint = {25732748},
  eprinttype = {pmid},
  pages = {894--899},
  issn = {1468-201X},
  doi = {10.1136/heartjnl-2014-307043},
  abstract = {OBJECTIVE: Atrial fibrillation (AF) often progresses from paroxysmal or persistent to more sustained forms, but the rate and predictors of AF progression in clinical practice are not well described. METHODS: Using the Outcomes Registry for Better Informed Treatment of AF, we analysed the incidence and predictors of progression and tested the discrimination and calibration of the HATCH (hypertension, age, TIA/stroke, chronic obstructive pulmonary disease, heart failure) and CHAâ‚‚DSâ‚‚VASc scores for identifying AF progression. RESULTS: Among 6235 patients with paroxysmal or persistent AF at baseline, 1479 progressed, during follow-up (median 18 (IQR 12-24) months). These patients were older and had more comorbidities than patients who did not progress (CHADSâ‚‚ 2.3Â±1.3 vs 2.1Â±1.3, p{$<$}0.0001). At baseline, patients with AF progression were more often on a rate control as opposed to a rhythm control strategy (66 vs 56\%, p{$<$}0.0001) and had higher heart rate (72(64-80) vs 68(60-76) bpm, p{$<$}0.0001). The strongest predictors of AF progression were AF on the baseline ECG (OR 2.30, 95\% CI 1.95 to 2.73, p{$<$}0.0001) and increasing age (OR 1.16, 95\% CI1.09 to 1.24, p{$<$}0.0001, per 10 increase), while patients with lower heart rate (OR 0.84, 95\% CI 0.79 to 0.89, p{$<$}0.0001, per 10 decrease â‰¤80) were less likely to progress. There was no significant interaction between rhythm on baseline ECG and heart rate (p=0.71). The HATCH and CHAâ‚‚DSâ‚‚VASc scores had modest discriminatory power for AF progression (C-indices 0.55 (95\% CI 0.53 to 0.58) and 0.55 (95\% CI 0.52 to 0.57)). CONCLUSIONS: Within 1.5\hspace{0.25em}years, almost a quarter of the patients with paroxysmal or persistent AF progress to a more sustained form. Progression is strongly associated with heart rate, and age.},
  langid = {english},
  pmcid = {PMC4453487},
  keywords = {ðŸ”´,Age Factors,Aged,{Aged, 80 and over},Atrial Fibrillation,Cohort Studies,Disease Progression,Female,Heart Failure,Heart Rate,Humans,{Hypertrophy, Left Ventricular},Male,Risk Factors},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Holmqvist et al_2015_Heart rate is associated with progression of atrial fibrillation, independent.pdf}
}

@article{Honarbakhsh2022,
  title = {Noninvasive Electrocardiographic Imagingâ€“Guided Targeting of Drivers of Persistent Atrial Fibrillation: {{The TARGET-AF1}} Trial},
  shorttitle = {Noninvasive Electrocardiographic Imagingâ€“Guided Targeting of Drivers of Persistent Atrial Fibrillation},
  author = {Honarbakhsh, Shohreh and Dhillon, Gurpreet and Abbass, Hakam and Waddingham, Peter H. and Dennis, Adam and Ahluwalia, Nikhil and Welch, Sophie and Daw, Holly and Sporton, Simon and Chow, Anthony and Earley, Mark J. and Lambiase, Pier D. and Hunter, Ross J.},
  date = {2022-06-01},
  journaltitle = {Heart Rhythm},
  shortjournal = {Heart Rhythm},
  volume = {19},
  number = {6},
  eprint = {35134548},
  eprinttype = {pmid},
  pages = {875--884},
  publisher = {{Elsevier}},
  issn = {1547-5271, 1556-3871},
  doi = {10.1016/j.hrthm.2022.01.042},
  url = {https://www.heartrhythmjournal.com/article/S1547-5271(22)00120-5/fulltext},
  urldate = {2023-07-26},
  langid = {english},
  keywords = {ðŸ”´,Atrial fibrillation,Atrial mapping,Catheter ablation,Mapping system,Rotor},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Honarbakhsh et al_2022_Noninvasive electrocardiographic imagingâ€“guided targeting of drivers of.pdf}
}

@article{Hopp2013,
  title = {High Cardiac Vagal Control Protects against Future Depressive Symptoms under Conditions of High Social Support},
  author = {Hopp, Henrik and Shallcross, Amanda J. and Ford, Brett Q. and Troy, Allison S. and Wilhelm, Frank H. and Mauss, Iris B.},
  date = {2013-04},
  journaltitle = {Biological Psychology},
  volume = {93},
  number = {1},
  eprint = {23352570},
  eprinttype = {pmid},
  pages = {143--149},
  publisher = {{NIH Public Access}},
  issn = {03010511},
  doi = {10.1016/j.biopsycho.2013.01.004},
  url = {/pmc/articles/PMC3622765/?report=abstract},
  urldate = {2020-11-05},
  abstract = {High cardiac vagal control (as measured by respiratory sinus arrhythmia; RSA) is associated with lower depression. Recent theories argue that people's responsiveness to social resources is a key mechanism in this association. This argument implies two hypotheses: first, high RSA should be related to decreased depressive symptoms only when social resources (social support) are available; second, utilization of available social resources (social engagement) should serve as a mechanism for the positive effects of RSA. To test these hypotheses, we measured RSA in 131 adults. Participants reported their social support, social engagement, and depressive symptoms. Six months later, they again reported their depressive symptoms. Participants with higher RSA reported fewer depressive symptoms six months later, but only under conditions of high social support. The interaction between RSA and social support in predicting depressive symptoms was fully mediated by social engagement. These findings provide crucial support for the idea that cardiac vagal control contributes to decreased depressive symptoms via social processes. Implications for biological sensitivity to context and differential susceptibility theories as well as for the prevention and treatment of depression are discussed. Â© 2013 Elsevier B.V.},
  keywords = {ðŸ”´,Cardiac vagal control,Heart rate variability,Major depressive disorder,Person by environment interaction,Psychophysiology,Respiratory sinus arrhythmia,Social engagement,Social support},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Hopp et al_2013_High cardiac vagal control protects against future depressive symptoms under.pdf}
}

@article{Houle1999,
  title = {Low-Frequency Component of the Heart Rate Variability Spectrum: A Poor Marker of Sympathetic Activity},
  author = {Houle, Melanie S. and Billman, George E.},
  date = {1999-01},
  journaltitle = {American Journal of Physiology-Heart and Circulatory Physiology},
  volume = {276},
  number = {1},
  eprint = {9887035},
  eprinttype = {pmid},
  pages = {H215-H223},
  issn = {0363-6135},
  doi = {10.1152/ajpheart.1999.276.1.H215},
  url = {http://www.physiology.org/doi/10.1152/ajpheart.1999.276.1.H215},
  urldate = {2018-09-29},
  abstract = {The low-frequency component of the heart rate variability spectrum (0.06-0.10 Hz) is often used as an accurate reflection of sympathetic activity. Therefore, interventions that enhance cardiac sympathetic drive, e.g., exercise and myocardial ischemia, should elicit increases in the low-frequency power. Furthermore, because an enhanced sympathetic activation has been linked to an increased propensity for malignant arrhythmias, one might also predict a greater low-frequency power in animals that are susceptible to ventricular fibrillation than in resistant animals. To test these hypotheses, a 2-min coronary occlusion was made during the last minute of exercise in 71 dogs with healed myocardial infarctions: 43 had ventricular fibrillation (susceptible) and 28 did not experience arrhythmias (resistant). Exercise or ischemia alone provoked significant heart rate increases in both groups of animals, with the largest increase in the susceptible animals. These heart rate increases were attenuated by beta-adrenergic receptor blockade. Despite the sympathetically mediated increases in heart rate, the low-frequency power decreased, rather than increased, in both groups, with the largest decrease again in the susceptible animals: 4.0 +/- 0.2 (susceptible) vs. 4.1 +/- 0.2 ln ms2 (resistant) in preexercise control and 2.2 +/- 0.2 (susceptible) vs. 2.9 +/- 0.2 ln ms2 (resistant) at highest exercise level. In a similar manner the parasympathetic antagonist atropine sulfate elicited significant reductions in the low-frequency power. Although sympathetic nerve activity was not directly recorded, these data suggest that the low-frequency component of the heart rate power spectrum probably results from an interaction of the sympathetic and parasympathetic nervous systems and, as such, does not accurately reflect changes in the sympathetic activity.},
  isbn = {0002-9513 (Print)\textbackslash r0002-9513 (Linking)},
  keywords = {ðŸ”´,Autonomic nervous system,Baroreceptor reflex,done,Spectral analysis},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Houle_Billman_1999_Low-frequency component of the heart rate variability spectrum.pdf}
}

@article{Hu2018,
  title = {Association between Depression, Anxiety, and Antidepressant Use with {{T-Wave}} Amplitude and {{QT-interval}}},
  author = {Hu, Mandy X and Lamers, Femke and Penninx, Brenda W.J.H. and family=Geus, given=Eco J.C., prefix=de, useprefix=true},
  date = {2018},
  journaltitle = {Frontiers in Neuroscience},
  volume = {12},
  eprint = {29922124},
  eprinttype = {pmid},
  pages = {375},
  issn = {1662453X},
  doi = {10.3389/fnins.2018.00375},
  url = {www.frontiersin.org},
  urldate = {2018-10-24},
  abstract = {Objectives: Cardiac repolarization may be affected by psychiatric disorders and/or antidepressant use, but evidence for this is inconclusive. This study examined the relationship between depressive and anxiety disorder and use of antidepressants with T-wave amplitude (TWA) and QT-interval. Methods: Data was obtained from the Netherlands Study of Depression and Anxiety (n = 1,383). Depression/anxiety was diagnosed with the DSM-IV based Composite International Diagnostic Interview. The use of tricyclic antidepressants (TCAs), selective serotonin and noradrenalin reuptake inhibitors (SNRIs), and selective serotonin reuptake inhibitors (SSRIs) was established. T-wave amplitude and QT-interval corrected for heart rate (QTc) were obtained from an ECG measured in a type II axis configuration. Results: Compared to controls, persons with depression or anxiety disorders did not show a significantly different TWA (p = 0.58; Cohen's d = 0.046) or QTc (p = 0.48; Cohen's d = -0.057). In spite of known sympathomimetic effects, TCA use (p = 0.26; Cohen's d = -0.162) and SNRI use (p = 0.70; Cohen's d = -0.055) were not significantly associated with a lower TWA. TCA use (p = 0.12; Cohen's d = 0.225) and SNRI use (p = 0.11; Cohen's d = 0.227) were also not significantly associated with a prolonged QTc. Conclusion: We did not find evidence that either depressive/anxiety disorder or antidepressant use is associated with abnormalities in TWA or QTc. Earlier found sympathomimetic effects of TCAs and SNRIs are not evident in these measures of cardiac repolarization.},
  issue = {JUN},
  keywords = {ðŸ”´,Antidepressant,Anxiety,Autonomic nervous system,Cardiac repolarization,Depression},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Hu et al_2018_Association between depression, anxiety, and antidepressant use with T-Wave.pdf}
}

@article{Huang2018,
  title = {Association of {{Depressive Symptoms}} and {{Heart Rate Variability}} in {{Vietnam War}}â€“{{Era Twins}}},
  author = {Huang, Minxuan and Shah, Amit and Su, Shaoyong and Goldberg, Jack and Lampert, Rachel J. and Levantsevych, Oleksiy M. and Shallenberger, Lucy and Pimple, Pratik and Bremner, J. Douglas and Vaccarino, Viola},
  date = {2018-07-01},
  journaltitle = {JAMA Psychiatry},
  volume = {75},
  number = {7},
  pages = {705},
  issn = {2168-622X},
  doi = {10.1001/jamapsychiatry.2018.0747},
  url = {http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/jamapsychiatry.2018.0747},
  urldate = {2018-05-28},
  abstract = {Importance Depressive symptoms are associated with lower heart rate variability (HRV), an index of autonomic dysregulation, but the direction of the association remains unclear. Objective To investigate the temporal association between depression and HRV. Design, Settings, and Participants A longitudinal, cross-lagged twin difference study, with baseline assessments from March 2002 to March 2006 (visit 1) and a 7-year follow-up (visit 2) at an academic research center with participants recruited from a national twin registry. Twins (n = 166) from the Vietnam Era Twin Registry, who served in the US military during the Vietnam War, and were discordant for depression at baseline were recruited. Main Outcomes and Measures At both visits, depressive symptoms were measured using the Beck Depression Inventory-II (BDI-II), and HRV was measured through 24-hour electrocardiogram monitoring. To assess the direction of the association, within-pair differences in multivariable mixed-effects regression models were examined, and standardized Î² coefficients for both pathways were calculated. The associations were evaluated separately in monozygotic and dizygotic twins. Results In the final analytic sample (N = 146), all participants were men, 138 (95\%) were white, and the mean (SD) age was 54 (3) years at baseline. Results showed consistent associations between visit 1 HRV and visit 2 BDI score across all HRV domains and models (Î² coefficients ranging from âˆ’0.14 to âˆ’0.29), which were not explained by antidepressants or other participant characteristics. The magnitude of the association was similar in the opposite pathway linking visit 1 BDI score to visit 2 HRV, with Î² coefficients ranging from 0.05 to âˆ’0.30, but it was largely explained by antidepressant use. In stratified analysis by zygosity, significant associations were observed in monozygotic and dizygotic twins for the path linking visit 1 HRV to visit 2 BDI score, although the associations were slightly stronger in dizygotic twins. Conclusions and Relevance The association between depression and autonomic dysregulation, indexed by HRV, is bidirectional, with stronger evidence suggesting that autonomic function affects depression risk rather than vice versa. The opposite causal pathway from depression to lower HRV is mostly driven by antidepressant use. These findings highlight an important role of autonomic nervous system in the risk of depression and contribute new understanding of the mechanisms underlying the comorbidity of depression and cardiovascular disease.},
  keywords = {ðŸ”´,depressive disorders,dysautonomia,heart rate variability,twins,veterans},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Huang et al_2018_Association of Depressive Symptoms and Heart Rate Variability in Vietnam.pdf}
}

@article{Hughes2008,
  title = {Depressive Symptoms Predict Heart Rate Recovery after Exercise Treadmill Testing in Patients with Coronary Artery Disease: {{Results}} from the Psychophysiological Investigations of Myocardial Ischemia Study},
  author = {Hughes, Joel W. and York, Kaki M. and Li, Qin and Freedland, Kenneth E. and Carney, Robert M. and Sheps, David S.},
  date = {2008},
  journaltitle = {Psychosomatic Medicine},
  volume = {70},
  number = {4},
  eprint = {18434491},
  eprinttype = {pmid},
  pages = {456--460},
  issn = {15347796},
  doi = {10.1097/PSY.0b013e31816fcab3},
  abstract = {BACKGROUND: Depression is associated with increased risk of death among patients with coronary disease. Cardiovascular autonomic dysregulation may be one of the mechanisms by which depression exerts its effects on cardiovascular function. The purpose of this study was to determine whether depressive symptoms are associated with low heart rate variability (HRV) and prolonged HR recovery after exercise testing in patients with coronary artery disease (CAD). METHODS: The Psychophysiological Investigation of Myocardial Ischemia (PIMI) was a large, multicenter study designed to assess psychological and physiological correlates of stress in patients with CAD. One hundred and eighty-eight patients with CAD as evidenced by at least 50\% blockage of one major artery and a previous positive exercise stress test were included in this study. Patients included in this report were not taking beta blockers. Cardiovascular functioning was assessed by a modified Bruce protocol treadmill stress test. Measures of psychological functioning, including the Beck Depression Inventory (BDI), were also obtained. RESULTS: BDI scores were negatively correlated with HR recovery (r = -0.15, p = .04). Depression scores accounted for 3.5\% of the variance in HR recovery when controlling for participant age (p {$<$} .01). Depressive symptoms were related to two HRV indices (ultra-low frequency, high frequency). CONCLUSIONS: Depressive symptoms are associated with cardiovascular autonomic nervous system dysfunction as assessed by HR recovery. This relationship is not merely due to an association of depression severity with beta blocker usage or a failure of depressed patients to achieve an adequate chronotropic response.},
  isbn = {0033-3174},
  keywords = {ðŸ”´,Autonomic nervous system,Coronary disease,Depression,Heart rate recovery},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Hughes et al_2008_Depressive symptoms predict heart rate recovery after exercise treadmill.pdf}
}

@article{Husser2009,
  title = {A {{Genotype-Dependent Intermediate ECG Phenotype}} in {{Patients With Persistent Lone Atrial Fibrillation}}},
  author = {Husser, Daniela and Stridh, Martin and SÃ¶rnmo, Leif and Roden, Dan M. and Darbar, Dawood and Bollmann, Andreas},
  date = {2009-02},
  journaltitle = {Circulation: Arrhythmia and Electrophysiology},
  volume = {2},
  number = {1},
  pages = {24--28},
  publisher = {{American Heart Association}},
  doi = {10.1161/CIRCEP.108.799098},
  url = {https://www.ahajournals.org/doi/10.1161/CIRCEP.108.799098},
  urldate = {2023-07-26},
  abstract = {Backgroundâ€” Atrial fibrillation (AF) is heterogeneous at the clinical and molecular levels. Association studies have reported that common single-nucleotide polymorphisms in KCNE1 and SCN5A may predispose to AF. In this study, we tested the hypothesis that specific AF-associated genotypes confer variation on the appearance of AF assessed by analysis of fibrillatory rate of the atria. Methods and Resultsâ€” Twenty-six nonrelated patients (21 males, mean age 55ï¿½12 years) with persistent lone AF (median AF duration 5 weeks) not taking class I or III antiarrhythmic drugs were studied. Fibrillatory rate was obtained by spatiotemporal QRST cancellation and time-frequency analysis of the index surface ECG. Genotypes at the AF-associated loci in KCNE1 (S38G) and SCN5A (H558R) were determined by direct DNA sequencing. The atrial fibrillatory rate was 418ï¿½50 fibrillations per minute (range, 336 to 521) in the study cohort. Carriers of the 38GG KCNE1 genotype (n=13) had significantly lower fibrillatory rates (392ï¿½36 versus 443ï¿½49 fibrillations per minute, P=0.006) compared to those with GS or SS genotype (n=13). Six patients (23\%) with fibrillatory rates {$>$}450 fibrillations per minute, all had either the GS or SS genotype (Ï‡2P=0.008). In contrast, both the heterozygeous and homozygeous SCN5A H558R polymorphism had no effect on fibrillatory rate. There were no significant associations between fibrillatory rate and clinical (age, gender, AF duration, drug treatment) or echocardiographic (left atrial diameter, left ventricular ejection fraction) variables. In multivariable regression analysis, the KCNE1 S38G genotype (SS/GS coded 0, GG coded 1) was the only independent predictor of fibrillatory rate (Î²=âˆ’0.437, P=0.006) with a SE of the estimate of 44 fibrillations per minute. Conclusionsâ€” This study suggests that atrial fibrillatory rate obtained from the surface ECG is at least in part determined by KCNE1 (S38G) genotype, implying that this variant exerts functional effects on atrial electrophysiology. This intermediate ECG phenotype may be useful for elaborating genetic influences on AF mechanisms and identifying subsets of patients for variability in AF susceptibility or response to therapies.},
  keywords = {ðŸ”´,atrial fibrillation,electrocardiography,electrophysiology,genetics},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Husser et al_2009_A Genotype-Dependent Intermediate ECG Phenotype in Patients With Persistent.pdf}
}

@article{Jha2019,
  title = {Screening and {{Management}} of {{Depression}} in {{Patients With Cardiovascular Disease}}: {{JACC State-of-the-Art Review}}},
  author = {Jha, Manish K and Qamar, Arman and Vaduganathan, Muthiah and Charney, Dennis S and Murrough, James W},
  date = {2019-04-16},
  journaltitle = {Journal of the American College of Cardiology},
  volume = {73},
  number = {14},
  eprint = {30975301},
  eprinttype = {pmid},
  pages = {1827--1845},
  issn = {15583597},
  doi = {10.1016/j.jacc.2019.01.041},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/30975301},
  urldate = {2019-10-19},
  abstract = {Depression is a common problem in patients with cardiovascular disease (CVD) and is associated with increased mortality, excess disability, greater health care expenditures, and reduced quality of life. Depression is present in 1 of 5 patients with coronary artery disease, peripheral artery disease, and heart failure. Depression complicates the optimal management of CVD by worsening cardiovascular risk factors and decreasing adherence to healthy lifestyles and evidence-based medical therapies. As such, standardized screening pathways for depression in patients with CVD offer the potential for early identification and optimal management of depression to improve health outcomes. Unfortunately, the burden of depression in patients with CVD is under-recognized; as a result, screening and management strategies targeting depression have been poorly implemented in patients with CVD. In this review, the authors discuss a practical approach for the screening and management of depression in patients with CVD.},
  keywords = {ðŸ”´,antidepressant treatment,cardiovascular disease,depression,screening}
}

@article{Jia2018,
  title = {Diabetic Cardiomyopathy: {{An}} Update of Mechanisms Contributing to This Clinical Entity},
  author = {Jia, Guanghong and Hill, Michael A. and Sowers, James R.},
  date = {2018-02-01},
  journaltitle = {Circulation Research},
  volume = {122},
  number = {4},
  eprint = {29449364},
  eprinttype = {pmid},
  pages = {624--638},
  publisher = {{Lippincott Williams and Wilkins}},
  issn = {15244571},
  doi = {10.1161/CIRCRESAHA.117.311586},
  abstract = {Heart failure and related morbidity and mortality are increasing at an alarming rate, in large part, because of increases in aging, obesity, and diabetes mellitus. The clinical outcomes associated with heart failure are considerably worse for patients with diabetes mellitus than for those without diabetes mellitus. In people with diabetes mellitus, the presence of myocardial dysfunction in the absence of overt clinical coronary artery disease, valvular disease, and other conventional cardiovascular risk factors, such as hypertension and dyslipidemia, has led to the descriptive terminology, diabetic cardiomyopathy. The prevalence of diabetic cardiomyopathy is increasing in parallel with the increase in diabetes mellitus. Diabetic cardiomyopathy is initially characterized by myocardial fibrosis, dysfunctional remodeling, and associated diastolic dysfunction, later by systolic dysfunction, and eventually by clinical heart failure. Impaired cardiac insulin metabolic signaling, mitochondrial dysfunction, increases in oxidative stress, reduced nitric oxide bioavailability, elevations in advanced glycation end products and collagen-based cardiomyocyte and extracellular matrix stiffness, impaired mitochondrial and cardiomyocyte calcium handling, inflammation, renin-angiotensin-aldosterone system activation, cardiac autonomic neuropathy, endoplasmic reticulum stress, microvascular dysfunction, and a myriad of cardiac metabolic abnormalities have all been implicated in the development and progression of diabetic cardiomyopathy. Molecular mechanisms linked to the underlying pathophysiological changes include abnormalities in AMP-Activated protein kinase, peroxisome proliferator-Activated receptors, O-linked N-Acetylglucosamine, protein kinase C, microRNA, and exosome pathways. The aim of this review is to provide a contemporary view of these instigators of diabetic cardiomyopathy, as well as mechanistically based strategies for the prevention and treatment of diabetic cardiomyopathy.},
  keywords = {ðŸ”´,Cardiac,Diabetes mellitus,Heart failure,Myocytes,Proxisome proliferator-Activated receptors,Renin-Angiotensin system},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Jia et al_2018_Diabetic cardiomyopathy.pdf}
}

@article{JÃ¸rgensen2015,
  title = {Heart Rate Variability Density Analysis ({{Dyx}}) for Identification of Appropriate Implantable Cardioverter Defibrillator Recipients among Elderly Patients with Acute Myocardial Infarction and Left Ventricular Systolic Dysfunction},
  author = {JÃ¸rgensen, Rikke MÃ¸rch and Levitan, Jacob and Halevi, Zohar and Puzanov, Natalia and AbildstrÃ¸m, Steen Zabell and Messier, Marc D. and Huikuri, Heikki V. and Haarbo, Jens and Thomsen, Poul Erik Bloch and Jons, Christian},
  date = {2015},
  journaltitle = {Europace},
  volume = {17},
  number = {12},
  eprint = {25755288},
  eprinttype = {pmid},
  pages = {1848--1854},
  issn = {15322092},
  doi = {10.1093/europace/euu394},
  abstract = {AIMS: Dyx is a new heart rate variability (HRV) density analysis specifically designed to identify patients at high risk for malignant ventricular arrhythmias. The aim of this study was to test if Dyx can improve risk stratification for malignant ventricular tachyarrhythmias and to test if the previously identified cut-off can be reproduced. METHODS AND RESULTS: This study included 248 patients from the CARISMA study with ejection fraction â‰¤40\% after an acute myocardial infarction and an analysable 24 h Holter recording. All patients received an implantable cardiac monitor, which was used to diagnose the primary endpoint of near-fatal or fatal ventricular tachyarrhythmias likely preventable by an implantable cardioverter defibrillator (ICD), during a period of 2 years. A Dyx â‰¤ 1.96 was considered abnormal. The secondary endpoint was cardiovascular death. At enrolment 59 patients (24\%) had a Dyx â‰¤ 1.96 and 20 experienced a primary endpoint. A Dyx â‰¤ 1.96 was associated with a significantly increased risk for malignant arrhythmias [hazards ratio (HR) = 4.36 (1.81â€“10.52), P = 0.001] and cardiovascular death [HR = 3.47 (1.38â€“8.74), P = 0.008]. Compared with important clinical risk parameters (age {$>$}70 years and QRS {$>$} 120 ms), Dyx â‰¤ 1.96 significantly added predictive value (P = 0.0066). CONCLUSIONS: Dyx was a better predictor of ventricular tachyarrhythmias than the traditional measures of HRV and heart rate turbulence, particularly in the elderly. Dyx might be a useful tool for better selection of ICD candidates in the elderly population, since a normal Dyx in this group was associated with a very low risk for malignant ventricular arrhythmias. ClinicalTrials.gov Identifier NCT00145119.},
  isbn = {1532-2092 (Electronic)\textbackslash r1099-5129 (Linking)},
  keywords = {ðŸ”´,Acute myocardial infarction,Cardiovascular risk,CARISMA,dyx,Heart rate variability,Malignant arrhythmias,Multipole analysis},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/JÃ¸rgensen et al_2015_Heart rate variability density analysis (Dyx) for identification of appropriate.pdf}
}

@article{JÃ¸rgensen2016,
  title = {Heart {{Rate Variability Density Analysis}} ({{Dyx}}) and {{Prediction}} of {{Long-Term Mortality}} after {{Acute Myocardial Infarction}}.},
  author = {JÃ¸rgensen, Rikke MÃ¸rch and AbildstrÃ¸m, Steen Z and Levitan, Jacob and Kobo, Roi and Puzanov, Natalia and Lewkowicz, Meir and Huikuri, Heikki and Peltola, Mirja and Haarbo, Jens and Thomsen, Poul Erik Bloch and family=Group, given=Nordic I C D, prefix=pilot study, useprefix=false},
  date = {2016},
  journaltitle = {Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc},
  volume = {21},
  number = {1},
  pages = {60--68},
  issn = {1082720X},
  doi = {10.1111/anec.12297},
  url = {http://onlinelibrary.wiley.com/doi/10.1111/anec.12297/full%5Cnpapers3://publication/doi/10.1111/anec.12297},
  abstract = {AIMS:The density HRV parameter Dyx is a new heart rate variability (HRV) measure based on multipole analysis of the PoincarÃ© plot obtained from RR interval time series, deriving information from both the time and frequency domain. Preliminary results have suggested that the parameter may provide new predictive information on mortality in survivors of acute myocardial infarction (MI). This study compares the prognostic significance of Dyx to that of traditional linear and nonlinear measures of HRV.\textbackslash n\textbackslash nMETHODS AND RESULTS:In the Nordic ICD pilot study, patients with an acute MI were screened with 2D echocardiography and 24-hour Holter recordings. The study was designed to assess the power of several HRV measures to predict mortality. Dyx was tested in a subset of 206 consecutive Danish patients with analysable Holter recordings. After a median follow-up of 8.5 years 70 patients had died. Of all traditional and multipole HRV parameters, reduced Dyx was the most powerful predictor of all-cause mortality (HR 2.4; CI 1.5 to 3.8; P {$<$} 0.001). After adjustment for known risk markers, such as age, diabetes, ejection fraction, previous MI and hypertension, Dyx remained an independent predictor of mortality (P = 0.02). Reduced Dyx also predicted cardiovascular death (P {$<$} 0.01) and sudden cardiovascular death (P = 0.05). In Kaplan-Meier analysis, Dyx significantly predicted mortality in patients both with and without impaired left ventricular systolic function (P {$<$} 0.0001).\textbackslash n\textbackslash nCONCLUSION:The new nonlinear HRV measure Dyx is a promising independent predictor of mortality in a long-term follow-up study of patients surviving a MI, irrespectively of left ventricular systolic function.},
  keywords = {ðŸ”´,done},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/JÃ¸rgensen et al_2016_Heart Rate Variability Density Analysis (Dyx) and Prediction of Long-Term.pdf}
}

@article{Kavousi2023,
  title = {Polygenic Risk Scores for Prediction of Atrial Fibrillation},
  author = {Kavousi, Maryam and Ellinor, Patrick T.},
  date = {2023-01-01},
  journaltitle = {Netherlands Heart Journal},
  shortjournal = {Neth Heart J},
  volume = {31},
  number = {1},
  pages = {1--2},
  issn = {1876-6250},
  doi = {10.1007/s12471-022-01755-y},
  url = {https://doi.org/10.1007/s12471-022-01755-y},
  urldate = {2023-07-27},
  langid = {english},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Kavousi_Ellinor_2023_Polygenic risk scores for prediction of atrial fibrillation.pdf}
}

@article{Kerr2005,
  title = {Progression to Chronic Atrial Fibrillation after the Initial Diagnosis of Paroxysmal Atrial Fibrillation: {{Results}} from the {{Canadian Registry}} of {{Atrial Fibrillation}}},
  shorttitle = {Progression to Chronic Atrial Fibrillation after the Initial Diagnosis of Paroxysmal Atrial Fibrillation},
  author = {Kerr, Charles R. and Humphries, Karin H. and Talajic, Mario and Klein, George J. and Connolly, Stuart J. and Green, Martin and Boone, John and Sheldon, Robert and Dorian, Paul and Newman, David},
  date = {2005-03-01},
  journaltitle = {American Heart Journal},
  shortjournal = {American Heart Journal},
  volume = {149},
  number = {3},
  pages = {489--496},
  issn = {0002-8703},
  doi = {10.1016/j.ahj.2004.09.053},
  url = {https://www.sciencedirect.com/science/article/pii/S0002870304008129},
  urldate = {2023-06-11},
  abstract = {Background After its initial diagnosis, atrial fibrillation (AF) may progress from paroxysmal to chronic AF (CAF). The rate of progression and risk factors for progression are not clearly defined. Methods The Canadian Registry of Atrial Fibrillation (CARAF) enrolled patients from 6 Canadian cities at the time of their first electrocardiographic diagnosis of AF. Comprehensive clinical and echocardiographic data were collected and patients were followed annually, carefully documenting clinical outcomes, recurrence of paroxysmal AF, and progression to CAF. Baseline clinical, electrocardiographic, and echocardiographic variables were evaluated by univariate Cox proportionate hazards analysis. A stepwise approach was used to model the association between echocardiographic and clinical variables with progression to CAF. Results A total of 757 patients with a baseline diagnosis of paroxysmal AF were evaluated. Median follow-up was 8.0 years (range 2 days to 11.1 years). The probability of progression to CAF by 1 year was 8.6\% and thereafter there was a slow but steady progression to 24.7\% by 5 years. By 5 years, the probability of documented recurrence of any AF (chronic or paroxysmal) was 63.2\%. Increasing age, significant aortic stenosis or mitral regurgitation, left atrial enlargement, and diagnosis of cardiomyopathy were independently associated with progression to CAF. A more rapid heart rate during AF was associated with decreased risk of progression. Conclusions After the initial diagnosis of paroxysmal AF, there is a slow but steady progression to CAF. Baseline echocardiographic variables, age, cardiomyopathy, and heart rate were independently associated with progression to CAF.},
  langid = {english},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/projects/zotero/storage/QARYIU79/S0002870304008129.html}
}

@article{Kidwell2018,
  title = {Heart and Soul: {{Heart}} Rate Variability and Major Depression},
  author = {Kidwell, Meyrick and Ellenbroek, Bart A.},
  date = {2018-04},
  journaltitle = {Behavioural Pharmacology},
  volume = {29},
  number = {1998},
  eprint = {29543649},
  eprinttype = {pmid},
  pages = {152--164},
  issn = {14735849},
  doi = {10.1097/FBP.0000000000000387},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/29543649},
  urldate = {2018-10-29},
  abstract = {There is a bidirectional relationship between affective disorders and cardiovascular abnormalities, often described as a downward spiral, whereas major depressive disorders (MDD, and anxiety disorders) significantly increase the risk of developing cardiovascular diseases (CVD); CVD are also associated with increased risk of developing MDD (and anxiety disorders). Moreover, the prognosis and progression of CVD is significantly worsened in the presence of MDD. Heart rate variability (HRV) has often been suggested as a potential mediator in this comorbidity. In this review, we discuss HRV alterations in MDD. However, we mainly focus on the direct relationship between HRV alterations and psychiatric symptoms, rather than its relationship with CVD, as this has been reviewed elsewhere. After a general introduction to HRV and how it can be measured, we review how HRV is altered in MDD. We subsequently describe how antidepressant drugs affect HRV, showing that some classes (such as tricyclics) generally worsen HRV, whereas others (most notably selective serotonin reuptake inhibitors) have a more positive influence. We also review the effects of several other treatments, with a special focus on vagal nerve stimulation, finishing with some further considerations and recommendation for further research, both in humans and animals., Copyright (C) 2018 YEAR Wolters Kluwer Health, Inc. All rights reserved.},
  isbn = {0955-8810},
  keywords = {ðŸ”´,Antidepressant drugs,Heart rate variability,Major depression,Selective serotonin reuptake inhibitors,Tricyclic,Vagal nerve},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Kidwell_Ellenbroek_2018_Heart and soul.pdf}
}

@article{Kim2018,
  title = {Effect of {{Escitalopram}} vs {{Placebo Treatment}} for {{Depression}} on {{Long-term Cardiac Outcomes}} in {{Patients With Acute Coronary Syndrome}}},
  author = {Kim, Jae-Min and Stewart, Robert and Lee, Yong-Seong and Lee, Hee-Joon and Kim, Min Chul and Kim, Ju-Wan and Kang, Hee-Ju and Bae, Kyung-Yeol and Kim, Sung-Wan and Shin, Il-Seon and Hong, Young Joon and Kim, Ju Han and Ahn, Youngkeun and Jeong, Myung Ho and Yoon, Jin-Sang},
  date = {2018-07-24},
  journaltitle = {JAMA},
  volume = {320},
  number = {4},
  pages = {350},
  publisher = {{American Medical Association}},
  issn = {0098-7484},
  doi = {10.1001/jama.2018.9422},
  url = {http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2018.9422},
  urldate = {2018-07-29},
  abstract = {Importance Depression has been associated with poorer medical outcomes in acute coronary syndrome (ACS), but there are few data on the effects of antidepressant treatment on long-term prognosis. Objective To investigate the effect on long-term major adverse cardiac events (MACE) of escitalopram treatment of depression in patients with recent ACS. Design, Setting, and Participants Randomized, double-blind, placebo-controlled trial conducted among 300 patients with recent ACS and depression enrolled from May 2007 to March 2013, with follow-up completed in June 2017, at Chonnam National University Hospital, Gwangju, South Korea. Interventions Patients were randomly assigned to receive either escitalopram in flexible dosages of 5, 10, 15, or 20 mg/d (n = 149) or matched placebo (n = 151) for 24 weeks. Main Outcomes and Measures The primary outcome was MACE, a composite of all-cause mortality, myocardial infarction (MI), and percutaneous coronary intervention (PCI). Four secondary outcomes were the individual MACE components of all-cause mortality, cardiac death, MI, and PCI. Cox proportional hazards models were used to compare the escitalopram and placebo groups by time to first MACE. Results Among 300 randomized patients (mean age, 60 years; 119 women [39.3\%]), 100\% completed a median of 8.1 (interquartile range, 7.5-9.0) years of follow-up. MACE occurred in 61 patients (40.9\%) receiving escitalopram and in 81 (53.6\%) receiving placebo (hazard ratio [HR], 0.69; 95\% CI, 0.49-0.96;P = .03). Comparing individual MACE outcomes between the escitalopram and placebo groups, respectively, incidences for all-cause mortality were 20.8\% vs 24.5\% (HR, 0.82; 95\% CI, 0.51-1.33;P = .43), for cardiac death, 10.7\% vs 13.2\% (HR, 0.79; 95\% CI, 0.41-1.52;P = .48); for MI, 8.7\% vs 15.2\% (HR, 0.54; 95\% CI, 0.27-0.96;P = .04), and for PCI, 12.8\% vs 19.9\% (HR, 0.58; 95\% CI, 0.33-1.04;P = .07). Conclusions and Relevance Among patients with depression following recent acute coronary syndrome, 24-week treatment with escitalopram compared with placebo resulted in a lower risk of major adverse cardiac events after a median of 8.1 years. Further research is needed to assess the generalizability of these findings. Trial Registration ClinicalTrials.gov Identifier:NCT00419471},
  keywords = {ðŸ”´,acute coronary syndromes,antidepressive agents,depressive disorders,escitalopram,follow-up},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Kim et al_2018_Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac.pdf}
}

@article{Kleiger1987,
  title = {Decreased Heart Rate Variability and Its Association with Increased Mortality after Acute Myocardial Infarction},
  author = {Kleiger, Robert E. and Miller, J. Philip and Bigger, J. Thomas and Moss, Arthur J.},
  date = {1987-02-01},
  journaltitle = {The American Journal of Cardiology},
  volume = {59},
  number = {4},
  eprint = {3812275},
  eprinttype = {pmid},
  pages = {256--262},
  publisher = {{Excerpta Medica}},
  issn = {00029149},
  doi = {10.1016/0002-9149(87)90795-8},
  url = {https://www-sciencedirect-com.proxy.library.emory.edu/science/article/pii/0002914987907958},
  urldate = {2018-09-29},
  abstract = {A high degree of heart rate (HR) variability is found in compensated hearts with good function, whereas HR variability can be decreased with severe coronary artery disease, congestive heart failure, aging and diabetic neuropathy. To test the hypothesis that HR variability is a predictor of long-term survival after acute myocardial infarction (AMI), the Holter tapes of 808 patients who survived AMI were analyzed. Heart rate variability was defined as the standard deviation of all normal RR intervals in a 24-hour continuous electrocardiogram recording made 11 Â± 3 days after AMI. In all patients demographic, clinical and laboratory variables were measured at baseline. Mean follow-up time was 31 months. Of all Holter variables measured, HR variability had the strongest univariate correlation with mortality. The relative risk of mortality was 5.3 times higher in the group with HR variability of less than 50 ms than the group with HR variability of more than 100 ms. HR variability remained a significant predictor of mortality after adjusting for clinical, demographic, other Holter features and ejection fraction. A hypothesis to explain this finding is that decreased HR variability correlates with increased sympathetic or decreased vagal tone, which may predispose to ventricular fibrillation. Â© 1987.},
  isbn = {0002-9149 (Print)\$\textbackslash\$n0002-9149 (Linking)},
  keywords = {ðŸ”´,done}
}

@article{Ko2017,
  title = {Cohort Profile: {{The Emory Cardiovascular Biobank}} ({{EmCAB}})},
  author = {Ko, Yi An and Hayek, Salim and Sandesara, Pratik and Samman Tahhan, Ayman and Quyyumi, Arshed},
  date = {2017},
  journaltitle = {BMJ Open},
  volume = {7},
  number = {12},
  eprint = {29288185},
  eprinttype = {pmid},
  pages = {e018753},
  publisher = {{BMJ Publishing Group}},
  issn = {20446055},
  doi = {10.1136/bmjopen-2017-018753},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/29288185},
  urldate = {2019-02-03},
  abstract = {A series of calcineurin-inhibiting compds. consisting of a central arom. N-heterocycle, two aryl substituents and a 3-(dimethylamino)propyl chain was synthesized by introduction of the side chain. A corresponding haloheterocyclic compd. was transformed into a 3-(dimethylamino)propynyl heterocyclic compd. by Sonogashira coupling and was in turn hydrogenated in the presence of Pd/C to afford the 3-(dimethylamino)propyl-substituted target compds. Some of the products showed calcineurin inhibiting activity. [on SciFinder(R)]},
  keywords = {ðŸ”´,biomarker,cardiovascular outcome,coronary heart disease,longitudinal cohort},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Ko et al_2017_Cohort profile.pdf}
}

@article{Kollia2017,
  title = {Exploring the Path between Depression, Anxiety and 10-Year Cardiovascular Disease Incidence, among Apparently Healthy {{Greek}} Middle-Aged Adults: {{The ATTICA}} Study},
  author = {Kollia, Natasa and Panagiotakos, Demosthenes and Georgousopoulou, Ekavi and Chrysohoou, Christina and Yannakoulia, Mary and Stefanadis, Christodoulos and Chatterji, Somnath and Haro, Josep Maria and Papageorgiou, Charalabos and Pitsavos, Christos},
  date = {2017-12},
  journaltitle = {Maturitas},
  volume = {106},
  eprint = {29150168},
  eprinttype = {pmid},
  pages = {73--79},
  issn = {18734111},
  doi = {10.1016/j.maturitas.2017.09.005},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/29150168},
  urldate = {2018-12-25},
  abstract = {Objectives Although there is substantial evidence that psychological factors play an important role in the onset and course of cardiovascular disease (CVD), less is known about their combined effect and the pathways by which they affect cardiovascular health. The present work aimed to prospectively explore the effects of depression and anxiety on the 10-year CVD incidence, in relation to other lifestyle determinants, as linking factors in the context of the ATTICA study. Study design/Main outcome measures: The ATTICA study is a population-based, health and nutrition prospective cohort study (2002â€“2012), during which 853 middle-aged participants without a history of CVD [453 men (aged 45 Â± 13 years) and 400 women (aged 44 Â± 18 years)], underwent psychological evaluations at enrollment. The latent trait of depression and anxiety combined measure was estimated and referred as â€œPsychological distressâ€; path analysis was applied to describe the relationships among the different factors. Results â€œPsychological distressâ€ was positively associated with the 10-year CVD incidence (adjusted OR per 10 units: 1.4, 95\% CI: 1.1, 1.7). Three linking pathways were revealed: sedentariness, inflammation and metabolic syndrome. Moreover, â€œPsychological distressâ€ mediated the association between socioeconomic status (SES) and CVD, with participants of low SES scoring higher on the psychological measure (adjusted linear regression coefficient b: âˆ’7.1, 95\% CI: âˆ’9.7, âˆ’4.5). Conclusions Lifestyle and clinical factors seem to link psychological distress with CVD development. Joint psychological assessments should be considered for inclusion in CVD preventive strategies, which should incorporate interventions for interrupting the linking pathways.},
  isbn = {2047-4873},
  keywords = {ðŸ”´,Anxiety,Cardiovascular disease,CVD risk factors,Depression,Mediation,Psychological distress}
}

@article{Kornej2020,
  title = {Epidemiology of {{Atrial Fibrillation}} in the 21st {{Century}}: {{Novel Methods}} and {{New Insights}}.},
  author = {Kornej, Jelena and BÃ¶rschel, Christin S and Benjamin, Emelia J and Schnabel, Renate B},
  date = {2020-06-19},
  journaltitle = {Circulation research},
  volume = {127},
  number = {1},
  eprint = {32716709},
  eprinttype = {pmid},
  pages = {4--20},
  publisher = {{Lippincott Williams and Wilkins}},
  issn = {1524-4571},
  doi = {10.1161/CIRCRESAHA.120.316340},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/32716709},
  abstract = {Accompanying the aging of populations worldwide, and increased survival with chronic diseases, the incidence and prevalence of atrial fibrillation (AF) are rising, justifying the term global epidemic. This multifactorial arrhythmia is intertwined with common concomitant cardiovascular diseases, which share classical cardiovascular risk factors. Targeted prevention programs are largely missing. Prevention needs to start at an early age with primordial interventions at the population level. The public health dimension of AF motivates research in modifiable AF risk factors and improved precision in AF prediction and management. In this review, we summarize current knowledge in an attempt to untangle these multifaceted associations from an epidemiological perspective. We discuss disease trends, preventive opportunities offered by underlying risk factors and concomitant disorders, current developments in diagnosis and risk prediction, and prognostic implications of AF and its complications. Finally, we review current technological (eg, eHealth) and methodological (artificial intelligence) advances and their relevance for future prevention and disease management.},
  keywords = {ðŸ”´,artificial intelligence,atrial fibrillation,incidence,prevalence,risk factors},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Kornej et al_2020_Epidemiology of Atrial Fibrillation in the 21st Century.pdf}
}

@article{Kroenke2001,
  title = {The {{PHQ-9}}: Validity of a Brief Depression Severity Measure.},
  author = {Kroenke, K and Spitzer, R L and Williams, J B},
  date = {2001-09},
  journaltitle = {Journal of general internal medicine},
  volume = {16},
  number = {9},
  eprint = {11556941},
  eprinttype = {pmid},
  pages = {606--13},
  issn = {0884-8734},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/11556941},
  urldate = {2019-03-03},
  abstract = {OBJECTIVE While considerable attention has focused on improving the detection of depression, assessment of severity is also important in guiding treatment decisions. Therefore, we examined the validity of a brief, new measure of depression severity. MEASUREMENTS The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders. The PHQ-9 is the depression module, which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). The PHQ-9 was completed by 6,000 patients in 8 primary care clinics and 7 obstetrics-gynecology clinics. Construct validity was assessed using the 20-item Short-Form General Health Survey, self-reported sick days and clinic visits, and symptom-related difficulty. Criterion validity was assessed against an independent structured mental health professional (MHP) interview in a sample of 580 patients. RESULTS As PHQ-9 depression severity increased, there was a substantial decrease in functional status on all 6 SF-20 subscales. Also, symptom-related difficulty, sick days, and health care utilization increased. Using the MHP reinterview as the criterion standard, a PHQ-9 score {$>$} or =10 had a sensitivity of 88\% and a specificity of 88\% for major depression. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively. Results were similar in the primary care and obstetrics-gynecology samples. CONCLUSION In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity. These characteristics plus its brevity make the PHQ-9 a useful clinical and research tool.},
  keywords = {ðŸ”´}
}

@article{Kronish2019,
  title = {Effect of {{Depression Screening}} after {{Acute Coronary Syndromes}} on {{Quality}} of {{Life}}: {{The CODIACS-QoL Randomized Clinical Trial}}},
  author = {Kronish, Ian M. and Moise, Nathalie and Cheung, Ying Kuen and Clarke, Gregory N. and Dolor, Rowena J. and Duer-Hefele, Joan and Margolis, Karen L. and St Onge, Tara and Parsons, Faith and Retuerto, Jessica and Thanataveerat, Anusorn and Davidson, Karina W.},
  date = {2019},
  journaltitle = {JAMA Internal Medicine},
  publisher = {{American Medical Association}},
  issn = {21686106},
  doi = {10.1001/jamainternmed.2019.4518},
  abstract = {Importance: Patients with acute coronary syndrome (ACS) and elevated depressive symptoms are at increased risk for recurrent cardiovascular events and mortality, worse quality of life, and higher health care costs. These observational findings prompted multiple scientific panels to advise universal depression screening in survivors of ACS prior to evidence from randomized screening trials. Objective: To determine whether systematically screening for depression in survivors of ACS improves quality of life and depression compared with usual care. Design, Setting, and Participants: A 3-group multisite randomized trial enrolled 1500 patients with ACS from 4 health care systems between November 1, 2013, and March 31, 2017, with follow-up ending July 31, 2018. Patients were eligible if they had been hospitalized for ACS in the previous 2 to 12 months and had no prior history of depression. All analyses were performed on an intention-to-treat basis. Interventions: Patients with ACS were randomly assigned 1:1:1 to receive (1) systematic depression screening using the 8-item Patient Health Questionnaire, with notification of primary care clinicians and provision of centralized, patient-preference, stepped depression care for those with positive screening results (8-item Patient Health Questionnaire score â‰¥10; screen, notify, and treat, n = 499); (2) systematic depression screening, with notification of primary care clinicians for those with positive screening results (screen and notify, n = 501); and (3) usual care (no screening, n = 500). Main Outcomes and Measures: The primary outcome was change in quality-adjusted life-years. The secondary outcome was depression-free days. Adverse effects and mortality were assessed by patient interview and hospital records. Results: A total of 1500 patients (424 women and 1076 men; mean [SD] age, 65.9 [11.5] years) were randomized in the 18-month trial. Only 71 of 1000 eligible survivors of ACS (7.1\%) had elevated 8-item Patient Health Questionnaire scores indicating depressive symptoms at screening. There were no differences in mean (SD) change in quality-adjusted life-years (screen, notify and treat, -0.06 [0.20]; screen and notify, -0.06 [0.20]; no screen, -0.06 [0.18]; P =.98) or cumulative mean (SD) depression-free days (screen, notify and treat, 343.1 [179.0] days; screen and notify, 351.3 [175.0] days; no screen, 339.0 [176.6] days; P =.63). Harms including death, bleeding, or sleep difficulties did not differ among groups. Conclusions and Relevance: In patients with ACS without a history of depression, systematic depression screening with or without providing depression treatment did not alter quality-adjusted life-years, depression-free days, or harms. Trial Registration: ClinicalTrials.gov identifier: NCT01993017.},
  keywords = {ðŸ”´}
}

@article{Kyrou2017,
  title = {Association of Depression and Anxiety Status with 10-Year Cardiovascular Disease Incidence among Apparently Healthy {{Greek}} Adults: {{The ATTICA Study}}},
  author = {Kyrou, Ioannis and Kollia, Natasa and Panagiotakos, Demosthenes and Georgousopoulou, Ekavi and Chrysohoou, Christina and Tsigos, Constantine and Randeva, Harpal S and Yannakoulia, Mary and Stefanadis, Christodoulos and Papageorgiou, Charalabos and Pitsavos, Christos},
  date = {2017-01-27},
  journaltitle = {European Journal of Preventive Cardiology},
  volume = {24},
  number = {2},
  eprint = {27671771},
  eprinttype = {pmid},
  pages = {145--152},
  issn = {20474881},
  doi = {10.1177/2047487316670918},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/27671771},
  urldate = {2018-12-25},
  abstract = {Background Chronic stress frequently manifests with anxiety and/or depressive symptomatology and may have detrimental cardiometabolic effects over time. As such, recognising the potential links between stress-related psychological disorders and cardiovascular disease (CVD) is becoming increasingly important in cardiovascular epidemiology research. The primary aim of this study was to explore prospectively potential associations between clinically relevant depressive symptomatology and anxiety levels and the 10-year CVD incidence among apparently healthy Greek adults. Design A population-based, health and nutrition prospective survey. Methods In the context of the ATTICA Study (2002-2012), 853 adult participants without previous CVD history (453 men (45+/-13 years) and 400 women (44+/-18 years)) underwent psychological evaluations through validated, self-reporting depression and anxiety questionnaires. Results After adjustment for multiple established CVD risk factors, both reported depression and anxiety levels were positively and independently associated with the 10-year CVD incidence, with depression markedly increasing the CVD risk by approximately fourfold (adjusted odds ratio (95\% confidence interval) 3.6 (1.3, 11) for depression status; 1.03 (1.0, 1.1) for anxiety levels). Conclusions Our findings indicate that standardised psychological assessments focusing on depression and anxiety should be considered as an additional and distinct aspect in the context of CVD preventive strategies that are designed and implemented by health authorities at the general population level.},
  isbn = {2047-4873},
  keywords = {ðŸ”´,anxiety,ATTICA Study,cardiovascular disease,CVD risk factors,depression}
}

@article{Lampert2003a,
  title = {Effects of {{Propranolol}} on Recovery of Heart Rate Variability Following Acute Myocardial Infarction and Relation to Outcome in the {{Beta-blocker Heart Attack Trial}}},
  author = {Lampert, Rachel and Ickovics, Jeannette R and Viscoli, Catherine J and Horwitz, Ralph I and Lee, Forrester A},
  date = {2003},
  journaltitle = {American Journal of Cardiology},
  volume = {91},
  number = {2},
  eprint = {12521623},
  eprinttype = {pmid},
  pages = {137--142},
  issn = {00029149},
  doi = {10.1016/S0002-9149(02)03098-9},
  abstract = {This study evaluated the effects of propranolol on recovery of heart rate variability (HRV) after acute myocardial infarction and its relation to outcome in the Beta-blocker Heart Attack Trial (BHAT). Beta blockers improve mortality after acute myocardial infarction, but through an unknown mechanism. Depressed HRV, a measure of autonomic tone, predicts mortality after acute myocardial infarction. Whether Î² blockers influence recovery of HRV after acute myocardial infarction, and thereby improve outcome, is unknown. We compared 24-hour HRV parameters at 1 week after acute myocardial infarction and after 6 weeks of treatment with propanolol (n = 88) or placebo (n = 96). The relation between 25-month outcome (death/acute myocardial infarction/congestive heart failure), propranolol treatment, and HRV was further analyzed. After 6 weeks, high-frequency (HF) power (log-normalized), an index of vagal tone, increased more in propranolol-treated patients (4.28 Â± 0.1 to 5.17 Â± 0.09 ms2) than in placebo-treated patients (4.26 Â± 0.09 to 4.77 Â± 0.1 ms2, p {$<$}0.05). Sympathovagal balance measured by the low-frequency (LF) to HF ratio increased in placebo-treated patients (3.55 Â± 0.24 to 3.86 Â± 0.24) but decreased in those treated with propranolol (3.76 Â± 0.29 to 3.17 Â± 0.23, p {$<$}0.01). Other frequency-domain parameters increased over time but were not affected by propranolol. Propranolol blunted the morning increase in the LF/HF ratio. Recovery of HF, the strongest HRV predictor of outcome, and propranolol therapy independently predicted outcome. In summary, after acute myocardial infarction, propranolol therapy improves recovery of parasympathetic tone, which correlates with improved outcome, and decreases morning sympathetic predominance. These findings may elucidate the mechanisms by which Î² blockers decrease mortality and reduce the early morning risk of sudden death after acute myocardial infarction. Â© 2003 by Excerpta Medica, Inc.},
  isbn = {0002-9149},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Lampert et al_2003_Effects of Propranolol on recovery of heart rate variability following acute.pdf}
}

@article{Liao2002,
  title = {Lower {{Heart Rate Variability Is Associated With}} the {{Development}} of {{Coronary Heart Disease}} in {{Individuals With Diabetes}}},
  author = {Liao, Duanping and Carnethon, Mercedes and Evans, Gregory W. and Cascio, Wayne E. and Heiss, Gerardo},
  date = {2002-12-01},
  journaltitle = {Diabetes},
  volume = {51},
  number = {12},
  pages = {3524--3531},
  issn = {0012-1797},
  doi = {10.2337/diabetes.51.12.3524},
  abstract = {{$<$}p{$>$}The objective of this study was to test prospectively in a population sample whether individuals with impaired heart rate variability (HRV) are at increased risk of developing coronary heart disease (CHD) and of non-CHD mortality and to test whether this relationship is more pronounced among individuals with diabetes. We examined the association between HRV and incident CHD and non-CHD mortality in a cohort of 11,654 men and women aged 45â€“64 years at intake, from the biracial, population-based Atherosclerosis Risk in Communities Study. Supine, resting, 2-min beat-to-beat heart rate data were collected at the baseline examination. High frequency (HF; 0.15â€“0.40 Hz) and low frequency (LF; 0.04â€“0.15 Hz) spectral powers, LF/HF ratio, normalized HF and LF, the standard deviation of all normal R-R intervals (SDNN), and the mean of the sum of the squared differences between adjacent normal R-R intervals (MSSD) were used as the conventional indexes of HRV to measure cardiac autonomic control. From this cohort, 635 cases of incident CHD (including 346 cases of incident myocardial infarction [MI] and 82 cases of fatal CHD), and 623 non-CHD deaths were identified and validated after an average of 8 years of follow-up. Among individuals with diabetes, the multivariable adjusted proportional hazards ratios (95\% CI) were 2.03 (1.28â€“3.23), 1.60 (1.12â€“2.27), 1.50 (0.65â€“3.42), and 1.27 (0.84â€“1.91) for incident MI, incident CHD, fatal CHD, and non-CHD deaths, respectively, comparing the lowest quartile to the upper most three quartiles of HF. A similar pattern of associations was found for LF, SDNN, and MSSD. By contrast, there was no consistent pattern of associations among individuals without diabetes. At the population level, a lower HRV (reflective of impaired cardiac autonomic control) is statistically significantly related to the development of CHD among individuals with diabetes, independent of markers of the duration/severity of the glucose metabolism impairment. These data suggest a contribution of an impaired cardiac autonomic control to the risk of CHD among individuals with diabetes.{$<$}/p{$>$}},
  keywords = {ðŸ”´}
}

@article{Lichtman2014,
  title = {Depression as a Risk Factor for Poor Prognosis among Patients with Acute Coronary Syndrome: {{Systematic}} Review and Recommendations: {{A}} Scientific Statement from the American Heart Association},
  author = {Lichtman, Judith H. and Froelicher, Erika S. and Blumenthal, James A. and Carney, Robert M. and Doering, Lynn V. and Frasure-Smith, Nancy and Freedland, Kenneth E. and Jaffe, Allan S. and Leifheit-Limson, Erica C. and Sheps, David S. and Vaccarino, Viola and Wulsin, Lawson},
  date = {2014-03-25},
  journaltitle = {Circulation},
  volume = {129},
  number = {12},
  pages = {1350--1369},
  publisher = {{Lippincott Williams and Wilkins}},
  issn = {15244539},
  doi = {10.1161/CIR.0000000000000019},
  abstract = {BACKGROUND - : Although prospective studies, systematic reviews, and meta-analyses have documented an association between depression and increased morbidity and mortality in a variety of cardiac populations, depression has not yet achieved formal recognition as a risk factor for poor prognosis in patients with acute coronary syndrome by the American Heart Association and other health organizations. The purpose of this scientific statement is to review available evidence and recommend whether depression should be elevated to the status of a risk factor for patients with acute coronary syndrome. METHODS AND RESULTS - : Writing group members were approved by the American Heart Association's Scientific Statement and Manuscript Oversight Committees. A systematic literature review on depression and adverse medical outcomes after acute coronary syndrome was conducted that included all-cause mortality, cardiac mortality, and composite outcomes for mortality and nonfatal events. The review assessed the strength, consistency, independence, and generalizability of the published studies. A total of 53 individual studies (32 reported on associations with all-cause mortality, 12 on cardiac mortality, and 22 on composite outcomes) and 4 meta-analyses met inclusion criteria. There was heterogeneity across studies in terms of the demographic composition of study samples, definition and measurement of depression, length of follow-up, and covariates included in the multivariable models. Despite limitations in some individual studies, our review identified generally consistent associations between depression and adverse outcomes. CONCLUSIONS - : Despite the heterogeneity of published studies included in this review, the preponderance of evidence supports the recommendation that the American Heart Association should elevate depression to the status of a risk factor for adverse medical outcomes in patients with acute coronary syndrome. Â© 2014 American Heart Association, Inc.},
  keywords = {ðŸ”´,acute coronary syndrome,AHA Scientific Statements,coronary heart disease,depression,risk factors},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Lichtman et al_2014_Depression as a risk factor for poor prognosis among patients with acute.pdf}
}

@article{Locci2018,
  title = {Social Isolation as a Promising Animal Model of {{PTSD}} Comorbid Suicide: Neurosteroids and Cannabinoids as Possible Treatment Options},
  author = {Locci, Andrea and Pinna, Graziano},
  date = {2018-12},
  journaltitle = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  issn = {02785846},
  doi = {10.1016/j.pnpbp.2018.12.014},
  url = {https://www.sciencedirect.com/science/article/pii/S0278584618305839?dgcid=rss_sd_all},
  abstract = {Publication date: Available online 23 December 2018 Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry Author(s): Andrea Locci, Graziano Pinna Abstract Post-traumatic stress disorder (PTSD) is a psychiatric condition characterized by drastic alterations in mood, emotions, social abilities and cognition. Notably, one aspect of PTSD, particularly in veterans, is its comorbidity with suicide. Elevated aggressiveness predicts high-risk to suicide in humans and despite the difficulty in reproducing a complex human suicidal behavior in rodents, aggressive behavior is a well reproducible behavioral trait of suicide. PTSD animal models are based on a peculiar phenotype, including exaggerated fear memory, anxiety- and depressive-like behaviors associated with neurochemical dysregulations in emotional brain circuitry. The endocannabinoid and the neurosteroid systems regulate emotions and stress responses, and recent evidence shows these two systems are interrelated and critically compromised in neuropsychiatric disorders. For instance, levels of the neurosteroid, allopregnanolone, as well as those of the endocannabinoids, anandamide and its congener, palmitoylethanolamide are decreased in PTSD. Similarly, the endocannabinoid system and neurosteroid biosynthesis are altered in suicidal individuals. Selective serotonin reuptake inhibitors (SSRIs), the only FDA-approved treatments for PTSD and depression, fail to help half of the treatment-seeking patients. This highlights the need for developing biomarker-based efficient therapies. One promising hypothesis points to stimulation of allopregnanolone biosynthesis as a valid end-point to predict treatment response in PTSD patients. This review highlights running findings on the role of the endocannabinoid and neurosteroid systems in PTSD and suicidal behavior both in a preclinical and clinical perspective. A specific focus is given to predictive PTSD/suicide animal models. Ultimately, we discuss the idea that disruption of neurosteroid and endocannabinoid biosynthesis may offer novel promising biomarker candidates to develop new treatments for PTSD and, perhaps, suicidal behavior.},
  keywords = {ðŸ”´}
}

@article{Lucini2020,
  title = {Heart Rate Variability, Autonomic Regulation and Myocardial Ischemia},
  author = {Lucini, Daniela and Pagani, Massimo},
  date = {2020-08},
  journaltitle = {International Journal of Cardiology},
  volume = {312},
  pages = {22--23},
  issn = {01675273},
  doi = {10.1016/j.ijcard.2020.03.012},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S0167527320307580},
  urldate = {2020-06-05},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Lucini_Pagani_2020_Heart rate variability, autonomic regulation and myocardial ischemia.pdf}
}

@article{Magnani2016,
  title = {Racial {{Differences}} in {{Atrial Fibrillation-Related Cardiovascular Disease}} and {{Mortality}}: {{The Atherosclerosis Risk}} in {{Communities}} ({{ARIC}}) {{Study}}},
  shorttitle = {Racial {{Differences}} in {{Atrial Fibrillation-Related Cardiovascular Disease}} and {{Mortality}}},
  author = {Magnani, Jared W. and Norby, Faye L. and Agarwal, Sunil K. and Soliman, Elsayed Z. and Chen, Lin Y. and Loehr, Laura R. and Alonso, Alvaro},
  date = {2016-07-01},
  journaltitle = {JAMA cardiology},
  shortjournal = {JAMA Cardiol},
  volume = {1},
  number = {4},
  eprint = {27438320},
  eprinttype = {pmid},
  pages = {433--441},
  issn = {2380-6591},
  doi = {10.1001/jamacardio.2016.1025},
  abstract = {IMPORTANCE: The adverse outcomes associated with atrial fibrillation (AF) have been studied in predominantly white cohorts. Racial differences in outcomes associated with AF merit continued investigation. OBJECTIVE: To evaluate the race-specific associations of AF with stroke, heart failure, coronary heart disease (CHD), and all-cause mortality in a community-based cohort. DESIGN, SETTING, AND PARTICIPANTS: The Atherosclerosis Risk in Communities (ARIC) Study is a prospective, observational cohort. From 1987 through 1989, the ARIC Study enrolled 15\,792 men and women and conducted 4 follow-up examinations (2011-2013) with active surveillance for vital status and hospitalizations. Race was determined by self-report and categorized as white, black, or other. MAIN OUTCOMES AND MEASURES: Atrial fibrillation (adjudicated using electrocardiograms, hospital discharge codes, and death certificates), stroke, heart failure, CHD, and mortality. RESULTS: After exclusions, 15\,080 participants (mean [SD] age, 54.2\,[5.8] years; 8290 women [55.5\%]; 3831 black individuals [25.4\%]) were included in this analysis. During a mean\,(SD) follow-up of 20.6\,(6.2) years, there were 2348 cases of incident AF. The incident rates of AF per 1000 person-years were 8.1 (95\% CI, 7.7-8.5) in white individuals and 5.8 (95\% CI, 5.2-6.3) in black individuals. The rates of stroke, heart failure, CHD, and mortality were higher in black individuals with AF than white individuals with AF. The association of AF with these outcomes, estimated with rate differences (rate of the end point in those with AF minus the rate in those without AF per 1000 person-years), also differed by race. The rate difference for stroke in individuals with AF was 10.2 (95\% CI, 6.6-13.9) in white individuals and 21.4 (95\% CI, 10.2-32.6) in black individuals. For heart failure and CHD, the rate differences were 1.5- to 2.0-fold higher in black individuals than white individuals. White individuals with AF had a rate difference of 55.9 (95\% CI, 48.1-63.7) for mortality compared with black individuals, who had a rate difference of 106.0 (95\% CI, 86.0-125.9). CONCLUSIONS AND RELEVANCE: In the prospective ARIC Study, the outcome of AF on the rates of stroke, heart failure, CHD, and mortality was considerably larger in black individuals than white individuals. These results indicate the vulnerability and increased risk in black individuals with AF. Continued investigation of racial differences in AF and its related adverse outcomes are essential to identify and mitigate racial disparities in the treatment of AF.},
  langid = {english},
  pmcid = {PMC5347977},
  keywords = {ðŸ”´,Atherosclerosis,Atrial Fibrillation,Black People,Cardiovascular Diseases,Cohort Studies,Female,Humans,Male,Middle Aged,Prospective Studies,Risk,White People},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Magnani et al_2016_Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and.pdf}
}

@article{Magruder2016,
  title = {Long-{{Term Trajectories}} of {{PTSD}} in {{Vietnam-Era Veterans}}: {{The Course}} and {{Consequences}} of {{PTSD}} in {{Twins}}},
  author = {Magruder, Kathryn M. and Goldberg, Jack and Forsberg, Christopher W. and Friedman, Matthew J. and Litz, Brett T. and Vaccarino, Viola and Heagerty, Patrick J. and Gleason, Theresa C. and Huang, Grant D. and Smith, Nicholas L.},
  date = {2016-02},
  journaltitle = {Journal of Traumatic Stress},
  volume = {29},
  number = {1},
  eprint = {20419729},
  eprinttype = {pmid},
  pages = {5--16},
  issn = {15736598},
  doi = {10.1002/jts.22075},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/26764215},
  urldate = {2018-11-25},
  abstract = {What do we know about resilience in crime victimization? In this article, the authors discuss resilience defined as protective factors (e.g., personality characteristics, biological characteristics, social and cultural factors, and community characteristics); as a process of adaptation (e.g., self-enhancement, positive cognitive appraisals, coping styles, and spirituality), including an iterative perspective on resilience as a cascade of protective processes; and as positive outcomes (e.g., lack of symptoms) following exposure to adverse events. Within each of these definitional frameworks, they consider general conceptual issues pertaining to resilience and then the small body of research that has focused specifically on resilience and some type of crime victimization. Research and clinical implications are discussed.},
  isbn = {0894-9867},
  keywords = {ðŸ”´}
}

@article{Manolis2017,
  title = {Contemporary {{Diagnosis}} and {{Management}} of {{Atrial Flutter}}: {{A Continuum}} of {{Atrial Fibrillation}} and {{Vice Versa}}?},
  author = {Manolis, Antonis S.},
  date = {2017},
  journaltitle = {Cardiology in Review},
  volume = {25},
  number = {6},
  eprint = {28832375},
  eprinttype = {pmid},
  pages = {289--297},
  issn = {15384683},
  doi = {10.1097/CRD.0000000000000162},
  abstract = {Atrial flutter (AFlu) is usually a fast ({$>$}240 bpm) and regular right atrial macroreentrant tachycardia, with a constrained critical region of the reentry circuit located at the cavotricuspid isthmus (CTI; typical CTI-dependent AFlu). However, a variety of right and left atrial tachycardias, resulting from different mechanisms, can also present as AFlu (atypical non-CTI-dependent AFlu). The electrocardiogram can provide clues to its origin and location; however, additional entrainment and more sophisticated electroanatomical mapping techniques may be required to identify its mechanism, location, and target area for a successful ablation. Although atrial fibrillation and AFlu are 2 separate arrhythmias, they often coexist before and after drug and/or ablation therapies. Indeed, there appears to be a close interrelationship between these 2 arrhythmias, and one may "transform" into the other. These issues are discussed in this overview, and practical algorithms are proposed to guide AFlu localization and illustrate the AFlu and atrial fibrillation continuum.},
  isbn = {0000000000000},
  keywords = {ðŸ”´,antiarrhythmic drugs,anticoagulation,atrial fibrillation,atrial flutter,catheter ablation,cavotricuspid isthmus,stroke,tachycardiomyopathy,thromboembolism},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Manolis_2017_Contemporary Diagnosis and Management of Atrial Flutter.pdf}
}

@article{Marcus2008,
  title = {Alcohol Intake Is Significantly Associated with Atrial Flutter in Patients under 60 Years of Age and a Shorter Right Atrial Effective Refractory Period},
  author = {Marcus, Gregory M. and Smith, Lisa M. and Whiteman, Dean and Tseng, Zian H. and Badhwar, Nitish and Lee, Byron K. and Lee, Randall J. and Scheinman, Melvin M. and Olgin, Jeffrey E.},
  date = {2008-03},
  journaltitle = {PACE - Pacing and Clinical Electrophysiology},
  volume = {31},
  number = {3},
  eprint = {18307620},
  eprinttype = {pmid},
  pages = {266--272},
  publisher = {{Pacing Clin Electrophysiol}},
  issn = {01478389},
  doi = {10.1111/j.1540-8159.2008.00985.x},
  url = {https://pubmed-ncbi-nlm-nih-gov.proxy.cc.uic.edu/18307620/},
  urldate = {2022-11-22},
  abstract = {Background: Although evidence suggests that alcohol is associated with atrial fibrillation (AF), the association between alcohol and atrial flutter (AFL) has not been examined. The mechanism connecting alcohol and atrial arrhythmias is unknown. Methods: Alcohol intake was determined in 195 consecutive patients with AF and AFL. Control subjects included patients with other supraventricular arrhythmias (n = 132) and healthy subjects (n = 54). Because of important competing risk factors for atrial arrhythmias in the elderly, stratification by age was performed. In a subset, atrial effective refractory periods (AERPs) were obtained from the high right atrium and proximal and distal coronary sinus. Results: AF and AFL patients were significantly more likely to be daily alcohol drinkers (27\% vs 14\% of controls, P = 0.001). In multivariable analysis, AFL patients â‰¤ 60 years of age were significantly more likely to be daily drinkers than to drink no alcohol compared to controls (odds ratio 17, 95\% confidence interval 1.6-192.0, P = 0.019). Progressively more frequent alcohol intake was significantly associated with a progressively greater odds of AFL in patients â‰¤ 60 years of age (P = 0.045). Neither AF subjects of any age nor AFL subjects {$>$} 60 years of age exhibited significant associations with alcohol after multivariable adjustment. Right AERPs shortened significantly with increasing amounts of alcohol intake (P = 0.025), whereas left AERPs were not associated with alcohol intake. Conclusions: Alcohol intake is positively associated with AFL in younger patients. The mechanism may be related to a shortening of the right AERP. Â© 2008, The Authors.},
  keywords = {ðŸ”´,Alcohol,Atrial effective refratory period (AERP),Atrial fibrillation,Atrial flutter,Refractory period},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Marcus et al_2008_Alcohol intake is significantly associated with atrial flutter in patients.pdf}
}

@article{Matthews1985,
  title = {Homeostasis Model Assessment: Insulin Resistance and Î²-Cell Function from Fasting Plasma Glucose and Insulin Concentrations in Man},
  author = {Matthews, D. R. and Hosker, J. P. and Rudenski, A. S. and Naylor, B. A. and Treacher, D. F. and Turner, R. C.},
  date = {1985},
  journaltitle = {Diabetologia},
  volume = {28},
  number = {7},
  eprint = {3899825},
  eprinttype = {pmid},
  pages = {412--419},
  issn = {0012186X},
  doi = {10.1007/BF00280883},
  abstract = {The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees of Î²-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient Î²-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and Î²-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p {$<$} 0.0001), the fasting insulin concentration (Rs = 0.81, p {$<$} 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p {$<$} 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient Î²-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p {$<$} 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p {$<$} 0.05). The low precision of the estimates from the model (coefficients of variation: 31\% for insulin resistance and 32\% for Î²-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop. Â© 1985 Springer-Verlag.},
  keywords = {ðŸ”´,glucose,glucose clamp,insulin,insulin receptors,insulin resistance,intravenous glucose tolerance test,mathematical model,Type 2 diabetes,Î²-cell function},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Matthews et al_1985_Homeostasis model assessment.pdf}
}

@article{McAloon2016b,
  title = {The Changing Face of Cardiovascular Disease 2000â€“2012: {{An}} Analysis of the World Health Organisation Global Health Estimates Data},
  author = {McAloon, Christopher J. and Boylan, Luke M. and Hamborg, Thomas and Stallard, Nigel and Osman, Faizel and Lim, Phang B. and Hayat, Sajad A.},
  date = {2016-12-01},
  journaltitle = {International Journal of Cardiology},
  volume = {224},
  pages = {256--264},
  publisher = {{Elsevier Ireland Ltd}},
  issn = {18741754},
  doi = {10.1016/j.ijcard.2016.09.026},
  abstract = {The pattern and global burden of disease has evolved considerably over the last two decades, from primarily communicable, maternal, and perinatal causes to non-communicable disease (NCD). Cardiovascular disease (CVD) has become the single most important and largest cause of NCD deaths worldwide at over 50\%. The World Health Organisation (WHO) estimates that 17.6 million people died of CVD worldwide in 2012. Proportionally, this accounts for an estimated 31.43\% of global mortality, with ischaemic heart disease (IHD) accounting for approximately 7.4 million deaths, 13.2\% of the total. IHD was also the greatest single cause of death in 2000, accounting for an estimated 6.0 million deaths. The global burden of CVD falls, principally, on the low and middle-income (LMI) countries, accounting for over 80\% of CVD deaths. Individual populations face differing challenges and each population has unique health burdens, however, CVD remains one of the greatest health challenges both nationally and worldwide.},
  keywords = {ðŸ”´,Cardiovascular disease,Epidemiology,Global burden of disease,World Health Organisation}
}

@article{Meijer2011,
  title = {Prognostic Association of Depression Following Myocardial Infarction with Mortality and Cardiovascular Events: {{A}} Meta-Analysis of 25 Years of Research},
  author = {Meijer, Anna and Conradi, Henk Jan and Bos, Elisabeth H. and Thombs, Brett D. and family=Melle, given=Joost P., prefix=van, useprefix=true and family=Jonge, given=Peter, prefix=de, useprefix=true},
  date = {2011-05},
  journaltitle = {General Hospital Psychiatry},
  volume = {33},
  number = {3},
  pages = {203--216},
  issn = {01638343},
  doi = {10.1016/j.genhosppsych.2011.02.007},
  abstract = {Objective: A meta-analysis of over 25 years of research into the relationship between post-myocardial infarction (MI) depression and cardiac prognosis was conducted to investigate changes in this association over time and to investigate subgroup effects. Method: A systematic literature search was performed (Medline, Embase and PsycINFO; 1975-2011) without language restrictions. Studies investigating the impact of post-MI depression on cardiovascular outcome, defined as all-cause mortality, cardiac mortality and cardiac events within 24 months after the index MI, were identified. Depression had to be assessed within 3 months after MI using established instruments. Pooled odds ratios (ORs) were calculated using a random effects model. Results: A total of 29 studies were identified, resulting in 41 comparisons. Follow-up (on average 16 months) was described for 16,889 MI patients. Post-MI depression was associated with an increased risk of all-cause mortality [(OR), 2.25; 95\% confidence interval [CI], 1.73-2.93; P{$<$}.001], cardiac mortality (OR, 2.71; 95\% CI, 1.68-4.36; P{$<$}.001) and cardiac events (OR, 1.59; 95\% CI, 1.37-1.85; P{$<$}.001). ORs proved robust in subgroup analyses but declined over the years for cardiac events. Conclusions: Post-MI depression is associated with a 1.6- to 2.7-fold increased risk of impaired outcomes within 24 months. This association has been relatively stable over the past 25 years. Â© 2011 Elsevier Inc.},
  keywords = {ðŸ”´,Depression,Meta-analysis,Mortality,Myocardial infarction,Prognosis},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Meijer et al_2011_Prognostic association of depression following myocardial infarction with.pdf}
}

@article{Minassian2015,
  title = {Association of Predeployment Heart Rate Variability with Risk of Postdeployment Posttraumatic Stress Disorder in Active-Duty Marines},
  author = {Minassian, Arpi and Maihofer, Adam X. and Baker, Dewleen G. and Nievergelt, Caroline M. and Geyer, Mark A. and Risbrough, Victoria B. and Hauger, Richard L. and Huang, Mingxiong and Murphy, Jennifer A. and Naviaux, Robert K. and Yurgil, Kate and Patel, Anjana and De La Rosa, Andrew and Gorman, Patricia},
  date = {2015-10-01},
  journaltitle = {JAMA Psychiatry},
  volume = {72},
  number = {10},
  eprint = {26353072},
  eprinttype = {pmid},
  pages = {979--986},
  publisher = {{American Medical Association}},
  issn = {2168622X},
  doi = {10.1001/jamapsychiatry.2015.0922},
  url = {https://pubmed.ncbi.nlm.nih.gov/26353072/},
  urldate = {2020-08-28},
  abstract = {IMPORTANCE Disrupted autonomic nervous system functioning as measured by heart rate variability (HRV) has been associated with posttraumatic stress disorder (PTSD). It is not clear, however, whether reduced HRV before trauma exposure contributes to the risk for development of PTSD. OBJECTIVE To examine whether HRV before combat deployment is associated with increased risk of a PTSD diagnosis after deployment when accounting for deployment-related combat exposure. DESIGN, SETTING, AND PARTICIPANTS Between July 14, 2008, and May 24, 2012, active-duty Marines were assessed 1 to 2 months before a combat deployment and again 4 to 6 months after their return. The first phase of the Marine Resiliency Study (MRS-I) included 1415 male Marines, 59 of whom developed PTSD after deployment. Participants in the second phase of the Marine Resiliency Study (MRS-II) included 745 male Marines, 25 of whom developed PTSD after deployment. Analysis was conducted from November 25, 2013, to April 16, 2015. MAIN OUTCOMES AND MEASURES Predeployment HRVwas measured via finger photoplethysmography during a 5-minute period of rest. Frequency-domain measures of HRV were generated. Diagnosis of PTSD was determined using the Clinician-Administered PTSD Scale. RESULTS After accounting for deployment-related combat exposure, lower HRV before deployment as measured by an increased low-frequency (LF) to high-frequency (HF) ratio of HRV was associated with risk of PTSD diagnosis after deployment (combined MRS-I and MRS-II cohortmeta-analysis odds ratio, 1.47; 95\%CI, 1.10-1.98; P = .01). The prevalence of postdeployment PTSD was higher in participants with high predeployment LF:HF ratios (15.8\% [6 of 38 participants]) compared with participants who did not have high LF:HF ratios (3.7\%[78 of 2122 participants]). CONCLUSIONS AND RELEVANCE This prospective longitudinal study provides initial and modest evidence that an altered state of autonomic nervous system functioning contributes to PTSD vulnerability, taking into account other key risk factors. If these findings are replicated, interventions that change autonomic nervous system function may open novel opportunities for prevention and treatment of PTSD.},
  keywords = {ðŸ”´,2003-2011,Adam X Maihofer,Adult,Afghan Campaign 2001-,Arpi Minassian,Cohort Studies,doi:10.1001/jamapsychiatry.2015.0922,Extramural,Heart Rate / physiology*,Humans,Iraq War,Logistic Models,Longitudinal Studies,Male,Marine Resiliency Study Team,MEDLINE,Military Personnel / psychology*,Multivariate Analysis,N.I.H.,National Center for Biotechnology Information,National Institutes of Health,National Library of Medicine,NCBI,NIH,NLM,Non-P.H.S.,Photoplethysmography,pmid:26353072,Post-Traumatic / epidemiology*,Prevalence,Prospective Studies,PubMed Abstract,Research Support,Risk,Stress Disorders,U.S. Gov't,Young Adult},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Minassian et al_2015_Association of predeployment heart rate variability with risk of postdeployment.pdf}
}

@article{Mittleman1995,
  title = {Triggering of Acute Myocardial Infarction Onset by Episodes of Anger},
  author = {Mittleman, Murray A and Maclure, Malcolm and Sherwood, Jane B and Mulry, Richard P and Tofler, Geoffrey H and Jacobs, Sue C and Friedman, Richard and Benson, Herbert and Muller, James E},
  date = {1995-10-01},
  journaltitle = {Circulation},
  volume = {92},
  number = {7},
  eprint = {7671353},
  eprinttype = {pmid},
  pages = {1720--1725},
  publisher = {{American Heart Association, Inc.}},
  issn = {00097322},
  doi = {10.1161/01.CIR.92.7.1720},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/7671353},
  urldate = {2018-05-31},
  abstract = {Background Many anecdotes and several uncontrolled case series have suggested that emotionally stressful events, and more specifically, anger, immediately precede and appear to trigger the onset of acute myocardial infarction. However, controlled studies to determine the relative risk of myocardial infarction after episodes of anger have not been reported. Methods and Results We interviewed 1623 patients (501 women) an average of 4 days after myocardial infarction. The interview identified the time, place, and quality of myocardial infarction pain and other symptoms, the estimated usual frequency of anger during the previous year, and the intensity and timing of anger and other potentially triggering factors during the 26 hours before the onset of myocardial infarction. Anger was assessed by the onset anger scale, a single-item, seven-level, self-report scale, and the state anger subscale of the State-Trait Personality Inventory. Occurrence of anger in the 2 hours preceding the onset of myocardial infarction was compared with its expected frequency using two types of self-matched control data based on the case-crossover study design. The onset anger scale identified 39 patients with episodes of anger in the 2 hours before the onset of myocardial infarction. The relative risk of myocardial infarction in the 2 hours after an episode of anger was 2.3 (95\% confidence interval, 1.7 to 3.2). The state anger subscale corroborated these findings with a relative risk of 1.9 (95\% confidence interval, 1.3 to 2.7). Regular users of aspirin had a significantly lower relative risk (1.4; 95\% confidence interval, 0.8 to 2.6) than nonusers (2.9; 95\% confidence interval, 2.0 to 4.1) (P{$<$}.05). Conclusions Episodes of anger are capable of triggering the onset of acute myocardial infarction, but aspirin may reduce this risk. A better understanding of the manner in which external events trigger the onset of acute cardiovascular events may lead to innovative preventive strategies aimed at severing the link between these external stressors and their pathological consequences.},
  isbn = {0009-7322 (Print)\textbackslash r0009-7322 (Linking)},
  keywords = {ðŸ”´,anger,myocardial infarction}
}

@article{Moazzami2020,
  title = {Higher {{Activation}} of the {{Rostromedial Prefrontal Cortex}} during {{Mental Stress Predicts Major Cardiovascular Disease Events}} in {{Individuals}} with {{Coronary Artery Disease}}},
  author = {Moazzami, Kasra and Wittbrodt, Matthew T. and Lima, Bruno B. and Nye, Jonathon A. and Mehta, Puja K. and Pearce, Brad D. and Almuwaqqat, Zakaria and Hammadah, Muhammad and Levantsevych, Oleksiy and Sun, Yan V. and Raggi, Paolo and Garcia, Ernest V. and Goetz, Margarethe and Quyyumi, Arshed A. and Bremner, J. Douglas and Vaccarino, Viola and Shah, Amit J.},
  date = {2020-08-04},
  journaltitle = {Circulation},
  volume = {142},
  number = {5},
  eprint = {32522022},
  eprinttype = {pmid},
  pages = {455--465},
  publisher = {{Lippincott Williams and Wilkins}},
  issn = {15244539},
  doi = {10.1161/CIRCULATIONAHA.119.044442},
  url = {https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.119.044442},
  urldate = {2022-06-10},
  abstract = {Background: Psychological stress is a risk factor for major adverse cardiovascular events (MACE) in individuals with coronary artery disease. Certain brain regions that control both emotional states and cardiac physiology may be involved in this relationship. The rostromedial prefrontal cortex (rmPFC) is an important brain region that processes stress and regulates immune and autonomic functions. Changes in rmPFC activity with emotional stress (reactivity) may be informative of future risk for MACE. Methods: Participants with stable coronary artery disease underwent acute mental stress testing using a series of standardized speech/arithmetic stressors and simultaneous brain imaging with high-resolution positron emission tomography brain imaging. We defined high rmPFC activation as a difference between stress and control scans greater than the median value for the entire cohort. Interleukin-6 levels 90 minutes after stress, and high-frequency heart rate variability during stress were also assessed. We defined MACE as a composite of cardiovascular death, myocardial infarction, unstable angina with revascularization, and heart failure hospitalization. Results: We studied 148 subjects (69\% male) with meanÂ±SD age of 62Â±8 years. After adjustment for baseline demographics, risk factors, and baseline levels of interleukin-6 and high-frequency heart rate variability, higher rmPFC stress reactivity was independently associated with higher interleukin-6 and lower high-frequency heart rate variability with stress. During a median follow-up of 3 years, 34 subjects (21.3\%) experienced a MACE. Each increase of 1 SD in rmPFC activation with mental stress was associated with a 21\% increase risk of MACE (hazard ratio, 1.21 [95\% CI, 1.08-1.37]). Stress-induced interleukin-6 and high-frequency heart rate variability explained 15.5\% and 32.5\% of the relationship between rmPFC reactivity and MACE, respectively. Addition of rmPFC reactivity to conventional risk factors improved risk reclassification for MACE prediction, and C-statistic improved from 0.71 to 0.76 (P=0.03). Conclusions: Greater rmPFC stress reactivity is associated with incident MACE. Immune and autonomic responses to mental stress may play a contributory role.},
  keywords = {âœ”ï¸,coronary artery disease,heart rate,inflammation,prefrontal cortex,psychological,stress,treatment outcome},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Moazzami et al_2020_Higher Activation of the Rostromedial Prefrontal Cortex during Mental Stress.pdf}
}

@article{Mostofsky2014,
  title = {Outbursts of Anger as a Trigger of Acute Cardiovascular Events: {{A}} Systematic Review and Meta-Analysis},
  author = {Mostofsky, Elizabeth and Penner, Elizabeth Anne and Mittleman, Murray A},
  date = {2014-06-01},
  journaltitle = {European Heart Journal},
  volume = {35},
  number = {21},
  eprint = {24591550},
  eprinttype = {pmid},
  pages = {1404--1410},
  publisher = {{Oxford University Press}},
  issn = {15229645},
  doi = {10.1093/eurheartj/ehu033},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/24591550},
  urldate = {2018-12-25},
  abstract = {AIM: Short-term psychological stress is associated with an immediate physiological response and may be associated with a transiently higher risk of cardiovascular events. The aim of this study was to determine whether brief episodes of anger trigger the onset of acute myocardial infarction (MI), acute coronary syndromes (ACS), ischaemic and haemorrhagic stroke, and ventricular arrhythmia.\textbackslash n\textbackslash nMETHODS AND RESULTS: We performed a systematic review of studies evaluating whether outbursts of anger are associated with the short-term risk of heart attacks, strokes, and disturbances in cardiac rhythm that occur in everyday life. We performed a literature search of the CINAHL, Embase, PubMed, and PsycINFO databases from January 1966 to June 2013 and reviewed the reference lists of retrieved articles and included meeting abstracts and unpublished results from experts in the field. Incidence rate ratios and 95\% confidence intervals were calculated with inverse-variance-weighted random-effect models. The systematic review included nine independent case-crossover studies of anger outbursts and MI/ACS (four studies), ischaemic stroke (two studies), ruptured intracranial aneurysm (one study), and ventricular arrhythmia (two studies). There was evidence of substantial heterogeneity between the studies (I(2) = 92.5\% for MI/ACS and 89.8\% for ischaemic stroke). Despite the heterogeneity, all studies found that, compared with other times, there was a higher rate of cardiovascular events in the 2h following outbursts of anger.\textbackslash n\textbackslash nCONCLUSION: There is a higher risk of cardiovascular events shortly after outbursts of anger.},
  isbn = {0195-668x},
  keywords = {ðŸ”´,Anger,Cardiovascular disease,Case-crossover,Epidemiology}
}

@article{Nievergelt2015,
  title = {Genomic Predictors of Combat Stress Vulnerability and Resilience in {{U}}.{{S}}. {{Marines}}: {{A}} Genome-Wide Association Study across Multiple Ancestries Implicates {{PRTFDC1}} as a Potential {{PTSD}} Gene},
  author = {Nievergelt, Caroline M. and Maihofer, Adam X. and Mustapic, Maja and Yurgil, Kate A. and Schork, Nicholas J. and Miller, Mark W. and Logue, Mark W. and Geyer, Mark A. and Risbrough, Victoria B. and O'Connor, Daniel T. and Baker, Dewleen G.},
  date = {2015-01},
  journaltitle = {Psychoneuroendocrinology},
  volume = {51},
  eprint = {25456346},
  eprinttype = {pmid},
  pages = {459--471},
  issn = {18733360},
  doi = {10.1016/j.psyneuen.2014.10.017},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/25456346},
  urldate = {2018-12-24},
  abstract = {Background: Research on the etiology of post-traumatic stress disorder (PTSD) has rapidly matured, moving from candidate gene studies to interrogation of the entire human genome in genome-wide association studies (GWAS). Here we present the results of a GWAS performed on samples from combat-exposed U.S. Marines and Sailors from the Marine Resiliency Study (MRS) scheduled for deployment to Iraq and/or Afghanistan. The MRS is a large, prospective study with longitudinal follow-up designed to identify risk and resiliency factors for combat-induced stress-related symptoms. Previously implicated PTSD risk loci from the literature and polygenic risk scores across psychiatric disorders were also evaluated in the MRS cohort. Methods: Participants (. N=. 3494) were assessed using the Clinician-Administered PTSD Scale and diagnosed using the DSM-IV diagnostic criterion. Subjects with partial and/or full PTSD diagnosis were called cases, all other subjects were designated controls, and study-wide maximum CAPS scores were used for longitudinal assessments. Genomic DNA was genotyped on the Illumina HumanOmniExpressExome array. Individual genetic ancestry was determined by supervised cluster analysis for subjects of European, African, Hispanic/Native American, and other descent. To test for association of SNPs with PTSD, logistic regressions were performed within each ancestry group and results were combined in meta-analyses. Measures of childhood and adult trauma were included to test for gene-by-environment (GxE) interactions. Polygenic risk scores from the Psychiatric Genomic Consortium were used for major depressive disorder (MDD), bipolar disorder (BPD), and schizophrenia (SCZ). Results: The array produced {$>$}800K directly genotyped and {$>$}21M imputed markers in 3494 unrelated, trauma-exposed males, of which 940 were diagnosed with partial or full PTSD. The GWAS meta-analysis identified the phosphoribosyl transferase domain containing 1 gene (PRTFDC1) as a genome-wide significant PTSD locus (rs6482463; OR=1.47, SE=0.06, p=2.04Ã—10-9), with a similar effect across ancestry groups. Association of PRTFDC1 with PTSD in an independent military cohort showed some evidence for replication. Loci with suggestive evidence of association (n=25 genes, p{$<$}5Ã—10-6) further implicated genes related to immune response and the ubiquitin system, but these findings remain to be replicated in larger GWASs. A replication analysis of 25 putative PTSD genes from the literature found nominally significant SNPs for the majority of these genes, but associations did not remain significant after correction for multiple comparison. A cross-disorder analysis of polygenic risk scores from GWASs of BPD, MDD, and SCZ found that PTSD diagnosis was associated with risk sores of BPD, but not with MDD or SCZ. Conclusions: This first multi-ethnic/racial GWAS of PTSD highlights the potential to increase power through meta-analyses across ancestry groups. We found evidence for PRTFDC1 as a potential novel PTSD gene, a finding that awaits further replication. Our findings indicate that the genetic architecture of PTSD may be determined by many SNPs with small effects, and overlap with other neuropsychiatric disorders, consistent with current findings from large GWAS of other psychiatric disorders.},
  isbn = {0306-4530},
  keywords = {ðŸ”´,Ancestry,Bipolar disorder,GWAS,GxE,Meta-analysis,Pleiotropy,Polygenic risk score,PTSD,Trauma}
}

@article{Norby2021,
  title = {Racial and {{Ethnic Considerations}} in {{Patients}} with {{Atrial Fibrillation}}: {{JACC Focus Seminar}}},
  shorttitle = {Racial and {{Ethnic Considerations}} in {{Patients}} with {{Atrial Fibrillation}}},
  author = {Norby, Faye L. and Benjamin, Emelia J. and Alonso, Alvaro and Chugh, Sumeet S.},
  date = {2021-12-21},
  journaltitle = {Journal of the American College of Cardiology},
  shortjournal = {J Am Coll Cardiol},
  volume = {78},
  number = {25},
  eprint = {34887142},
  eprinttype = {pmid},
  pages = {2563--2572},
  issn = {0735-1097},
  doi = {10.1016/j.jacc.2021.04.110},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688256/},
  urldate = {2023-11-09},
  abstract = {Atrial fibrillation (AF) affects at least 60 million individuals globally, and is associated with substantial impacts on morbidity, mortality, and health care expenditure. In this review, we focus on how race and ethnicity influence AF epidemiology, risk prediction, treatment, and outcomes, and identify knowledge gaps in these areas. Most AF studies have predominantly included White populations with an underrepresentation of racial and ethnic groups including, but not limited to, Black, Hispanic, and Indigenous individuals. Enhancement and implementation of AF risk prediction, prevention, and management call for studies that will gather accurate race-based epidemiological data and evaluate social determinants and genetic factors in the context of multiple races and ethnicities. Available studies highlight inequities in access to treatment as well as outcomes between White individuals and persons of other races/ethnicities. These will need to be addressed by a renewed emphasis on structural and social determinants of health that contribute to AF., In this review, we focus on how race and ethnicity influence AF epidemiology, risk prediction, treatment, and outcomes, and identify knowledge gaps in these areas. Most AF studies have predominantly included White populations with an underrepresentation of other racial and ethnic groups. There is a critical need for studies that will gather accurate race-based epidemiological and genetic data. Available studies highlight sizeable inequities in access to treatment as well as outcomes between Whites individuals and persons of other races/ethnicities. These will need to be addressed by a renewed emphasis on structural and social determinants of health that contribute to AF.},
  pmcid = {PMC8688256},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Norby et al_2021_Racial and Ethnic Considerations in Patients with Atrial Fibrillation.pdf}
}

@article{OFee2021,
  title = {Assessment of {{Nonfatal Myocardial Infarction}} as a {{Surrogate}} for {{All-Cause}} and {{Cardiovascular Mortality}} in {{Treatment}} or {{Prevention}} of {{Coronary Artery Disease}}: {{A Meta-analysis}} of {{Randomized Clinical Trials}}},
  author = {O'Fee, Kevin and Deych, Elena and Ciani, Oriana and Brown, David L.},
  date = {2021-12-01},
  journaltitle = {JAMA Internal Medicine},
  volume = {181},
  number = {12},
  eprint = {34694318},
  eprinttype = {pmid},
  pages = {1575--1587},
  publisher = {{American Medical Association}},
  issn = {21686114},
  doi = {10.1001/jamainternmed.2021.5726},
  url = {https://jamanetwork-com.proxy.cc.uic.edu/journals/jamainternalmedicine/fullarticle/2785560},
  urldate = {2022-09-27},
  abstract = {Importance: Although nonfatal myocardial infarction (MI) is associated with an increased risk of mortality, evidence validating nonfatal MI as a surrogate end point for all-cause or cardiovascular (CV) mortality is lacking. Objective: To examine whether nonfatal MI may be a surrogate for all-cause or CV mortality in patients with or at risk for coronary artery disease. Data Sources: In this meta-analysis, PubMed was searched from inception until December 31, 2020, for randomized clinical trials of interventions to treat or prevent coronary artery disease reporting mortality and nonfatal MI published in 3 leading journals. Study Selection: Randomized clinical trials including at least 1000 patients with 24 months of follow-up. Data Extraction and Synthesis: Trial-level correlations between nonfatal MI and all-cause or CV mortality were assessed for surrogacy using the coefficient of determination (R2). The criterion for surrogacy was set at 0.8. Subgroup analyses based on study subject (primary prevention, secondary prevention, mixed primary and secondary prevention, and revascularization), era of trial (before 2000, 2000-2009, and 2010 and after), and follow-up duration (2.0-3.9, 4.0-5.9, and â‰¥6.0 years) were performed. Main Outcomes and Measures: All-cause or CV mortality and nonfatal MI. Results: A total of 144 articles randomizing 1211897 patients met the criteria for inclusion. Nonfatal MI did not meet the threshold for surrogacy for all-cause (R2= 0.02; 95\% CI, 0.00-0.08) or CV (R2= 0.11; 95\% CI, 0.02-0.27) mortality. Nonfatal MI was not a surrogate for all-cause mortality in primary (R2= 0.01; 95\% CI, 0.001-0.26), secondary (R2= 0.03; 95\% CI, 0.00-0.20), mixed primary and secondary prevention (R2= 0.001; 95\% CI, 0.00-0.08), or revascularization trials (R2= 0.21; 95\% CI, 0.002-0.50). For trials enrolling patients before 2000 (R2= 0.22; 95\% CI, 0.08-0.36), between 2000 and 2009 (R2= 0.02; 95\% CI, 0.00-0.17), and from 2010 and after (R2= 0.01; 95\% CI, 0.00-0.09), nonfatal MI was not a surrogate for all-cause mortality. Nonfatal MI was not a surrogate for all-cause mortality in randomized clinical trials with 2.0 to 3.9 (R2= 0.004; 95\% CI, 0.00-0.08), 4.0 to 5.9 (R2= 0.06; 95\% CI, 0.001-0.16), or 6.0 or more years of follow-up (R2= 0.30; 95\% CI, 0.01-0.55). Conclusions and Relevance: The findings of this meta-analysis do not appear to establish nonfatal MI as a surrogate for all-cause or CV mortality in randomized clinical trials of interventions to treat or prevent coronary artery disease..},
  keywords = {ðŸ”´,cardiovascular death,coronary arteriosclerosis,follow-up,myocardial infarction,revascularization,surrogate endpoints},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/O'Fee et al_2021_Assessment of Nonfatal Myocardial Infarction as a Surrogate for All-Cause and.pdf}
}

@article{Ohira2008,
  title = {Associations of Psychosocial Factors with Heart Rate and Its Short-Term Variability: {{Multi-ethnic}} Study of Atherosclerosis},
  author = {Ohira, Tetsuya and Roux, Ana V.Diez and Prineas, Ronald J. and Kizilbash, Mohammad A. and Carnethon, Mercedes R. and Folsom, Aaron R.},
  date = {2008-02},
  journaltitle = {Psychosomatic Medicine},
  volume = {70},
  number = {2},
  pages = {141--146},
  issn = {00333174},
  doi = {10.1097/PSY.0b013e318160686a},
  abstract = {OBJECTIVE: To examine the association of psychosocial factors with heart rate (HR) and its variability across multiple ethnic groups and by gender. Increased HR and reduced HR variability are markers of increased cardiovascular risk. METHODS: Between 2000 and 2002, 6814 men and women (2624 Whites, 1895 African-Americans, 1492 Hispanics, and 803 Chinese) aged 45 to 84 years took part in the first examination of the Multi-Ethnic Study of Atherosclerosis. Associations of psychosocial variables with mean values of HR and its short-term variability were tested, using multivariate regression models. RESULTS: In age, gender, race/ethnicity, and risk factor-adjusted analyses, a depressive symptom score was positively associated with HR and inversely associated with HR variability (standard deviation of normal-to-normal (N-N) interbeat intervals (SDNN) and the root mean square of successive differences in N-N intervals (RMSSD)). The adjusted mean differences per 1-SD (8 points) increment of depression score for HR, RMSSD, and SDNN were 0.5 (95\% confidence interval (CI), 0.2-0.7), -0.8 (95\% CI, -1.5 to -0.2), and -0.7 (95\% CI, -1.1 to -0.2). The social support score was inversely associated with HR, but nonsignificantly associated with RMSSD and SDNN. There was no association of trait anger or trait anxiety with HR, RMSSD, or SDNN. Associations were generally consistent in men and women. CONCLUSIONS: These findings generally support the hypothesis that depression may be associated with increased HR and reduced HR variability, which increase the risk of cardiovascular diseases. Copyright Â© 2008 by American Psychosomatic Society.},
  keywords = {ðŸ”´,Autonomic nervous system,Coronary artery disease,Depression,Heart rate,Psychosocial factor,Race/ethnicity}
}

@article{Oieru2015,
  title = {A Novel Heart Rate Variability Algorithm for the Detection of Myocardial Ischemia: Pilot Data from a Prospective Clinical Trial.},
  author = {Oieru, Dan and Moalem, Israel and Rozen, Eli and Naimushin, Alexey and Klempfner, Robert and Goldenberg, Ilan and Goldkorn, Ronen},
  date = {2015},
  journaltitle = {The Israel Medical Association journal : IMAJ},
  volume = {17},
  number = {3},
  eprint = {25946767},
  eprinttype = {pmid},
  pages = {161--5},
  issn = {1565-1088},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/25946767},
  abstract = {BACKGROUND: Heart rate variability (HRV) analysis has been shown to be a predictor of sudden cardiac death and all-cause mortality in patients with cardiac disease. OBJECTIVES: To examine whether newer HRV analysis algorithms, as used by the HeartTrends device, are superior to exercise stress testing (EST) for the detection of myocardial ischemia in patients without known coronary artery disease (CAD). METHODS: We present pilot data of the first 100 subjects enrolled in a clinical trial designed to evaluate the yield of short-term (1 hour) HRV testing for the detection of myocardial ischemia. The study population comprised subjects without known CAD referred to a tertiary medical center for EST with single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). All patients underwent a 1 hour electrocardiographic acquisition for HRV analysis with a HeartTrends device prior to ESTwith MPI. Sensitivity, specificity, and positive and negative predictive values (PPV and NPV, respectively) were calculated for EST and HRV analysis, using MPI as the gold standard for the non-invasive detection of myocardial ischemia. RESULTS: In this cohort 15\% had a pathologic MPI result. HRV analysis showed superior sensitivity (85\%), PPV (50\%) and NPV (97\%) as compared to standard EST (53\%, 42\%, 90\%, respectively), while the specificity of the two tests was similar (86\% and 85\%, respectively). The close agreement between HRV and MPI was even more pronounced among patients {$>$} 65 years of age. CONCLUSIONS: Our pilot data suggest that the diagnostic yield of the novel HeartTrends HRV algorithm is superior to conventional EST for the non-invasive detection of myocardial ischemia.},
  keywords = {ðŸ”´,artery disease,cad,coronary,for the diagnosis of,heart rate variability,hrv,myocardial ischemia,patients and methods,the hearttrends hrv algorithm},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Oieru et al_2015_A novel heart rate variability algorithm for the detection of myocardial.pdf}
}

@article{Ossola2018,
  title = {Anxiety, {{Depression}}, and {{Cardiac Outcomes}} after a First {{Acute Coronary Syndrome}}},
  author = {Ossola, Paolo and Gerra, Maria Lidia and Panfilis, Chiara De and Tonna, Matteo and Marchesi, Carlo},
  date = {2018-10-11},
  journaltitle = {Health Psychology},
  eprint = {30307271},
  eprinttype = {pmid},
  issn = {19307810},
  doi = {10.1037/hea0000658},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/30307271},
  urldate = {2018-10-28},
  abstract = {OBJECTIVE Depression is an established risk factor for acute coronary syndrome (ACS), with an impact on cardiac prognosis; nonetheless, the literature disagrees on the role played by anxiety. No study has evaluated this relationship in a cardiac population with no history of depression and after their first diagnosis of ACS. The aim of this study is to explore these associations without the confounding role of long-lasting heart disease or psychiatric illnesses. METHOD Two hundred sixty-six patients with no history of depression completed the Hospital Anxiety and Depression Scale and the Primary Care Evaluation of Mental Disorder at baseline and at 1, 2, 4, 6, 9, 12, and 24 months follow-up after their first diagnosis of ACS. During the follow-up period, we collected information regarding the major adverse cardiac events. RESULTS Developing a first-ever depressive episode, in a proportional hazard model, was associated with almost 3 times the risk of a recurrent cardiac event (odds ratio = 2.590, 95\% confidence interval [CI] [1.321, 5.078], p = .006). Furthermore, a moderation analysis revealed that increasing levels of baseline anxiety had opposing effects on cardiac outcomes, being protective only in those who did not develop incident depression (B = -0.0824, 95\% CI [-0.164, -0.005], p = .048). No dose-response effect between depressive or anxious symptoms and cardiac outcomes emerged. CONCLUSION Our results confirm the detrimental effect of depression on cardiac prognosis in a selected population and suggest that anxiety after the first diagnosis of ACS might have different roles depending on the illness' course. (PsycINFO Database Record (c) 2018 APA, all rights reserved).},
  keywords = {ðŸ”´}
}

@article{Paniccia2017,
  title = {Clinical and Non-Clinical Depression and Anxiety in Young People: {{A}} Scoping Review on Heart Rate Variability},
  author = {Paniccia, Melissa and Paniccia, David and Thomas, Scott and Taha, Tim and Reed, Nick},
  date = {2017-12},
  journaltitle = {Autonomic Neuroscience: Basic and Clinical},
  volume = {208},
  eprint = {28870754},
  eprinttype = {pmid},
  pages = {1--14},
  issn = {18727484},
  doi = {10.1016/j.autneu.2017.08.008},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/28870754},
  urldate = {2018-10-29},
  abstract = {Background Heart rate variability (HRV), a measure of cardiac autonomic nervous system functioning, has emerged as a physiological indicator for emotional regulation and psychological well-being. HRV is understudied in the context of depression and anxiety in young people (10â€“24 years old). Main objectives: (1) describe the nature and breadth of reviewed studies; and (2) synthesize main findings in the context of clinical and non-clinical populations of young people with depression and/or anxiety. Methods The Arksey and O'Malley methodology was utilized for this scoping review. CINHAL, EMBASE, Medline, PsychInfo, Scopus, Web of Science, as well as grey literature, were searched. Two reviewers screened titles, abstracts and full papers for inclusion. A total of 20 citations were included in the final review (19 citations peer-reviewed journal articles, 1 journal abstract). Numerical and thematic analysis was used to summarize study findings. Results In clinical populations of either depression or anxiety, HRV was lower compared to controls. In non-clinical populations of either depression or anxiety, HRV was found to be lower in those who reported more depression or anxiety symptoms. Limitations The quality of the reviewed articles was not assessed which limits the ability to generate conclusions regarding study findings. Conclusion Changes in HRV were found across the spectrum of clinical and non-clinical populations of young people with depression or anxiety. Neurophysiological research on depression and anxiety in young people can act as a first step to understanding how physiological flexibility (i.e. HRV) is related to psychological flexibility (i.e. adaptive or maladaptive responses to life events).},
  isbn = {1872-7484 (Electronic) 1566-0702 (Linking)},
  keywords = {ðŸ”´,Anxiety,Autonomic nervous system,Depression,Heart rate variability,Young people}
}

@article{Parvez2012a,
  title = {Symptomatic Response to Antiarrhythmic Drug Therapy Is Modulated by a Common Single Nucleotide Polymorphism in Atrial Fibrillation},
  author = {Parvez, Babar and Vaglio, Joseph and Rowan, Shane and Muhammad, Raafia and Kucera, Gayle and Stubblefield, Tanya and Carter, Shannon and Roden, Dan and Darbar, Dawood},
  date = {2012-08-07},
  journaltitle = {Journal of the American College of Cardiology},
  volume = {60},
  number = {6},
  eprint = {22726630},
  eprinttype = {pmid},
  pages = {539--545},
  publisher = {{J Am Coll Cardiol}},
  issn = {07351097},
  doi = {10.1016/j.jacc.2012.01.070},
  url = {https://pubmed.ncbi.nlm.nih.gov/22726630/},
  urldate = {2022-05-09},
  abstract = {Objectives: This study tested the hypothesis that response to antiarrhythmic drugs (AADs) is modulated by 3 common loci associated with atrial fibrillation (AF). Background: Recent genome-wide association studies have identified 3 loci, on chromosomes 4q25 (near PITX2), 16q22 (in ZFHX3), and 1q21 (in KCNN3), that associate with either typical or lone AF. These findings indicate that variable mechanisms contribute to AF susceptibility, and suggest that response to therapy may be genotype dependent. Methods: We studied 478 and 198 Caucasian patients in the discovery cohort and validation cohort, respectively, who were prospectively enrolled in the Vanderbilt AF registry. Response was defined prospectively as successful rhythm control if the patient remained on the same AAD therapy for a minimum of 6 months with {$<$}75\% reduction in symptomatic AF burden. We also evaluated AF recurrence by 12-lead electrocardiogram (ECG) at 3, 6, and 12 months. Symptomatic patients were also given a 24- to 48-h Holter monitor or 30-day event recorder when AF recurrence was not captured by 12-lead ECG. Results: In the discovery cohort, 399 (83\%) patients were successfully rhythm controlled. Multiple clinical variables (including age, hypertension, lone AF) failed to significantly predict response to AADs; however, single nucleotide polymorphism (SNP) rs10033464 at 4q25 was an independent predictor of successful rhythm control in patients with typical AF carrying the ancestral allele (wild type) versus carriers of variant allele (odds ratio [OR]: 4.7, 95\% confidence interval [CI]: 1.83 to 12, p = 0.0013. In the validation cohort, 143 (72\%) patients met the criteria for successful rhythm control, and rs10033464 was again an independent predictor of successful rhythm control, OR: 1.5, 95\% CI: 1.02 to 3.06, p = 0.04. This SNP (rs10033464) was an independent predictor of AF recurrence in the discovery (39\% AF recurrence) and validation (38\% AF recurrence) cohorts; OR: 3.27, 95\% CI: 1.7 to 6, p {$<$} 0.001 and OR: 4.3, 95\% CI: 1.98 to 9.4, p {$<$} 0.001, respectively. Conclusions: These results suggest that a common SNP on chromosome 4q25 associated with AF modulates response to AAD therapy and points to a potential role for stratification of therapeutic approaches by genotype. Â© 2012 American College of Cardiology Foundation.},
  keywords = {ðŸ”´,antiarrhythmics,atrial fibrillation,genomics,polymorphisms},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Parvez et al_2012_Symptomatic response to antiarrhythmic drug therapy is modulated by a common.pdf}
}

@article{Paur2012,
  title = {High Levels of Circulating Epinephrine Trigger Apical Cardiodepression in a Î² 2-Adrenergic Receptor/{{Gi-dependent}} Manner: {{A}} New Model of Takotsubo Cardiomyopathy},
  author = {Paur, Helen and Wright, Peter T. and Sikkel, Markus B. and Tranter, Matthew H. and Mansfield, Catherine and O'Gara, Peter and Stuckey, Daniel J. and Nikolaev, Viacheslav O. and Diakonov, Ivan and Pannell, Laura and Gong, Haibin and Sun, Hong and Peters, Nicholas S. and Petrou, Mario and Zheng, Zhaolun and Gorelik, Julia and Lyon, Alexander R. and Harding, Sian E.},
  date = {2012-08-07},
  journaltitle = {Circulation},
  volume = {126},
  number = {6},
  eprint = {22732314},
  eprinttype = {pmid},
  pages = {697--706},
  publisher = {{Europe PMC Funders}},
  issn = {00097322},
  doi = {10.1161/CIRCULATIONAHA.112.111591},
  url = {/pmc/articles/PMC4890655/?report=abstract},
  urldate = {2020-09-20},
  abstract = {Background-Takotsubo cardiomyopathy is an acute heart failure syndrome characterized by myocardial hypocontractility from the mid left ventricle to the apex. It is precipitated by extreme stress and can be triggered by intravenous catecholamine administration, particularly epinephrine. Despite its grave presentation, Takotsubo cardiomyopathy is rapidly reversible, with generally good prognosis. We hypothesized that this represents switching of epinephrine signaling through the pleiotropic Î² 2-adrenergic receptor (Î² 2AR) from canonical stimulatory G-protein-activated cardiostimulant to inhibitory G-protein-activated cardiodepressant pathways. Methods and Results-We describe an in vivo rat model in which a high intravenous epinephrine, but not norepinephrine, bolus produces the characteristic reversible apical depression of myocardial contraction coupled with basal hypercontractility. The effect is prevented via Gi inactivation by pertussis toxin pretreatment. Î² 2AR number and functional responses were greater in isolated apical cardiomyocytes than in basal cardiomyocytes, which confirmed the higher apical sensitivity and response to circulating epinephrine. In vitro studies demonstrated high-dose epinephrine can induce direct cardiomyocyte cardiodepression and cardioprotection in a Î² 2AR- Gi-dependent manner. Preventing epinephrine-Gi effects increased mortality in the Takotsubo model, whereas Î²-blockers that activate Î² 2AR- Gi exacerbated the epinephrine-dependent negative inotropic effects without further deaths. In contrast, levosimendan rescued the acute cardiac dysfunction without increased mortality. Conclusions-We suggest that biased agonism of epinephrine for Î² 2AR-Gs at low concentrations and for Gi at high concentrations underpins the acute apical cardiodepression observed in Takotsubo cardiomyopathy, with an apical-basal gradient in Î² 2ARs explaining the differential regional responses. We suggest this epinephrine-specific Î² 2AR-Gi signaling may have evolved as a cardioprotective strategy to limit catecholamine-induced myocardial toxicity during acute stress. Â© 2012 American Heart Association, Inc.},
  keywords = {ðŸ”´,acute heart failure,adrenergic,beta,catecholamines,receptors,Takotsubo syndrome},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Paur et al_2012_High levels of circulating epinephrine trigger apical cardiodepression in a Î².pdf}
}

@article{Penninx2017,
  title = {Depression and Cardiovascular Disease: {{Epidemiological}} Evidence on Their Linking Mechanisms},
  author = {Penninx, Brenda W.J.H.},
  date = {2017},
  journaltitle = {Neuroscience and Biobehavioral Reviews},
  volume = {74},
  pages = {277--286},
  issn = {18737528},
  doi = {10.1016/j.neubiorev.2016.07.003},
  url = {http://dx.doi.org/10.1016/j.neubiorev.2016.07.003},
  urldate = {2019-02-24},
  abstract = {Depression's burden of disease goes beyond functioning and quality of life and extends to somatic health. Results from longitudinal cohort studies converge in illustrating that major depressive disorder (MDD) subsequently increases the risk of cardiovascular morbidity and mortality with about 80\%. The impact of MDD on cardiovascular health may be partly explained by mediating mechanisms such as unhealthy lifestyle (smoking, excessive alcohol use, physical inactivity, unhealthy diet, therapy non-compliance) and unfavorable pathophysiological disturbances (autonomic, HPA-axis, metabolic and immuno-inflammatory dysregulations). A summary of the literature findings as well as relevant results from the large-scale Netherlands Study of Depression and Anxiety (N = 2981) are presented. Persons with MDD have significantly worse lifestyles as well as more pathophysiological disturbances as compared to healthy controls. Some of these differences seem to be specific for (typical versus â€˜atypicalâ€™, or antidepressant treated versus drug-naive) subgroups of MDD patients. Alternative explanations are also present, namely undetected confounding, iatrogenic effects or â€˜third factorsâ€™ such as genetics.},
  keywords = {ðŸ”´,Cardiac autonomic control,Cardiovascular,Cortisol,Depression,Epidemiology,Inflammation,Lifestyle,Metabolic syndrome},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Penninx_2017_Depression and cardiovascular disease.pdf}
}

@article{Petrazzini2022,
  title = {Coronary {{Risk Estimation Based}} on {{Clinical Data}} in {{Electronic Health Records}}},
  author = {Petrazzini, Ben O. and Chaudhary, Kumardeep and MÃ¡rquez-Luna, Carla and Forrest, Iain S. and Rocheleau, Ghislain and Cho, Judy and Narula, Jagat and Nadkarni, Girish and Do, Ron},
  date = {2022-03-29},
  journaltitle = {Journal of the American College of Cardiology},
  volume = {79},
  number = {12},
  eprint = {35331410},
  eprinttype = {pmid},
  pages = {1155--1166},
  publisher = {{American College of Cardiology Foundation Washington D.C.}},
  issn = {15583597},
  doi = {10.1016/j.jacc.2022.01.021},
  url = {https://www.jacc.org/doi/10.1016/j.jacc.2022.01.021},
  urldate = {2022-08-12},
  abstract = {Background: Clinical features from electronic health records (EHRs) can be used to build a complementary tool to predict coronary artery disease (CAD) susceptibility. Objectives: The purpose of this study was to determine whether an EHR score can improve CAD prediction and reclassification 1 year before diagnosis, beyond conventional clinical guidelines as determined by the pooled cohort equations (PCE) and a polygenic risk score for CAD. Methods: We applied a machine learning framework using clinical features from the EHR in a multiethnic, clinical care cohort (BioMe) comprising 555 CAD cases and 6,349 control subjects and in a population-based cohort (UK Biobank) comprising 3,130 CAD cases and 378,344 control subjects for external validation. Results: Compared with the PCE, the EHR score improved CAD prediction by 12\% in the BioMe Biobank and by 9\% in the UK Biobank. The EHR score reclassified 25.8\% and 15.2\% individuals in each cohort respectively, compared with the PCE score. We observed larger improvements in the EHR score over the PCE in a subgroup of individuals with low CAD risk, with 20\% increased discrimination and 34.4\% increased reclassification. In all models, the polygenic risk score for CAD did not improve CAD prediction, compared with the PCE or EHR score. Conclusions: The EHR score resulted in increased prediction and reclassification for CAD, demonstrating its potential use for population health monitoring of short-term CAD risk in large health systems.},
  keywords = {ðŸ”´,biobank,coronary artery disease,electronic health record,machine learning,polygenic risk score,pooled cohort equations,prevention}
}

@article{Pimple2014,
  title = {Association between Anger and Mental Stress-Induced Myocardial Ischemia},
  author = {Pimple, Pratik and Shah, Amit and Rooks, Cherie and Bremner, J. Douglas and Nye, Jonathon and Ibeanu, Ijeoma and Murrah, Nancy and Shallenberger, Lucy and Kelley, Mary and Raggi, Paolo and Vaccarino, Viola},
  date = {2014-01},
  journaltitle = {American Heart Journal},
  volume = {169},
  number = {1},
  eprint = {25497256},
  eprinttype = {pmid},
  pages = {115-121.e2},
  issn = {10976744},
  doi = {10.1016/j.ahj.2014.07.031},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/25497256},
  urldate = {2018-11-25},
  abstract = {Background Mental stress-induced myocardial ischemia is associated with adverse prognosis in coronary artery disease patients. Anger is thought to be a trigger of acute coronary syndromes and is associated with increased cardiovascular risk; however, little direct evidence exists for a link between anger and myocardial ischemia. Methods [99mTc]-sestamibi single-photon emission tomography was performed at rest, after mental stress (a social stressor with a speech task) and after exercise/pharmacologic stress. Summed scores of perfusion abnormalities were obtained by observer-independent software. A summed-difference score, the difference between stress and rest scores, was used to quantify myocardial ischemia under both stress conditions. The Spielberger's State-Trait Anger Expression Inventory was used to assess different anger dimensions. Results The mean age was 50 years, 50\% were female, and 60\% were non-white. After adjusting for demographic factors, smoking, coronary artery disease severity, depressive, and anxiety symptoms, each IQR increment in state-anger score was associated with 0.36 U-adjusted increase in ischemia as measured by the summed-difference score (95\% CI 0.14-0.59); the corresponding association for trait anger was 0.95 (95\% CI 0.21-1.69). Anger expression scales were not associated with ischemia. None of the anger dimensions was related to ischemia during exercise/pharmacologic stress. Conclusion Anger, both as an emotional state and as a personality trait, is significantly associated with propensity to develop myocardial ischemia during mental stress but not during exercise/pharmacologic stress. Patients with this psychologic profile may be at increased risk for silent ischemia induced by emotional stress, and this may translate into worse prognosis. (Am Heart J 2015;169:115-121.e2.).},
  isbn = {1097-6744 (Electronic)\textbackslash r0002-8703 (Linking)},
  keywords = {ðŸ”´}
}

@article{Rahman2016,
  title = {Atrial Flutter: {{Clinical}} Risk Factors and Adverse Outcomes in the {{Framingham Heart Study}}},
  author = {Rahman, Faisal and Wang, Na and Yin, Xiaoyan and Ellinor, Patrick T. and Lubitz, Steven A. and Lelorier, Paul A. and McManus, David D. and Sullivan, Lisa M. and Seshadri, Sudha and Vasan, Ramachandran S. and Benjamin, Emelia J. and Magnani, Jared W.},
  date = {2016-01-01},
  journaltitle = {Heart Rhythm},
  volume = {13},
  number = {1},
  eprint = {26226213},
  eprinttype = {pmid},
  pages = {233--240},
  publisher = {{Elsevier}},
  issn = {15563871},
  doi = {10.1016/j.hrthm.2015.07.031},
  abstract = {Background Few epidemiologic cohort studies have evaluated atrial flutter (flutter) as an arrhythmia distinct from atrial fibrillation (AF). Objective The purpose of this study was to examine the clinical correlates of flutter and its associated outcomes to distinguish them from those associated with AF in the Framingham Heart Study. Methods We reviewed and adjudicated electrocardiograms (ECGs) previously classified as flutter or AF/flutter and another 100 ECGs randomly selected from AF cases. We examined the clinical correlates of flutter by matching up to 5 AF and 5 referents to each flutter case using a nested case referent design. We determined the 10-year outcomes associated with flutter with Cox models. Results During mean follow-up of 33.0 Â± 12.2 years, 112 participants (mean age 72 Â± 10 years, 30\% women) developed flutter. In multivariable analyses, smoking (odds ratio [OR] 2.84, 95\% confidence interval [CI] 1.54-5.23), increased PR interval (OR 1.28 per SD, 95\% CI 1.03-1.60), myocardial infarction (OR 2.25, 95\% CI 1.05-4.80) and heart failure (OR 5.22, 95\% CI 1.26-21.64) were associated with incident flutter. In age- and sex-adjusted models, flutter (vs referents) was associated with 10-year increased risk of AF (hazard ratio [HR] 5.01, 95\% CI 3.14-7.99), myocardial infarction (HR 3.05, 95\% CI 1.42-6.59), heart failure (HR 4.14, 95\% CI 1.90-8.99), stroke (HR 2.17, 95\% CI 1.13-4.17), and mortality (HR 2.00, 95\% CI 1.44-2.79). Conclusion We identified the clinical correlates associated with flutter and observed that flutter was associated with multiple adverse outcomes.},
  keywords = {ðŸ”´,Atrial fibrillation,Atrial flutter,Epidemiology,Outcomes,Risk factors},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Rahman et al_2016_Atrial flutter.pdf}
}

@article{Ritchie2012,
  title = {Chromosome 4q25 Variants Are Genetic Modifiers of Rare Ion Channel Mutations Associated with Familial Atrial Fibrillation},
  author = {Ritchie, Marylyn D. and Rowan, Shane and Kucera, Gayle and Stubblefield, Tanya and Blair, Marcia and Carter, Shannon and Roden, Dan M. and Darbar, Dawood},
  date = {2012-09-25},
  journaltitle = {Journal of the American College of Cardiology},
  volume = {60},
  number = {13},
  eprint = {22818067},
  eprinttype = {pmid},
  pages = {1173--1181},
  publisher = {{J Am Coll Cardiol}},
  issn = {07351097},
  doi = {10.1016/j.jacc.2012.04.030},
  url = {https://pubmed.ncbi.nlm.nih.gov/22818067/},
  urldate = {2022-05-09},
  abstract = {Objectives: The aim of this study was to test the hypothesis that 2 common polymorphisms in the chromosome 4q25 region that have been associated with atrial fibrillation (AF) contribute to the variable penetrance of familial AF. Background: Although mutations in ion channels, gap junction proteins, and signaling molecules have been described for Mendelian forms of AF, penetrance is highly variable. Recent studies have consistently identified 2 common single-nucleotide polymorphisms in the chromosome 4q25 region as independent AF susceptibility alleles. Methods: Eleven families in which AF was present in {$<$}2 members who also shared a candidate gene mutation were studied. These mutations were identified in all subjects with familial lone AF (n = 33) as well as apparently unaffected family members (age {$>$}50 years with no AF; n = 17). Results: Mutations were identified in SCN5A (n = 6), NPPA (n = 2), KCNQ1 (n = 1), KCNA5 (n = 1), and NKX2.5 (n = 1). In genetic association analyses, unstratified and stratified according to age of onset of AF and unaffected age {$>$}50 years, there was a highly statistically significant association between the presence of both common (rs2200733 and rs10033464) and rare variants and AF (unstratified p = 1 Ã— 10-8, stratified [age of onset {$<$}50 years and unaffected age {$>$}50 years] p = 7.6 Ã— 10-5) (unstratified p {$<$} 0.0001, stratified [age of onset {$<$}50 years and unaffected age {$>$}50 years] p {$<$} 0.0001). Genetic association analyses showed that the presence of common 4q25 risk alleles predicted whether carriers of rare mutations developed AF (p = 2.2 Ã— 10-4). Conclusions: Common AF-associated 4q25 polymorphisms modify the clinical expression of latent cardiac ion channel and signaling molecule gene mutations associated with familial AF. These findings support the idea that the genetic architecture of AF is complex and includes both rare and common genetic variants. Â© 2012 American College of Cardiology Foundation.},
  keywords = {ðŸ”´,atrial fibrillation,genetics,mutations,polymorphisms},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Ritchie et al_2012_Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations.pdf}
}

@article{Roberts2014a,
  title = {Impact of a 4q25 Genetic Variant in Atrial Flutter and on the Risk of Atrial Fibrillation after Cavotricuspid Isthmus Ablation},
  author = {Roberts, Jason D. and Hsu, Jonathan C. and Aouizerat, Bradley E. and Pullinger, Clive R. and Malloy, Mary J. and Kane, John P. and Olgin, Jeffrey E. and Marcus, Gregory M.},
  date = {2014-03-01},
  journaltitle = {Journal of Cardiovascular Electrophysiology},
  volume = {25},
  number = {3},
  eprint = {24237655},
  eprinttype = {pmid},
  pages = {271--277},
  publisher = {{John Wiley \& Sons, Ltd}},
  issn = {15408167},
  doi = {10.1111/jce.12317},
  url = {https://onlinelibrary.wiley.com/doi/full/10.1111/jce.12317},
  urldate = {2022-11-22},
  abstract = {Role of a 4q25 Genetic Variant in Atrial Flutter Background The prediction of atrial fibrillation (AF) following catheter ablation of atrial flutter (Afl) would be helpful to facilitate targeted arrhythmia monitoring and anti-coagulation strategies. A single nucleotide polymorphism, rs2200733, is strongly associated with AF. We sought to characterize the association between rs2200733 and prevalent Afl and to determine if the variant could predict AF after cavotricuspid isthmus ablation. Methods and Results We performed a genetic association study of 295 patients with Afl and/or AF and 469 controls using multivariable logistic regression. The variant was then assessed as a predictor of incident AF after cavotricuspid isthmus ablation in 87 consecutive typical Afl patients with Cox proportional hazards models. The rs2200733 rare allele was associated with an adjusted 2.06-fold increased odds of isolated Afl (95\% CI: 1.13-3.76, P = 0.019) and an adjusted 2.79-fold increased odds of a combined phenotype of AF and Afl (95\% CI: 1.81-4.28, P {$<$} 0.001). Following catheter ablation for Afl, carrier status of rs2200733 failed to predict an increased risk of AF either among all subjects (adjusted HR: 0.94; 95\% CI: 0.58-1.53, P = 0.806) or among those with isolated Afl (adjusted HR: 1.29; 95\% CI: 0.51-3.26, P = 0.585). Conclusions Our study demonstrates that Afl, whether occurring in isolation or along with AF, is associated with the rs2200733 AF risk allele. Genetic carrier status of rs2200733 failed to predict an increased risk of incident or recurrent AF following catheter ablation for Afl. These findings suggest that the causal mechanism associated with rs2200733 is germane to both AF and Afl. Â© 2013 Wiley Periodicals, Inc.},
  keywords = {ðŸ”´,atrial fibrillation,atrial flutter,catheter ablation,genetics,molecular biology},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Roberts et al_2014_Impact of a 4q25 genetic variant in atrial flutter and on the risk of atrial.pdf}
}

@article{Roberts2016,
  title = {Genetic {{Investigation Into}} the {{Differential Risk}} of {{Atrial Fibrillation Among Black}} and {{White Individuals}}},
  author = {Roberts, Jason D. and Hu, Donglei and Heckbert, Susan R. and Alonso, Alvaro and Dewland, Thomas A. and Vittinghoff, Eric and Liu, Yongmei and Psaty, Bruce M. and Olgin, Jeffrey E. and Magnani, Jared W. and Huntsman, Scott and Burchard, Esteban G. and Arking, Dan E. and Bibbins-Domingo, Kirsten and Harris, Tamara B. and Perez, Marco V. and Ziv, Elad and Marcus, Gregory M.},
  date = {2016-07-01},
  journaltitle = {JAMA cardiology},
  shortjournal = {JAMA Cardiol},
  volume = {1},
  number = {4},
  eprint = {27438321},
  eprinttype = {pmid},
  pages = {442--450},
  issn = {2380-6591},
  doi = {10.1001/jamacardio.2016.1185},
  abstract = {IMPORTANCE: White persons have a higher risk of atrial fibrillation (AF) compared with black individuals despite a lower prevalence of risk factors. This difference may be due, at least in part, to genetic factors. OBJECTIVES: To determine whether 9 single-nucleotide polymorphisms (SNPs) associated with AF account for this paradoxical differential racial risk for AF and to use admixture mapping to search genome-wide for loci that may account for this phenomenon. DESIGN, SETTING, AND PARTICIPANTS: Genome-wide admixture analysis and candidate SNP study involving 3 population-based cohort studies that were initiated between 1987 and 1997, including the Cardiovascular Health Study (CHS) (n\,=\,4173), the Atherosclerosis Risk in Communities (ARIC) (n\,=\,12\,341) study, and the Health, Aging, and Body Composition (Health ABC) (n\,=\,1015) study. In all 3 studies, race was self-identified. Cox proportional hazards regression models and the proportion of treatment effect method were used to determine the impact of 9 AF-risk SNPs among participants from CHS and the ARIC study. The present study began July 1, 2012, and was completed in 2015. MAIN OUTCOMES AND MEASURES: Incident AF systematically ascertained using clinic visit electrocardiograms, hospital discharge diagnosis codes, death certificates, and Medicare claims data. RESULTS: A single SNP, rs10824026 (chromosome 10: position 73661450), was found to significantly mediate the higher risk for AF in white participants compared with black participants in CHS (11.4\%; 95\% CI, 2.9\%-29.9\%) and ARIC (31.7\%; 95\% CI, 16.0\%-53.0\%). Admixture mapping was performed in a meta-analysis of black participants within CHS (n\,=\,811), ARIC (n\,=\,3112), and Health ABC (n\,=\,1015). No loci that reached the prespecified statistical threshold for genome-wide significance were identified. CONCLUSIONS AND RELEVANCE: The rs10824026 SNP on chromosome 10q22 mediates a modest proportion of the increased risk of AF among white individuals compared with black individuals, potentially through an effect on gene expression levels of MYOZ1. No additional genetic variants accounting for a significant portion of the differential racial risk of AF were identified with genome-wide admixture mapping, suggesting that additional genetic or environmental influences beyond single SNPs in isolation may account for the paradoxical racial risk of AF among white individuals and black individuals.},
  langid = {english},
  pmcid = {PMC5395094},
  keywords = {âœ”ï¸,Atherosclerosis,Atrial Fibrillation,Black People,Carrier Proteins,{Chromosomes, Human, Pair 10},Genetic Predisposition to Disease,Humans,Incidence,Muscle Proteins,{Polymorphism, Single Nucleotide},Risk Factors,White People},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Roberts et al_2016_Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among.pdf}
}

@article{Rodriguez2015,
  title = {Atrial Fibrillation Incidence and Risk Factors in Relation to Race-Ethnicity and the Population Attributable Fraction of Atrial Fibrillation Risk Factors: The {{Multi-Ethnic Study}} of {{Atherosclerosis}}.},
  author = {Rodriguez, Carlos J and Soliman, Elsayed Z and Alonso, Alvaro and Swett, Katrina and Okin, Peter M and Goff, David C and Heckbert, Susan R},
  date = {2015-02},
  journaltitle = {Annals of epidemiology},
  volume = {25},
  number = {2},
  eprint = {25523897},
  eprinttype = {pmid},
  pages = {71--6, 76.e1},
  issn = {1873-2585},
  doi = {10.1016/j.annepidem.2014.11.024},
  abstract = {PURPOSE We studied incident atrial fibrillation (AF) in the prospective community-based Multi-Ethnic Study of Atherosclerosis (MESA). Reportedly, non-Hispanic blacks (NHBs) have a lower AF burden compared with their non-Hispanic white (NHW) counterparts. Information on the epidemiology of AF in Hispanic and Asian populations is much more limited. METHODS We excluded participants with a history of AF at enrollment. A total of 6721 MESA participants were monitored for the first AF event ascertained according to hospital discharge International Classification of Diseases, Ninth Revision, codes. Age- and sex-adjusted incidence rates (IRs) of AF were calculated per 1000 person-years of observation. IR ratios were calculated using NHWs as the reference group. Age- and sex-adjusted population attributable fractions (PAFs) of established modifiable AF risk factors were ascertained. RESULTS In the MESA cohort, 47.2\% was male; at baseline, 25.7\% had hypertension; 12.5\% had diabetes. Three hundred five incident hospitalized AF events occurred over a mean follow-up of 7.3~years. Age- and sex-adjusted IRs and IR ratios showed that overall AF incidence was significantly lower among Hispanics, NHBs and Chinese compared with NHWs (all P~{$<~$}.001). Among participants 65~years of age or greater, Hispanics, Chinese, and blacks had significantly lower AF incidence than NHWs (all P~â‰¤~.01), but IRs were similar among participants under age 65 years. The PAF for smoking was 27\% among NHBs but lower among other race-ethnic groups. Among NHWs, the PAF for hypertension was 22.2\%, but this was higher among NHBs (33.1\%), Chinese (46.3\%), and Hispanics (43.9\%). CONCLUSIONS Overall, the incidence of hospitalized AF was significantly lower in Hispanics, NHBs, and Chinese than in NHWs. A larger proportion of AF events appear to be attributable to hypertension among nonwhite populations compared with NHWs.},
  keywords = {ðŸ”´}
}

@article{Rush2005b,
  title = {Vagus Nerve Stimulation for Treatment-Resistant Depression: {{A}} Randomized, Controlled Acute Phase Trial},
  author = {Rush, A. John and Marangell, Lauren B. and Sackeim, Harold A. and George, Mark S. and Brannan, Stephen K. and Davis, Sonia M. and Howland, Robert and Kling, Mitchel A. and Rittberg, Barry R. and Burke, William J. and Rapaport, Mark H. and Zajecka, John and Nierenberg, Andrew A. and Husain, Mustafa M. and Ginsberg, David and Cooke, Robert G.},
  date = {2005-09-01},
  journaltitle = {Biological Psychiatry},
  volume = {58},
  number = {5},
  pages = {347--354},
  issn = {00063223},
  doi = {10.1016/j.biopsych.2005.05.025},
  abstract = {Background: Vagus nerve stimulation (VNS) alters both concentrations of neurotransmitters or their metabolites and functional activity of central nervous system regions dysregulated in mood disorders. An open trial has suggested efficacy. Methods: This 10-week, acute, randomized, controlled, masked trial compared adjunctive VNS with sham treatment in 235 outpatients with nonpsychotic major depressive disorder (n = 210) or nonpsychotic, depressed phase, bipolar disorder (n = 25). In the current episode, participants had not responded adequately to between two and six research-qualified medication trials. A two-week, single-blind recovery period (no stimulation) and then 10 weeks of masked active or sham VNS followed implantation. Medications were kept stable. Primary efficacy outcome among 222 evaluable participants was based on response rates ({$<$}50\% reduction from baseline on the 24-item Hamilton Rating Scale for Depression [HRSD 24]). Results: At 10-weeks, HRSD 24 response rates were 15.2\% for the active (n = 112) and 10.0\% for the sham (n = 110) groups (p = .251, last observation carried forward [LOCF]). Response rates with a secondary outcome, the Inventory of Depressive Symptomatology - Self-Report (IDS-SR 30), were 17.0\% (active) and 7.3\% (sham) (p = .032, LOCF). VNS was well tolerated; 1\% (3/235) left the study because of adverse events. Conclusions: This study did not yield definitive evidence of short-term efficacy for adjunctive VNS in treatment-resistant depression. Â© 2005 Society of Biological Psychiatry.},
  keywords = {ðŸ”´,Bipolar disorder,Clinical trial,Efficacy,Major depressive disorder,Side effects,Treatment-resistant depression (TRD),Vagus nerve stimulation (VNS)}
}

@article{Russo2016,
  title = {Diabetes-Associated Cardiac Fibrosis: {{Cellular}} Effectors, Molecular Mechanisms and Therapeutic Opportunities},
  author = {Russo, Ilaria and Frangogiannis, Nikolaos G},
  date = {2016},
  journaltitle = {Journal of Molecular and Cellular Cardiology},
  volume = {90},
  pages = {84--93},
  issn = {10958584},
  doi = {10.1016/j.yjmcc.2015.12.011},
  abstract = {Both type 1 and type 2 diabetes are associated with cardiac fibrosis that may reduce myocardial compliance, contribute to the pathogenesis of heart failure, and trigger arrhythmic events. Diabetes-associated fibrosis is mediated by activated cardiac fibroblasts, but may also involve fibrogenic actions of macrophages, cardiomyocytes and vascular cells. The molecular basis responsible for cardiac fibrosis in diabetes remains poorly understood. Hyperglycemia directly activates a fibrogenic program, leading to accumulation of advanced glycation end-products (AGEs) that crosslink extracellular matrix proteins, and transduce fibrogenic signals through reactive oxygen species generation, or through activation of Receptor for AGEs (RAGE)-mediated pathways. Pro-inflammatory cytokines and chemokines may recruit fibrogenic leukocyte subsets in the cardiac interstitium. Activation of transforming growth factor-Î²/Smad signaling may activate fibroblasts inducing deposition of structural extracellular matrix proteins and matricellular macromolecules. Adipokines, endothelin-1 and the renin-angiotensin-aldosterone system have also been implicated in the diabetic myocardium. This manuscript reviews our current understanding of the cellular effectors and molecular pathways that mediate fibrosis in diabetes. Based on the pathophysiologic mechanism, we propose therapeutic interventions that may attenuate the diabetes-associated fibrotic response and discuss the challenges that may hamper clinical translation.},
  keywords = {ðŸ”´,Diabetes,Fibroblast,Fibrosis,Heart failure,Obesity},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Russo_Frangogiannis_2016_Diabetes-associated cardiac fibrosis.pdf}
}

@article{Sandhu2021,
  title = {Temporal {{Trends}} in {{Population Rates}} of {{Incident Atrial Fibrillation}} and {{Atrial Flutter Hospitalizations}}, {{Stroke Risk}}, and {{Mortality Show Decline}} in {{Hospitalizations}}},
  author = {Sandhu, Roopinder K and Wilton, Stephen B and Islam, Sunjiduatul and Atzema, Clare L and Deyell, Mark and Wyse, D. George and Cox, Jafna L and Skanes, Allan and Kaul, Padma},
  date = {2021},
  journaltitle = {Canadian Journal of Cardiology},
  volume = {37},
  number = {2},
  eprint = {32360794},
  eprinttype = {pmid},
  pages = {310--318},
  issn = {0828282X},
  doi = {10.1016/j.cjca.2020.04.026},
  url = {https://doi.org/10.1016/j.cjca.2020.04.026},
  urldate = {2022-11-22},
  abstract = {Background: Hospitalization for nonvalvular atrial fibrillation (NVAF) is common and results in substantial cost burden. Current national data trends for the incidence, stroke risk profiles, and mortality of hospitalization for NVAF and atrial flutter (AFL) are sparse. Methods: The Canadian Institute of Health Information Discharge Abstract Database was used to identify patients â‰¥ 20 years with incident NVAF/AFL (NVAF, ICD-9 code 427.3 or ICD-10 I48) in any diagnosis field from 2006 to 2015 in Canada, except QuÃ©bec. National and provincial trends in rate over time (rate ratio, 95\% confidence interval [CI]) were calculated for age-sex standardized hospitalizations. Trends in stroke risk profiles and in-hospital mortality rates adjusted for stroke risk factors were also calculated. Results: A total of 578,947 patients were hospitalized with incident NVAF/AFL. The median age was 77 years (interquartile range: 68-84), 82\% were â‰¥ 65 years, 54\% were men, 54\% had a CHADS2 â‰¥ 2, and 69\% had a CHA2DS2-Vasc â‰¥ 3. The overall age- and sex-standardized rate of NVAF/AFL hospitalization was 315 per 100,000 population and declined by 2\% per year (P {$<$} 0.001). There was an annual rate decline in NVAF/AFL hospitalizations in every province. The majority of hospitalized patients are at high risk of stroke, and this risk remained unchanged. The average adjusted in-hospital mortality was 8.80 per 100 patients 95\% CI, 8.80-8.81 with a 2\% annual decline in rate (P {$<$} 0.001). Conclusion: Between 2006 and 2015, we found national and provincial hospitalization rates for incident NVAF/AFL are declining. The majority of patients are at high risk for stroke. In-hospital mortality has declined but remains substantial.},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Sandhu et al_2021_Temporal Trends in Population Rates of Incident Atrial Fibrillation and Atrial.pdf}
}

@article{Sarason1987,
  title = {A Brief Measure of Social Support: {{Practical}} and Theoretical Implications},
  author = {Sarason, Irwin G. and Sarason, Barbara R. and Shearin, Edward N. and Pierce, Gregory R.},
  date = {1987-11-30},
  journaltitle = {Journal of Social and Personal Relationships},
  volume = {4},
  number = {4},
  pages = {497--510},
  issn = {14603608},
  doi = {10.1177/0265407587044007},
  abstract = {Two studies leading to the development of a short form of the Social Support Questionnaire (SSQ) are reported. In Study 1 three items selected for high correlations with the total score (SSQ3) were administered to 182 university students together with several personality measures. SSQ3 had acceptable test-retest reliability and correlations with personality variables similar to those of the SSQ. Internal reliability was marginal although acceptable for an instrument with so few items. Study 2 employed three sets of data in developing a six-item instrument (SSQ6). The SSQ6 had high internal reliability and correlated highly with the SSQ and similarly to it with personality variables. The research findings accompanying the development of the short form social support measure suggest that perceived social support in adults may be a reflection of early attachment experience. Â© 1987, Sage Publications. All rights reserved.},
  keywords = {ðŸ”´}
}

@article{Sarraju2020,
  title = {Under-{{Reporting}} and {{Under-Representation}} of {{Racial}}/{{Ethnic Minorities}} in {{Major Atrial Fibrillation Clinical Trials}}},
  author = {Sarraju, Ashish and Maron, David J. and Rodriguez, Fatima},
  date = {2020-06},
  journaltitle = {JACC: Clinical Electrophysiology},
  volume = {6},
  number = {6},
  pages = {739--741},
  issn = {2405500X},
  doi = {10.1016/j.jacep.2020.03.001},
  keywords = {ðŸ”´}
}

@article{Sgoifo2015,
  title = {Autonomic Dysfunction and Heart Rate Variability in Depression},
  author = {Sgoifo, Andrea and Carnevali, Luca and Pico Alfonso, Maria de los Angeles and Amore, Mario},
  date = {2015-05-04},
  journaltitle = {Stress},
  volume = {18},
  number = {3},
  eprint = {26004818},
  eprinttype = {pmid},
  pages = {343--352},
  issn = {16078888},
  doi = {10.3109/10253890.2015.1045868},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/26004818},
  urldate = {2018-10-29},
  abstract = {Depression occurs in people of all ages across all world regions; it is the second leading cause of disability and its global burden increased by 37.5\% between 1990 and 2010. Autonomic changes are often found in altered mood states and appear to be a central biological substrate linking depression to a number of physical dysfunctions. Alterations of autonomic nervous system functioning that promotes vagal withdrawal are reflected in reductions of heart rate variability (HRV) indexes. Reduced HRV characterizes emotional dysregulation, decreased psychological flexibility and defective social engagement, which in turn are linked to prefrontal cortex hypoactivity. Altogether, these pieces of evidence support the idea that HRV might represent a useful endophenotype for psychological/physical comorbidities, and its routine application should be advised to assess the efficacy of prevention/intervention therapies in a number of psychosomatic and psychiatric dysfunctions. Further research, also making use of appropriate animal models, could provide a significant support to this point of view and possibly help to identify appropriate antidepressant therapies that do not interefere with physical health.},
  isbn = {1607-8888 (Electronic)\textbackslash r1025-3890 (Linking)},
  keywords = {ðŸ”´,Animal models,autonomic function,cardiovascular disease,depression,emotion,heart rate variability}
}

@article{Shah2013,
  title = {Posttraumatic Stress Disorder and Impaired Autonomic Modulation in Male Twins},
  author = {Shah, Amit J. and Lampert, Rachel and Goldberg, Jack and Veledar, Emir and Bremner, J. Douglas and Vaccarino, Viola},
  date = {2013},
  journaltitle = {Biological Psychiatry},
  volume = {73},
  number = {11},
  eprint = {23434412},
  eprinttype = {pmid},
  pages = {1103--1110},
  publisher = {{Elsevier}},
  issn = {00063223},
  doi = {10.1016/j.biopsych.2013.01.019},
  url = {http://dx.doi.org/10.1016/j.biopsych.2013.01.019},
  abstract = {Background: Posttraumatic stress disorder (PTSD) has been linked to increased morbidity. An inflexibility of the autonomic nervous system might be the underlying mechanism. We aimed to assess whether PTSD and combat trauma exposure are associated with lower heart rate variability (HRV), a measure of autonomic function and a predictor of death. Methods: We measured HRV by power spectral analysis on 24-hour ambulatory electrocardiogram in 459 middle-aged veteran male twins. Combat trauma was assessed with the combat exposure scale, and current and remitted PTSD was assessed with the Structured Clinical Interview for Psychiatry Disorders. Mixed-effects regression models were used to test associations of PTSD and HRV between and within twin pairs. Results: Of all twins, 211 had combat exposure, 31 had current PTSD, and 43 had remitted PTSD. Current PTSD was inversely associated with very-low-frequency and low-frequency HRV both in individual twins and within 20 pairs discordant for current PTSD. Twins with current PTSD had a 49\% lower low-frequency HRV than their brothers without PTSD (p{$<$}.001). Remitted PTSD was not associated with HRV. Results were robust to adjustment for depression and other risk factors. Combat exposure was inversely associated with most HRV frequencies, but this association mostly diminished after adjustment for current PTSD. Conclusion: In middle-aged veteran men, combat exposure and current PTSD are associated with measures of autonomic inflexibility previously shown to have prognostic significance. The negative health impact of combat exposure on autonomic function is mediated largely through PTSD and might reverse with remission of PTSD. Â© 2013 Society of Biological Psychiatry.},
  isbn = {1873-2402 (Electronic) 0006-3223 (Linking)},
  keywords = {ðŸ”´,Autonomic nervous system,circadian,heart disease,heart rate variability,mental stress,military combat trauma,posttraumatic stress disorder},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Shah et al_2013_Posttraumatic stress disorder and impaired autonomic modulation in male twins.pdf}
}

@article{Shah2014,
  title = {Sex and Age Differences in the Association of Depression with Obstructive Coronary Artery Disease and Adverse Cardiovascular Events},
  author = {Shah, Amit J. and Ghasemzadeh, Nima and Zaragoza-Macias, Elisa and Patel, Riyaz and Eapen, Danny J. and Neeland, Ian J. and Pimple, Pratik M. and Zafari, A. Maziar and Quyyumi, Arshed A. and Vaccarino, Viola},
  date = {2014-06-18},
  journaltitle = {Journal of the American Heart Association},
  volume = {3},
  number = {3},
  eprint = {24943475},
  eprinttype = {pmid},
  pages = {e000741},
  publisher = {{American Heart Association, Inc.}},
  issn = {20479980},
  doi = {10.1161/JAHA.113.000741},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/24943475},
  urldate = {2018-03-17},
  abstract = {BACKGROUND: Young women with coronary heart disease have high rates of depression and a higher risk of adverse events than men of similar age. Whether depression has a higher prognostic value in this group than in men and older women is not known. Our objective was to assess whether depression in young women is associated with higher risk of coronary artery disease (CAD) and adverse outcomes compared with similarly aged men and older women. METHODS AND RESULTS: We examined 3237 patients undergoing coronary angiography for evaluation of CAD and followed them for 2.9 years (median). Depressive symptoms were assessed with the Patient Health Questionnaire (PHQ)-9, and CAD burden was dichotomized based on its presence or absence. After multivariable adjustment for CAD risk factors, depressive symptoms predicted CAD presence in women aged â‰¤ 55 years (odds ratio=1.07 95\% confidence interval [CI] 1.02 to 1.13 per 1 point increase in PHQ-9 score), but not in men aged â‰¤ 55 years or women aged {$>$}55 years. Depressive symptoms also predicted increased risk of death in women aged â‰¤ 55 years (adjusted hazard ratio=1.07, 95\% CI 1.02 to 1.14, per 1 point increase in PHQ-9 score), but not in men aged â‰¤ 55 years and women aged {$>$}55 years, with P=0.02 for the depression-sex interaction and P=0.02 for depression-sex-age interaction. CONCLUSIONS: Among patients with suspected or established CAD, depressive symptoms are associated with increased risk of death, particularly in young women. This group may be especially vulnerable to the adverse cardiovascular effects of depression.},
  isbn = {2047-9980},
  keywords = {ðŸ”´,cad,Coronary artery disease,depression,Depression,hrv,Sex differences},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Shah et al_2014_Sex and age differences in the association of depression with obstructive.pdf}
}

@article{shah2015,
  title = {Heart Rate Variability in the Prediction of Risk for Posttraumatic Stress Disorder},
  author = {Shah, Amit and Vaccarino, Viola},
  date = {2015},
  journaltitle = {JAMA psychiatry},
  volume = {72},
  number = {10},
  pages = {964--965},
  url = {http://jamanetwork.com/journals/jamapsychiatry/fullarticle/2436273},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Shah_Vaccarino_2015_Heart rate variability in the prediction of risk for posttraumatic stress.pdf;/Users/asshah4/projects/zotero/storage/KE6SXJQR/2436273.html}
}

@article{Shah2020,
  title = {Alterations in Heart Rate Variability Are Associated with Abnormal Myocardial Perfusion},
  author = {Shah, Anish S and Shah, Amit J and Lampert, Rachel and Goldberg, Jack and Bremner, J. Douglas and Li, Lian and Thames, Marc D. and Vaccarino, Viola and Shah, Anish S. Amit J.},
  date = {2020-04-15},
  journaltitle = {International Journal of Cardiology},
  volume = {305},
  eprint = {32024598},
  eprinttype = {pmid},
  pages = {99--105},
  publisher = {{Elsevier Ireland Ltd}},
  issn = {1874-1754},
  doi = {10.1016/j.ijcard.2020.01.069},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S0167527319355214},
  abstract = {BACKGROUND Abnormalities in the autonomic nervous system may occur in ischemic heart disease, but the mechanisms by which they are linked are not fully defined. The risk of cardiac events is increased during morning hours. Studying the contributions of autonomic mechanisms may yield insights into risk stratification and treatment. We hypothesize that autonomic dysfunction, measured by decreased heart rate variability (HRV), associates with abnormal stress myocardial perfusion imaging (MPI). METHODS We performed a cross-sectional study of the association between abnormal myocardial stress perfusion with HRV using 276 middle-aged veteran twins without known ischemic heart disease. The primary independent variable was cardiac autonomic regulation measured with 24-hour electrocardiogram (ECG) monitoring, using linear and non-linear (multipole density, or Dyx) HRV metrics. The primary outcome was abnormal perfusion ({$>$}5\% affected myocardium) during adenosine stress on [13N]-ammonia myocardial perfusion imaging with positron emission tomography. RESULTS The mean (SD) age was 53 (3) years and 55 (20\%) had abnormal perfusion. HRV (by Dyx) was reduced during morning hours in subjects with abnormal perfusion. At 7 AM, each standard deviation (SD) decrease in Dyx was associated a 4.8 (95\% CI, 1.5 - 15.8) odds ratio (OR) for abnormal MPI. With Dyx {$<$} 2.0, the 7 AM OR for abnormal MPI was 11.8 (95\% CI, 1.2 - 111.4). CONCLUSIONS Autonomic dysfunction, measured by non-linear HRV in the morning hours, was associated with an increased OR of abnormal MPI. These results suggest a potentially important role of ECG-based biomarkers in risk stratification for individuals with suspected ischemic heart disease.},
  keywords = {â˜…,â­ï¸â­ï¸â­ï¸,ðŸ”´,Autonomic nervous system,Coronary artery disease,Heart rate variability,Myocardial perfusion,Positron emission tomography},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Shah et al_2020_Alterations in heart rate variability are associated with abnormal myocardial.pdf}
}

@article{Shep,
  title = {Depression, Anxiety, and the Cardiovascular System: {{The}} Cardiologist's Perspective},
  author = {Sheps, David S. and Sheffield, David},
  date = {2001},
  journaltitle = {The Journal of clinical psychiatry},
  volume = {62 Suppl 8},
  eprint = {12108816},
  eprinttype = {pmid},
  pages = {12-6; discussion 17-8},
  issn = {0160-6689},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/12108816},
  abstract = {Notes that depression in patients with cardiovascular disease is a significant risk factor for developing symptomatic and fatal ischemic heart disease. Moreover, depressed patients have a higher than expected rate of sudden cardiovascular death. Therefore, appropriate treatment of patients with depression and cardiovascular disease cannot be restricted to considerations of either depression or cardiovascular disease in isolation. The tricyclic antidepressants have various effects on the cardiovascular system, including Type IA antiarrhythmic activity that has been associated with an increased risk of mortality in post-myocardial infarction patients. The selective serotonin reuptake inhibitors (SSRIs) are not associated with adverse cardiac effects. On the basis of this favorable cardiovascular profile, the SSRIs should therefore be the preferred choice for the treatment of most patients with comorbid depression and cardiovascular disease. Investigation of putative pathophysiologic mechanisms linking depression and cardiovascular mortality, such as the role of platelet activation, will form the basis for further investigation of antidepressant treatments in order to establish if the antidepressants have a beneficial effect on the prognosis of cardiovascular diseases. (PsycINFO Database Record (c) 2000 APA, all rights reserved)},
  isbn = {0160-6689},
  issue = {SUPPL. 8},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Sheps_Sheffield_2001_Depression, anxiety, and the cardiovascular system.pdf}
}

@article{Shiyovich2010,
  title = {Accuracy of {{Diagnosing Atrial Flutter}} and {{Atrial Fibrillation From}} a {{Surface Electrocardiogram}} by {{Hospital Physicians}}: {{Analysis}} of {{Data From Internal Medicine Departments}}},
  author = {Shiyovich, Arthur and Wolak, Arik and Yacobovich, Lital and Grosbard, Aviva and Katz, Amos},
  date = {2010-10},
  journaltitle = {The American Journal of the Medical Sciences},
  volume = {340},
  number = {4},
  pages = {271--275},
  issn = {00029629},
  doi = {10.1097/MAJ.0b013e3181e73fcf},
  keywords = {ðŸ”´}
}

@article{Siontis2020,
  title = {How {{Will Machine Learning Inform}} the {{Clinical Care}} of {{Atrial Fibrillation}}?},
  author = {Siontis, Konstantinos C. and Yao, Xiaoxi and Pirruccello, James P. and Philippakis, Anthony A. and Noseworthy, Peter A.},
  date = {2020-06-19},
  journaltitle = {Circulation Research},
  volume = {127},
  number = {1},
  pages = {155--169},
  publisher = {{American Heart Association}},
  doi = {10.1161/CIRCRESAHA.120.316401},
  url = {https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.120.316401},
  urldate = {2023-07-26},
  abstract = {Machine learning applications in cardiology have rapidly evolved in the past decade. With the availability of machine learning tools coupled with vast data sources, the management of atrial fibrillation (AF), a common chronic disease with significant associated morbidity and socioeconomic impact, is undergoing a knowledge and practice transformation in the increasingly complex healthcare environment. Among other advances, deep-learning machine learning methods, including convolutional neural networks, have enabled the development of AF screening pathways using the ubiquitous 12-lead ECG to detect asymptomatic paroxysmal AF in at-risk populations (such as those with cryptogenic stroke), the refinement of AF and stroke prediction schemes through comprehensive digital phenotyping using structured and unstructured data abstraction from the electronic health record or wearable monitoring technologies, and the optimization of treatment strategies, ranging from stroke prophylaxis to monitoring of antiarrhythmic drug (AAD) therapy. Although the clinical and population-wide impact of these tools continues to be elucidated, such transformative progress does not come without challenges, such as the concerns about adopting black box technologies, assessing input data quality for training such models, and the risk of perpetuating rather than alleviating health disparities. This review critically appraises the advances of machine learning related to the care of AF thus far, their potential future directions, and its potential limitations and challenges.},
  keywords = {ðŸ”´,artificial intelligence,atrial fibrillation,ECG,electronic health record,machine learning,natural language processing},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Siontis et al_2020_How Will Machine Learning Inform the Clinical Care of Atrial Fibrillation.pdf}
}

@article{Smolderen2009,
  title = {The Association of Cognitive and Somatic Depressive Symptoms with Depression Recognition and Outcomes after Myocardial Infarction},
  author = {Smolderen, Kim G and Spertus, John A and Reid, Kimberly J and Buchanan, Donna M and Krumholz, Harlan M and Denollet, Johan and Vaccarino, Viola and Chan, Paul S},
  date = {2009-07},
  journaltitle = {Circulation: Cardiovascular Quality and Outcomes},
  volume = {2},
  number = {4},
  eprint = {20031858},
  eprinttype = {pmid},
  pages = {328--337},
  publisher = {{NIH Public Access}},
  issn = {19417713},
  doi = {10.1161/CIRCOUTCOMES.109.868588},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/20031858},
  urldate = {2019-09-13},
  abstract = {Background-Among patients with acute myocardial infarction (AMI), depression is both common and underrecognized. The association of different manifestations of depression, somatic and cognitive, with depression recognition and long-term prognosis is poorly understood. Methods and Results-Depression was confirmed in 481 AMI patients enrolled from 21 sites during their index hospitalization with a Patient Health Questionnaire (PHQ-9) score â‰¥10. Within the PHQ-9, separate somatic and cognitive symptom scores were derived, and the independent association between these domains and the clinical recognition of depression, as documented in the medical records, was evaluated. In a separate multisite AMI registry of 2347 patients, the association between somatic and cognitive depressive symptoms and 4-year all-cause mortality and 1-year all-cause rehospitalization was evaluated. Depression was clinically recognized in 29\% (n=140) of patients. Cognitive depressive symptoms (relative risk per SD increase, 1.14; 95\% CI, 1.03 to 1.26; Pâ‰¥0.01) were independently associated with depression recognition, whereas the association for somatic symptoms and recognition (relative risk, 1.04; 95\% CI, 0.87 to 1.26; P=0.66) was not significant. However, unadjusted Cox regression analyses found that only somatic depressive symptoms were associated with 4-year mortality (hazard ratio [HR] per SD increase, 1.22; 95\% CI, 1.08 to 1.39) or 1-year rehospitalization (HR, 1.22; 95\% CI, 1.11 to 1.33), whereas cognitive manifestations were not (HR for mortality, 1.01; 95\% CI, 0.89 to 1.14; HR for rehospitalization, 1.01; 95\% CI, 0.93 to 1.11). After multivariable adjustment, the association between somatic symptoms and rehospitalization persisted (HR, 1.16; 95\% CI, 1.06 to 1.27; P=0.01) but was attenuated for mortality (HR, 1.07; 95\% CI, 0.94 to 1.21; P=0.30). Conclusions-Depression after AMI was recognized in fewer than 1 in 3 patients. Although cognitive symptoms were associated with recognition of depression, somatic symptoms were associa ed with long-term outcomes. Comprehensive screening and treatment of both somatic and cognitive symptoms may be necessary to optimize depression recognition and treatment in AMI patients. (Circ Cardiovasc Qual Outcomes. 2009;2:328-337.) Â© 2009 American Heart Association, Inc.},
  keywords = {ðŸ”´,Depression,Mortality,Myocardial infarction,Rehospitalization,Therapy},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Smolderen et al_2009_The association of cognitive and somatic depressive symptoms with depression.pdf}
}

@article{Smolderen2012,
  title = {Association of Somatic and Cognitive Depressive Symptoms and Biomarkers in Acute Myocardial Infarction: {{Insights}} from the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status Registry},
  author = {Smolderen, Kim G and Spertus, John A and Reid, Kimberly J and Buchanan, Donna M and Vaccarino, Viola and Lichtman, Judith H and Bekelman, David B and Chan, Paul S},
  date = {2012-01-01},
  journaltitle = {Biological Psychiatry},
  volume = {71},
  number = {1},
  eprint = {21903199},
  eprinttype = {pmid},
  pages = {22--29},
  publisher = {{NIH Public Access}},
  issn = {00063223},
  doi = {10.1016/j.biopsych.2011.07.029},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/21903199},
  urldate = {2019-09-13},
  abstract = {Background: Somatic depressive symptoms and certain biomarkers are each associated with worse acute myocardial infarction (AMI) prognosis, but the relationship between depressive symptom domains and inflammatory, neurohormonal, and coagulation markers is unknown. Methods: We examined the relationship between depressive symptoms and 1-month biomarker levels (high-sensitivity C-reactive protein [hs-CRP], N-terminal pro-brain natriuretic peptide [NT-proBNP], white blood cell [WBC], platelet counts) in 1265 AMI patients. Depressive symptoms (9-item Patient Health Questionnaire) were assessed during index hospitalization and categorized as somatic or cognitive. Using median regression models, the upper quartile of somatic and cognitive depression scores and each biomarker were compared with the lower three quartiles, adjusting for site, demographics, and clinical characteristics. Results: Although hs-CRP values were higher in patients with somatic symptoms, this association was attenuated after adjustment (B per SD increase =.02, 95\% confidence interval:.00;.05, p =.07). WBC count was independently associated with somatic depressive symptoms (B per SD increase =.28, 95\% confidence interval:.12;.44, p {$<$}.001). Cognitive depressive symptoms were not associated with hs-CRP or WBC count. Neither dimension was associated with NT-proBNP or platelet levels. For each biomarker, the depression dimensions explained {$<$}1\% of their variation. Conclusions: Neither somatic nor cognitive depressive symptoms were meaningfully associated with hs-CRP, NT-proBNP, WBC, or platelet counts 1 month after AMI, suggesting that the association between depression and long-term outcomes may be unrelated to these biomarkers. Future research should explore other biomarkers to better illuminate pathways by which depression adversely impacts AMI prognosis. Â© 2012 Society of Biological Psychiatry.},
  keywords = {ðŸ”´,Coagulation,depressive symptoms,inflammation,mechanisms,myocardial infarction,neurohormones},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Smolderen et al_2012_Association of somatic and cognitive depressive symptoms and biomarkers in.pdf}
}

@article{Smolderen2017,
  title = {Depression {{Treatment}} and 1-{{Year Mortality}} after {{Acute Myocardial Infarction}}: {{Insights}} from the {{TRIUMPH Registry}} ({{Translational Research Investigating Underlying Disparities}} in {{Acute Myocardial Infarction Patients}}' {{Health Status}})},
  author = {Smolderen, Kim G. and Buchanan, Donna M. and Gosch, Kensey and Whooley, Mary and Chan, Paul S. and Vaccarino, Viola and Parashar, Susmita and Shah, Amit J. and Ho, P. Michael and Spertus, John A.},
  date = {2017},
  journaltitle = {Circulation},
  volume = {135},
  number = {18},
  eprint = {28209727},
  eprinttype = {pmid},
  pages = {1681--1689},
  issn = {15244539},
  doi = {10.1161/CIRCULATIONAHA.116.025140},
  abstract = {BACKGROUND Depression among patients with acute myocardial infarction (AMI) is prevalent and associated with an adverse quality of life and prognosis. Despite recommendations from some national organizations to screen for depression, it is unclear whether treatment of depression in patients with AMI is associated with better outcomes. We aimed to determine whether the prognosis of patients with treated versus untreated depression differs. METHODS The TRIUMPH study (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status) is an observational multicenter cohort study that enrolled 4062 patients aged â‰¥18 years with AMI between April 11, 2005, and December 31, 2008, from 24 US hospitals. Research coordinators administered the Patient Health Questionnaire-9 (PHQ-9) during the index AMI admission. Depression was defined by a PHQ-9 score of â‰¥10. Depression was categorized as treated if there was documentation of a discharge diagnosis, medication prescribed for depression, or referral for counseling, and as untreated if none of these 3 criteria was documented in the medical records despite a PHQ score â‰¥10. One-year mortality was compared between patients with AMI having: (1) no depression (PHQ-9{$<$}10; reference); (2) treated depression; and (3) untreated depression adjusting for demographics, AMI severity, and clinical factors. RESULTS Overall, 759 (18.7\%) patients met PHQ-9 criteria for depression and 231 (30.4\%) were treated. In comparison with 3303 patients without depression, the 231 patients with treated depression had 1-year mortality rates that were not different (6.1\% versus 6.7\%; adjusted hazard ratio, 1.12; 95\% confidence interval, 0.63-1.99). In contrast, the 528 patients with untreated depression had higher 1-year mortality in comparison with patients without depression (10.8\% versus 6.1\%; adjusted hazard ratio, 1.91; 95\% confidence interval, 1.39-2.62). CONCLUSIONS Although depression in patients with AMI is associated with increased long-term mortality, this association may be confined to patients with untreated depression.},
  isbn = {8169325846},
  keywords = {ðŸ”´,depression,mortality,myocardial infarction,survival},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Smolderen et al_2017_Depression Treatment and 1-Year Mortality after Acute Myocardial Infarction.pdf}
}

@article{Soliman2014,
  title = {The Paradox of Atrial Fibrillation in {{African Americans}}.},
  author = {Soliman, Elsayed Z and Prineas, Ronald J},
  date = {2014},
  journaltitle = {Journal of electrocardiology},
  volume = {47},
  number = {6},
  eprint = {25112176},
  eprinttype = {pmid},
  pages = {804--8},
  issn = {1532-8430},
  doi = {10.1016/j.jelectrocard.2014.07.010},
  abstract = {The reported lower prevalence and incidence of atrial fibrillation (AF) despite the higher prevalence of AF risk factors in African Americans compared to Caucasian whites has been referred to as the paradox of AF in African Americans. In this report we highlight this paradox and address potential explanations using data from several US populations studies. These possible explanations include limited methodology to detect AF patterns that are harder to detect (e.g. paroxysmal/intermittent AF or atrial flutter) coupled with the possibility of African Americans having more of these patterns, differential access to health care with African Americans having less access and subsequently less detected AF, survival bias with Caucasian whites living longer and subsequently having more AF, and finally differential impact of AF risk factors with Caucasian whites being more affected or African Americans less affected by AF risk factors whether this is genetically determined or via other unknown predispositions.},
  keywords = {ðŸ”´}
}

@incollection{Spielberger2010,
  title = {State-{{Trait Anger Expression Inventory}}},
  booktitle = {The {{Corsini Encyclopedia}} of {{Psychology}}},
  author = {Spielberger, Charles D.},
  date = {2010-01-30},
  pages = {1--1},
  publisher = {{John Wiley \& Sons, Inc.}},
  location = {{Hoboken, NJ, USA}},
  doi = {10.1002/9780470479216.corpsy0942},
  url = {http://doi.wiley.com/10.1002/9780470479216.corpsy0942},
  urldate = {2019-08-11},
  abstract = {Evolving conceptions of the nature of anger as a psychobiological emotional state are considered in historical perspective, and the relation of anger to aggression and hostility is examined advances in the measurement of anger and hostility are then briefly reviewed, and the construction of instruments to assess the experience and expression of anger is described in some detail gender differences in the experience and expression of anger are also noted concludes with a discussion of anger control and the construction of a new scale to assess the reduction of angry feelings State-Trait Anger Expression Inventory (STAXI)},
  keywords = {ðŸ”´,aggression,anger,anger control,anger expression,emotion,hostility,personality,STAXI}
}

@article{Stamos2016,
  title = {The "{{Double}}" {{Paradox}} of {{Atrial Fibrillation}} in {{Black Individuals}}},
  author = {Stamos, Thomas D. and Darbar, Dawood},
  date = {2016-07-01},
  journaltitle = {JAMA cardiology},
  shortjournal = {JAMA Cardiol},
  volume = {1},
  number = {4},
  eprint = {27438310},
  eprinttype = {pmid},
  pages = {377--379},
  issn = {2380-6591},
  doi = {10.1001/jamacardio.2016.1259},
  langid = {english},
  keywords = {âœ”ï¸,Atrial Fibrillation,Humans,Risk Factors},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Stamos_Darbar_2016_The Double Paradox of Atrial Fibrillation in Black Individuals.pdf}
}

@article{Stein2000,
  title = {Severe Depression Is Associated with Markedly Reduced Heart Rate Variability in Patients with Stable Coronary Heart Disease},
  author = {Stein, Phyllis K. and Carney, Robert M. and Freedland, Kenneth E. and Skala, Judith A. and Jaffe, Allan S. and Kleiger, Robert E. and Rottman, Jeffrey N.},
  date = {2000},
  journaltitle = {Journal of Psychosomatic Research},
  volume = {48},
  number = {4-5},
  eprint = {10880671},
  eprinttype = {pmid},
  pages = {493--500},
  issn = {00223999},
  doi = {10.1016/S0022-3999(99)00085-9},
  abstract = {Objective: The purpose of this study was to investigate the relationship between depression and heart rate variability in cardiac patients. Methods: Heart rate variability was measured during 24-hour ambulatory electrocardiographic (ECG) monitoring in 40 medically stable out-patients with documented coronary heart disease meeting current diagnostic criteria for major depression, and 32 nondepressed, but otherwise comparable, patients. Patients discontinued Î²-blockers and antidepressant medications at the time of study. Depressed patients were classified as mildly (n = 21) or moderately-to-severely depressed (n = 19) on the basis of Beck Depression Inventory scores. Results: There were no significant differences among the groups in age, gender, blood pressure, history of myocardial infarction, diabetes, or smoking. Heart rates were higher and nearly all indices of heart rate variability were significantly reduced in the moderately-to-severely versus the nondepressed group. Heart rates were also higher and mean values for heart rate variability lower in the mildly depressed group compared with the nondepressed group, but these differences did not attain statistical significance. Conclusion: The association of moderate to severe depression with reduced heart rate variability in patients with stable coronary heart disease may reflect altered cardiac autonomic modulation and may explain their increased risk for mortality. (C) 2000 Elsevier Science Inc. All rights reserved.},
  isbn = {3143622512},
  keywords = {ðŸ”´,Autonomic nervous system,Coronary heart disease,Depression},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Stein et al_2000_Severe depression is associated with markedly reduced heart rate variability in.pdf}
}

@article{Stein2005,
  title = {Traditional and Nonlinear Heart Rate Variability Are Each Independently Associated with Mortality after Myocardial Infarction},
  author = {Stein, Phyllis K. and Domitrovich, Peter P. and Huikuri, Heikki V. and Kleiger, Robert E.},
  date = {2005-01-01},
  journaltitle = {Journal of Cardiovascular Electrophysiology},
  volume = {16},
  number = {1},
  eprint = {15673380},
  eprinttype = {pmid},
  pages = {13--20},
  publisher = {{Wiley/Blackwell (10.1111)}},
  issn = {10453873},
  doi = {10.1046/j.1540-8167.2005.04358.x},
  url = {http://doi.wiley.com/10.1046/j.1540-8167.2005.04358.x},
  urldate = {2018-04-24},
  abstract = {INTRODUCTION: Decreased heart rate variability (HRV) and abnormal nonlinear HRV shortly after myocardial infarction (MI) are risk factors for mortality. Traditional HRV predicts mortality in patients with a range of times post-MI, but the association of nonlinear HRV and outcome in this population is unknown. METHODS AND RESULTS: HRV was determined from 740 tapes recorded before antiarrhythmic therapy in Cardiac Arrhythmia Suppression Trial patients with ventricular premature contractions (VPCs) suppressed on the first randomized treatment. Patients were 70 +/- 121 days post-MI. Follow up was 362 +/- 241 days (70 deaths). The association between traditional time and frequency-domain HRV and mortality and nonlinear HRV and mortality were compared for the entire population (ALL), those without coronary artery bypass graft post-MI (no CABG), and those without CABG or diabetes (no CABG, no DIAB) using univariate and multivariate Cox regression analysis. Strength of association was compared by P values and Wald Chi-square values. Nonlinear HRV included short-term fractal scaling exponent, power law slope, and SD12 (Poincare dimension). For ALL and for no CABG, increased daytime SD12 had the strongest association with mortality (P=0.002 ALL and P {$<$}0.001 no CABG). For no CABG, no DIAB increased 24-hour SD12 hours had the strongest association (P {$<$}0.001) with mortality. Upon multivariate analysis, increased SD12, decreased ln ULF (ultra low frequency), and history of prior MI and history of congestive heart failure each remained in the model. CONCLUSION: Nonlinear HRV is associated with mortality post-MI. However, as with traditional HRV, this is diluted by CABG surgery post-MI and by diabetes. Results suggest that decreased long-term HRV and increased randomness of heart rate are each independent risk factors for mortality post-MI.},
  isbn = {3142861394},
  keywords = {ðŸ”´,Ambulatory ECG,Heart rate variability,Postmyocardial infarction,Risk factors},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Stein et al_2005_Traditional and nonlinear heart rate variability are each independently.pdf}
}

@article{Steptoe2013a,
  title = {Social Isolation, Loneliness, and All-Cause Mortality in Older Men and Women},
  author = {Steptoe, Andrew and Shankar, Aparna and Demakakos, Panayotes and Wardle, Jane},
  date = {2013-04-09},
  journaltitle = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {110},
  number = {15},
  eprint = {23530191},
  eprinttype = {pmid},
  pages = {5797--5801},
  issn = {00278424},
  doi = {10.1073/pnas.1219686110},
  abstract = {Both social isolation and loneliness are associated with increased mortality, but it is uncertain whether their effects are independent or whether loneliness represents the emotional pathway through which social isolation impairs health. We therefore assessed the extent to which the association between social isolation and mortality is mediated by loneliness. We assessed social isolation in terms of contact with family and friends and participation in civic organizations in 6,500 men and women aged 52 and older who took part in the English Longitudinal Study of Ageing in 2004-2005. A standard questionnaire measure of loneliness was administered also. We monitored all-cause mortality up to March 2012 (mean follow-up 7.25 y) and analyzed results using Cox proportional hazards regression. We found that mortality was higher among more socially isolated and more lonely participants. However, after adjusting statistically for demographic factors and baseline health, social isolation remained significantly associated with mortality (hazard ratio 1.26, 95\% confidence interval, 1.08-1.48 for the top quintile of isolation), but loneliness did not (hazard ratio 0.92, 95\% confidence interval, 0.78-1.09). The association of social isolation with mortality was unchanged when loneliness was included in the model. Both social isolation and loneliness were associated with increased mortality. However, the effect of loneliness was not independent of demographic characteristics or health problems and did not contribute to the risk associated with social isolation. Although both isolation and loneliness impair quality of life and well-being, efforts to reduce isolation are likely to be more relevant to mortality.},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Steptoe et al_2013_Social isolation, loneliness, and all-cause mortality in older men and women.pdf}
}

@article{Taggart2011,
  title = {Anger, Emotion, and Arrhythmias: {{From}} Brain to Heart},
  author = {Taggart, Peter and Boyett, Mark R and Logantha, Sunil Jit R.J. and Lambiase, Pier D},
  date = {2011},
  journaltitle = {Frontiers in Physiology},
  volume = {2 OCT},
  eprint = {22022314},
  eprinttype = {pmid},
  issn = {1664042X},
  doi = {10.3389/fphys.2011.00067},
  url = {www.frontiersin.org},
  urldate = {2018-09-30},
  abstract = {Strong emotion and mental stress are now recognized as playing a significant role in severe and fatal ventricular arrhythmias. The mechanisms, although incompletely understood, include central processing at the cortical and brain stem level, the autonomic nerves and the electrophysiology of the myocardium. Each of these is usually studied separately by investigators from different disciplines. However, many are regulatory processes which incorporate interactive feedforward and feedback mechanisms. In this review we consider the whole as an integrated interactive brain-heart system.},
  isbn = {1664-042X (Electronic)\textbackslash r1664-042X (Linking)},
  keywords = {ðŸ”´,Anger,Brain-heart system,Emotion,Mental stress},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Taggart et al_2011_Anger, emotion, and arrhythmias.pdf}
}

@article{Takahira2021,
  title = {Pathophysiological Background and Prognosis of Common Atrial Flutter in Non-Elderly Patients: {{Comparison}} to {{Atrial Fibrillation}}},
  author = {Takahira, Haruhiro and Kajiyama, Takatsugu and Kondo, Yusuke and Nakano, Masahiro and Nakano, Miyo and Ito, Ryo and Kitagawa, Mari and Sugawara, Masafumi and Chiba, Toshinori and Kobayashi, Yoshio},
  date = {2021},
  journaltitle = {Journal of Cardiology},
  volume = {78},
  number = {5},
  eprint = {34140202},
  eprinttype = {pmid},
  pages = {362--367},
  issn = {18764738},
  doi = {10.1016/j.jjcc.2021.05.008},
  url = {https://doi.org/10.1016/j.jjcc.2021.05.008},
  urldate = {2022-11-22},
  abstract = {Background: It is unclear whether there is any difference in the background and prognosis between non-elderly patients who undergo catheter ablation of atrial fibrillation (AF) and common atrial flutter (CAFL). Purpose: To investigate the difference between the patient background of both CAFL and AF in the non-elderly. Methods: In 526 consecutive patients who underwent catheter ablation of clinical paroxysmal/persistent CAFL or AF in our hospital, we enrolled only patients under 60 years old. Cases harboring both AFL and AF were excluded. We analyzed the patient characteristics, echocardiographic findings, electrocardiographic (ECG) abnormalities during sinus rhythm, and clinical course after ablation. Results: In total, 196 patients (Cohort 1: 142 males, 156 AF cases) were analyzed. AFL patients were younger than AF patients (47.4 Â± 10.6 vs. 50.2 Â± 6.4years, p = 0.031) and organic heart disease (OHD) was significantly more common in AFL patients than AF patients (42.5\% vs. 11.5\%, p{$<$}0.001). In 161 patients excluding OHD (Cohort 2), ECG abnormalities were more frequent in AFL than in AF patients (78.3\% vs. 39.1\%, p = 0.001). There were no significant differences in all-cause death, onset of heart failure, and cerebral strokes. On the other hand, the number of cases that required a pacemaker was significantly higher in the CAFL group than AF group (0.0\% vs. 26.1\%, p-value {$<$}0.001). These results suggested that CAFL may reflect occurrence of any atrial myocardial damage, even if it does not lead to heart failure. Conclusions: Our present study suggested that CAFL may be associated with a broader atrial myocardial disorder in non-elderly patients.},
  keywords = {ðŸ”´,Atrial fibrillation,Common atrial flutter,Non-elderly,Pacemaker,Prognosis},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Takahira et al_2021_Pathophysiological background and prognosis of common atrial flutter in.pdf}
}

@article{Takigawa2014,
  title = {Long-{{Term Follow-Up After Catheter Ablation}} of {{Paroxysmal Atrial Fibrillation}}},
  author = {Takigawa, Masateru and Takahashi, Atsushi and Kuwahara, Taishi and Okubo, Kenji and Takahashi, Yoshihide and Watari, Yuji and Takagi, Katsumasa and Fujino, Tadashi and Kimura, Shigeki and Hikita, Hiroyuki and Tomita, Makoto and Hirao, Kenzo and Isobe, Mitsuaki},
  date = {2014-04},
  journaltitle = {Circulation: Arrhythmia and Electrophysiology},
  volume = {7},
  number = {2},
  pages = {267--273},
  publisher = {{American Heart Association}},
  doi = {10.1161/CIRCEP.113.000471},
  url = {https://www.ahajournals.org/doi/full/10.1161/CIRCEP.113.000471},
  urldate = {2023-06-11},
  abstract = {Backgroundâ€” Although catheter ablation (CA) is a standard treatment for atrial fibrillation (AF), its long-term efficacy remains unclear. This study aimed to elucidate the incidences of AF recurrence and of progression from paroxysmal to persistent AF, after CA, in patients with paroxysmal AF. Methods and Resultsâ€” We examined the incidence of AF recurrence and AF progression in 1220 consecutive patients (mean age, 61 years), with symptomatic paroxysmal AF, undergoing CA, based on extensive pulmonary vein isolation and focal ablation for nonpulmonary vein foci. AF recurrenceâ€“free survival probabilities at 5 years were 59.4\% after the initial CA and 81.1\% after the final CA (average, 1.3 procedures). During a median follow-up period of 47.9 (range, 5.3â€“123.3) months after the initial CA, AF progressed from paroxysmal to persistent in 15 (1.2\%) patients (0.3\%/y). The duration of AF history (hazard ratio [HR], 1.03; P{$<$}0.0001), number of ineffective antiarrhythmics (HR, 1.09; P=0.005), and left atrial diameter indexed by the body surface area (HR, 1.05; P=0.001) were significant predictors of AF recurrence. Patient age (HR, 1.12; P=0.0001) and left atrial diameter indexed by the body surface area (HR, 1.26; P=0.0006) were significantly associated with AF progression. Patients aged â‰¤65 years and with a left atrial diameter indexed by the body surface area of â‰¤24.0 mm/m2 did not develop AF progression for â‰¤10 years after the initial CA. Conclusionsâ€” Although the long-term follow-up revealed the effect of CA on preventing AF recurrence, repeated CA sessions might be required. The rate of progression from paroxysmal to persistent AF was 0.3\%/y.},
  keywords = {ðŸ”´,atrial fibrillation,catheter ablation,recurrence},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Takigawa et al_2014_Long-Term Follow-Up After Catheter Ablation of Paroxysmal Atrial Fibrillation.pdf}
}

@article{Vaccarino2008,
  title = {Depressive Symptoms and Heart Rate Variability: {{Evidence}} for a Shared Genetic Substrate in a Study of Twins},
  author = {Vaccarino, Viola and Lampert, Rachel and Bremner, J. Douglas and Lee, Forrester and Su, Shaoyong and Maisano, Carisa and Murrah, Nancy V and Jones, Linda and Jawed, Farhan and Afzal, Nadeem and Ashraf, Ali and Goldberg, Jack},
  date = {2008-07},
  journaltitle = {Psychosomatic Medicine},
  volume = {70},
  number = {6},
  eprint = {18606724},
  eprinttype = {pmid},
  pages = {628--636},
  publisher = {{NIH Public Access}},
  issn = {00333174},
  doi = {10.1097/PSY.0b013e31817bcc9e},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/18606724},
  urldate = {2018-04-16},
  abstract = {OBJECTIVE: To clarify the relationship between depression and heart rate variability (HRV) in a sample of twins. Reduced HRV, a measure of autonomic dysfunction, has been linked to depression but many studies have inadequately controlled for familial and environmental factors. Furthermore, little is known about whether depression and HRV share common genetic pathways.\textbackslash n\textbackslash nMETHODS: We performed power spectral analysis on 24-hour ambulatory electrocardiograms in 288 middle-aged male twins. Log-normalized ultra low, very low, low, high frequency, and total power were calculated. A lifetime history of major depressive disorder (MDD) was determined, using the Structured Clinical Interview for Psychiatry Disorders, and current depressive symptoms were measured with the Beck Depression Inventory. Mixed-effect regression models were used to account for intrapair variability and estimate within-pair effects at the same time controlling for potential confounders.\textbackslash n\textbackslash nRESULTS: Both current depressive symptoms and a history of MDD were significantly associated with lower HRV. There was a graded effect, and power in each frequency band was 29\% to 36\% lower in the lowest band compared with the highest BDI category. All HRV measures except high frequency remained significantly associated with current depressive symptoms in multivariable analysis, but not with lifetime history of MDD. When analyses were stratified by zygosity, a significant within-pair association between BDI score and HRV was found in the dizygotic but not in the monozygotic twins, suggesting a genetic influence on the association.\textbackslash n\textbackslash nCONCLUSIONS: A shared, genetically influenced biological pathway underlies the association between depression and lower HRV. These two phenotypes may be the expression of a generalized neurobiological perturbation.},
  isbn = {1534-7796 (Electronic)\textbackslash n0033-3174 (Linking)},
  keywords = {ðŸ”´,Autonomic function,Electrophysiology,Genetic factors,Psychosocial factors,Risk factors},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Vaccarino et al_2008_Depressive symptoms and heart rate variability.pdf}
}

@article{Vaccarino2009a,
  title = {Major Depression and Coronary Flow Reserve Detected by Positron Emission Tomography},
  author = {Vaccarino, Viola and Votaw, John and Faber, Tracy and Veledar, Emir and Murrah, Nancy V. and Jones, Linda R. and Zhao, Jinying and Su, Shaoyong and Goldberg, Jack and Raggi, J. Paolo and Quyyumi, Arshed A. and Sheps, David S. and Bremner, J. Douglas},
  date = {2009-10-12},
  journaltitle = {Archives of Internal Medicine},
  volume = {169},
  number = {18},
  pages = {1668--1676},
  publisher = {{American Medical Association}},
  issn = {00039926},
  doi = {10.1001/archinternmed.2009.330},
  url = {http://archinte.jamanetwork.com/article.aspx?doi=10.1001/archinternmed.2009.330},
  urldate = {2019-03-13},
  abstract = {Background Major depressive disorder (MDD) is associated with coronary heart disease (CHD), but the mechanisms are unclear. The presence of MDD may increase CHD risk by affecting microvascular circulation. It is also plausible that genetic factors influencing MDD may overlap with those for CHD. We sought to examine the relationship between MDD and coronary flow reserve (CFR), the ratio of maximum flow during stress to flow at rest measured in milliliters per minute per gram of tissue. Methods We examined 289 male middle-aged twins, including 106 twins (53 twin pairs) discordant for a lifetime history of MDD and 183 control twins (unrelated to any twins in the experimental group) without MDD. To calculate CFR, we used positron emission tomography with nitrogen 13 (13N) ammonia to evaluate myocardial blood flow at rest and after adenosine stress. A standard perfusion defect score was also used to assess myocardial ischemia. Results There was no difference in myocardial ischemia between twins with and without MDD. Among the dizygotic twin pairs discordant for MDD, the CFR was 14\% lower in the twins with MDD than in their brothers without MDD (2.36 vs 2.74) (P = .03). This association was not present in the monozygotic discordant pairs who were genetically matched (2.86 vs 2.64) (P = .19). The zygosity-MDD interaction after adjustment was significant (P = .006). The CFR in the dizygotic twins with MDD was also lower than in the control twins. Conclusions Our results provide evidence for a shared genetic pathway between MDD and microvascular dysfunction. Common pathophysiologic processes may link MDD and early atherosclerosis.},
  keywords = {ðŸ”´,adenosine,fractional coronary flow reserve,major depressive disorder,myocardial perfusion,positron-emission tomography,stress,twins},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Vaccarino et al_2009_Major depression and coronary flow reserve detected by positron emission.pdf}
}

@article{Vaccarino2011,
  title = {Inflammation Is Related to Coronary Flow Reserve Detected by Positron Emission Tomography in Asymptomatic Male Twins},
  author = {Vaccarino, Viola and Khan, Durreshahwar and Votaw, John and Faber, Tracy and Veledar, Emir and Jones, Dean P. and Goldberg, Jack and Raggi, Paolo and Quyyumi, Arshed A. and Bremner, J. Douglas},
  date = {2011-03-15},
  journaltitle = {Journal of the American College of Cardiology},
  volume = {57},
  number = {11},
  eprint = {21392641},
  eprinttype = {pmid},
  pages = {1271--1279},
  publisher = {{Elsevier USA}},
  issn = {07351097},
  doi = {10.1016/j.jacc.2010.09.074},
  url = {https://pubmed.ncbi.nlm.nih.gov/21392641/},
  urldate = {2021-03-09},
  abstract = {Objectives: This study sought to examine the relationship between inflammation and coronary microvascular function in asymptomatic individuals using positron emission tomography (PET) and assessment of coronary flow reserve (CFR). Background: Coronary microvascular dysfunction is an early precursor of coronary artery disease (CAD) thought to result from endothelial cell activation and inflammation, but data are limited. Methods: We examined 268 asymptomatic male monozygotic and dizygotic twins. Plasma biomarkers of inflammation and endothelial cell activation included C-reactive protein (CRP), interleukin (IL)-6, white blood cell count (WBC), vascular cell adhesion molecule (VCAM)-1, and intercellular adhesion molecule (ICAM)-1. Blood flow quantitation was obtained with [13N] ammonia PET at rest and after adenosine stress. CFR was measured as the ratio of maximum flow to baseline flow at rest; abnormal CFR was defined as a ratio {$<$}2.5. A summed stress score for visible perfusion defects was calculated. Results: In within-pair analyses, all biomarkers, except VCAM-1, were higher in twins with lower CFR than their brothers with higher CFR (p {$<$} 0.05). This was observed in the entire sample, as well as within pairs discordant for a CFR of {$<$}2.5. Associations persisted after adjusting for summed stress score and CAD risk factors. In contrast no biomarker, except IL-6, was related to the summed stress score of visible defects. Conclusions: Even in asymptomatic subjects, a decrease in coronary microvascular function is accompanied by a systemic inflammatory response, independent of CAD risk factors. Our results, using a controlled twin design, highlight the importance of coronary microvascular function in the early phases of CAD. Â© 2011 American College of Cardiology Foundation.},
  keywords = {ðŸ”´,circulation,coronary disease,endothelium,imaging,inflammation},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Vaccarino et al_2011_Inflammation is related to coronary flow reserve detected by positron emission.pdf}
}

@article{Vadmann2017,
  title = {Death and Thrombo-Embolic Risk after Ablation of Atrial Flutter Compared with Atrial Fibrillation: {{A}} Nationwide Cohort Study},
  author = {Vadmann, Henrik and Gorst-Rasmussen, Anders and HjortshÃ¸j, SÃ¸ren PihlkjÃ¦r and Riahi, Sam and Lip, Gregory Y.H. and Larsen, Torben Bjerregaard},
  date = {2017-05-01},
  journaltitle = {Europace},
  volume = {19},
  number = {5},
  eprint = {27738075},
  eprinttype = {pmid},
  pages = {838--842},
  publisher = {{Oxford Academic}},
  issn = {15322092},
  doi = {10.1093/europace/euw107},
  url = {https://academic.oup.com/europace/article/19/5/838/2194454},
  urldate = {2022-11-22},
  abstract = {Aims: The aim of this study was to investigate whether there is a similar mortality and thrombo-embolic risk, after an atrial ablation procedure, compared with an atrial fibrillation (AF) procedure. Methods and results: Using data from nationwide Danish health registries, we identified patients aged 18â€“75 years undergoing a first- time atrial flutter or an AF ablation procedure in the period 2000â€“13. Cox proportional hazards regression was used to calculate hazard ratios (HRs) after 5 years of follow-up, adjusting for concomitant risk factors. A total of 1096 and 2266 patients underwent an ablation for atrial flutter or AF, respectively. Age distribution was similar in the two, but atrial flutter patients had more co-morbidities. During 5 years of follow-up, we observed 38 and 36 deaths in the atrial flutter and AF groups, corresponding to an almost two-fold higher mortality rate among atrial flutter patients [crude HR 1.92, 95\% confidence interval (CI) 1.22â€“3.03]. The higher mortality rate persisted after adjustment for age, sex, diabetes mellitus, and hypertension (adjusted HR 1.68, 95\% CI 1.05â€“2.69). The rate of thrombo-embolic events was similar in the two groups (crude HR 1.34, 95\% CI 0.71â€“2.56; adjusted HR 1.22, 95\% CI 0.62â€“2.41). Conclusion: In this observational study, patients with atrial flutter had a significantly higher all-cause mortality rate compared with those with AF after an ablation procedure, but similar thrombo-embolic event rates. Future studies should elucidate the reason for this difference in mortality.},
  keywords = {ðŸ”´,Ablation,Atrial flutter,Death,Epidemiology,Thromboembolism},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Vadmann et al_2017_Death and thrombo-embolic risk after ablation of atrial flutter compared with.pdf}
}

@article{vandeLande2023,
  title = {Time of Onset of Atrial Fibrillation and Atrial Fibrillation Progression Data from the {{RACE V}} Study},
  author = {family=Lande, given=Martijn E, prefix=van de, useprefix=true and Rama, Rajiv S and Koldenhof, Tim and Arita, Vicente Artola and Nguyen, Bao-Oanh and family=Deutekom, given=Colinda, prefix=van, useprefix=true and Weberndorfer, Vanessa and Crijns, Harry J G M and Hemels, Martin E W and Tieleman, Robert G and family=Melis, given=Mirko, prefix=de, useprefix=true and Schotten, Ulrich and Linz, Dominik and Van Gelder, Isabelle C and Rienstra, Michiel and {for the RACE V Investigators}},
  date = {2023-05-01},
  journaltitle = {EP Europace},
  shortjournal = {EP Europace},
  volume = {25},
  number = {5},
  pages = {euad058},
  issn = {1099-5129},
  doi = {10.1093/europace/euad058},
  url = {https://doi.org/10.1093/europace/euad058},
  urldate = {2023-07-26},
  abstract = {Atrial fibrillation (AF) progression is associated with adverse outcome, but the role of the circadian or diurnal pattern of AF onset remains unclear. We aim to assess the association between the time of onset of AF episodes with the clinical phenotype and AF progression in patients with self-terminating AF.The Reappraisal of AF: Interaction Between Hypercoagulability, Electrical Remodelling, and Vascular Destabilization in the Progression of AF study included patients with self-terminating AF who underwent extensive phenotyping at baseline and continuous rhythm monitoring with an implantable loop recorder (ILR). In this subanalysis, ILR data were used to assess the development of AF progression and the diurnal pattern of AF onset: predominant (\&gt;80\%) nocturnal AF, predominant daytime AF, or mixed AF without a predominant diurnal AF pattern. The median follow-up was 2.2 (1.6â€“2.8) years. The median age was 66 (59â€“71) years, and 117 (42\%) were women. Predominant nocturnal (n = 40) and daytime (n = 43) AF onset patients had less comorbidities compared to that of mixed (n = 195) AF patients (median 2 vs. 2 vs. 3, respectively, P = 0.012). Diabetes was more common in the mixed group (12\% vs. 5\% vs. 0\%, respectively, P = 0.031), whilst obesity was more frequent in the nocturnal group (38\% vs. 12\% vs. 27\%, respectively, P = 0.028). Progression rates in the nocturnal vs. daytime vs. mixed groups were 5\% vs. 5\% vs. 24\%, respectively (P = 0.013 nocturnal vs. mixed and P = 0.008 daytime vs. mixed group, respectively).In self-terminating AF, patients with either predominant nocturnal or daytime onset of AF episodes had less associated comorbidities and less AF progression compared to that of patients with mixed onset of AF.NCT02726698},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/van de Lande et al_2023_Time of onset of atrial fibrillation and atrial fibrillation progression data.pdf;/Users/asshah4/projects/zotero/storage/LG7QCCUR/7086193.html}
}

@article{VanderKooy2006,
  title = {Differences in Heart Rate Variability between Depressed and Non-Depressed Elderly},
  author = {family=Kooy, given=Koen G., prefix=van der, useprefix=true and family=Hout, given=Hein P.J., prefix=van, useprefix=true and family=Marwijk, given=Harm W.J., prefix=van, useprefix=true and family=Haan, given=Marten, prefix=de, useprefix=true and Stehouwer, Coen D.A. and Beekman, Aartjan T.F.},
  date = {2006},
  journaltitle = {International Journal of Geriatric Psychiatry},
  volume = {21},
  number = {2},
  eprint = {16416460},
  eprinttype = {pmid},
  pages = {147--150},
  issn = {08856230},
  doi = {10.1002/gps.1439},
  abstract = {OBJECTIVE: To determine whether older primary care patients with a Major Depressive Disorder (MDD) have lower heart rate variability (HRV) compared to non-depressed patients. HRV is a measure of cardiac autonomic functioning. METHOD: A cross-sectional comparison of 136 elderly persons with MDD and 136 non-depressed controls (matched for age and gender) recruited in family practices in the Netherlands. Depression was determined according to the DSM-IV criteria using the PRIME-MD. HRV was measured with an electrocardiogram (ECG) during a 5-minute supine rest. RESULTS: Multivariate analyses showed statistically significant decrease in HRV in MDD patients compared with controls. CONCLUSION: Older primary care patients with MDD have a reduced HRV. This may explain why depression is a risk factor for cardiovascular disease and mortality.},
  keywords = {ðŸ”´,Autonomic nervous system,Heart rate variability,Major depression,Primary care},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/van der Kooy et al_2006_Differences in heart rate variability between depressed and non-depressed.pdf}
}

@article{VanMelle2007,
  title = {Effects of Antidepressant Treatment Following Myocardial Infarction},
  author = {Van Melle, Joost P. and De Jonge, Peter and Honig, Adriaan and Schene, Aart H and Kuyper, Astrid M.G. and Crijns, Harry J.G.M. and Schins, Annique and Tulner, Dorien and Van Den Berg, Maarten P. and Ormel, Johan},
  date = {2007-06},
  journaltitle = {British Journal of Psychiatry},
  volume = {190},
  eprint = {17541103},
  eprinttype = {pmid},
  pages = {460--466},
  issn = {00071250},
  doi = {10.1192/bjp.bp.106.028647},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/17541103},
  urldate = {2019-10-19},
  abstract = {Background: Depression following myocardial infarction is associated with poor cardiac prognosis. It is unclear whether antidepressant treatment improves long-term depression status and cardiac prognosis. Aims: To evaluate the effects of antidepressant treatment compared with usual care in an effectiveness study. Method: In a multicentre randomised controlled trial, 2177 myocardial infarction patients were evaluated for ICD-10 depression and randomised to intervention (n=209) or care as usual (n=122). Both arms were evaluated at 18 months post-myocardial infarction for long-term depression status and new cardiac events. Results: No differences were observed between intervention and control groups in mean scores on the Beck Depression Inventory (11.0, s.d.=7.5 v. 10.2, s.d.=5.1, P=0.45) or presence of ICD-10 depression (30.5 v. 32.1\%, P=0.68).The cardiac event rate was 14\% among the intervention group and 13\% among controls (OR=1.07,95\% CI 0.57-2.00). Conclusions: Antidepressant treatment did not alter long-term depression post-myocardial infarction status or improve cardiac prognosis.},
  issue = {JUNE},
  keywords = {ðŸ”´}
}

@article{Veith1994b,
  title = {Sympathetic {{Nervous System Activity}} in {{Major Depression}}: {{Basal}} and {{Desipramine-Induced Alterations}} in {{Plasma Norepinephrine Kinetics}}},
  author = {Veith, Richard C. and Lewis, Nancy and Linares, Oscar A. and Barnes, Robert F. and Raskind, Murray A. and Villacres, Enrique C. and Murburg, M. Michele and Ashleigh, E. Alexandra and Castillo, Sonia and Peskind, Elaine R. and Pascualy, Marcella and Halter, Jeffrey B.},
  date = {1994},
  journaltitle = {Archives of General Psychiatry},
  volume = {51},
  number = {5},
  pages = {411--422},
  issn = {15383636},
  doi = {10.1001/archpsyc.1994.03950050071008},
  keywords = {ðŸ”´}
}

@article{Vesela2023,
  title = {Prediction of Post-Operative Atrial Fibrillation in Patients after Cardiac Surgery Using Heart Rate Variability},
  author = {VeselÃ¡, Jana and OsmanÄÃ­k, Pavel and HeÅ™man, Dalibor and Hassouna, Sabri and RakovÃ¡, Radka and VeselÃ½, TomÃ¡Å¡ and Budera, Petr},
  date = {2023-06-07},
  journaltitle = {BMC Cardiovascular Disorders},
  shortjournal = {BMC Cardiovascular Disorders},
  volume = {23},
  number = {1},
  pages = {290},
  issn = {1471-2261},
  doi = {10.1186/s12872-023-03309-5},
  url = {https://doi.org/10.1186/s12872-023-03309-5},
  urldate = {2023-06-11},
  abstract = {Post-operative atrial fibrillation (PoAF) occurs in \textasciitilde\,30\% of patients after cardiac surgery. The etiology of PoAF is complex, but a disbalance in autonomic systems plays an important role. The goal of this study was to assess whether pre-operative heart rate variability analysis can predict the risk of PoAF.},
  keywords = {ðŸ”´,Cardiac surgery,Heart rate variability,Non-linear analysis,Post-operative atrial fibrillation},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/VeselÃ¡ et al_2023_Prediction of post-operative atrial fibrillation in patients after cardiac.pdf}
}

@article{Vroege2012,
  title = {Vital Exhaustion and Somatic Depression: {{The}} Same Underlying Construct in Patients with Myocardial Infarction?},
  author = {Vroege, Esther M and Zuidersma, Marij and De Jonge, Peter},
  date = {2012},
  journaltitle = {Psychosomatic Medicine},
  volume = {74},
  number = {5},
  eprint = {22685238},
  eprinttype = {pmid},
  pages = {446--451},
  issn = {15347796},
  doi = {10.1097/PSY.0b013e31825a7194},
  abstract = {To test whether vital exhaustion overlaps more with somatic/affective depression than with cognitive/affective depressive symptoms and evaluate the risk of recurrent cardiovascular events associated with these constructs.},
  isbn = {0033-3174},
  keywords = {ðŸ”´,depression,myocardial infarction,somatic/affective and cognitive/affective symptom,vital exhaustion},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Vroege et al_2012_Vital exhaustion and somatic depression.pdf}
}

@article{Walters2014,
  title = {Development of Atrial Fibrillation after Atrial Flutter Ablation: {{More}} a Question of When than Whether},
  author = {Walters, Tomos E. and Kalman, Jonathan M.},
  date = {2014-08-01},
  journaltitle = {Journal of Cardiovascular Electrophysiology},
  volume = {25},
  number = {8},
  eprint = {24762080},
  eprinttype = {pmid},
  pages = {821--823},
  publisher = {{John Wiley \& Sons, Ltd}},
  issn = {15408167},
  doi = {10.1111/jce.12446},
  url = {https://onlinelibrary-wiley-com.proxy.cc.uic.edu/doi/full/10.1111/jce.12446},
  urldate = {2022-11-22},
  abstract = {Editorial Comment The relationship between atrial fibrillation (AF) and cavotricuspid isthmus (CTI)-dependent atrial flutter (AFL) has long been recognized in clinical practice. The development of both is favored by the presence of common triggers and substrate, particularly in the setting of structural heart disease with its attendant electrical and structural remodel-ing. Conditions associated with atrial remodeling, including heart failure, hypertension, increasing age and valvular heart disease, predispose to both fibrillation and flutter. The nature of the "peri-tricuspid" macroreentry circuit, constrained by structural and functional barriers to electrical propagation, is now well understood. Experimental and clinical studies have demonstrated that CTI-dependent AFL is most frequently preceded by a period of short cycle length atrial activation, and in particular by a period of AF. 1-4 Such activity induces regions of functional conduction block and slowed conduction that are necessary for the transition from multiple unstable wavefronts to a single organized circuit. 5,6 The development of functional conduction block along the crista terminalis seems particularly important in the patho-genesis of CTI-dependent AFL. 7-9 Thus the same pulmonary vein (PV) and non-PV triggers that initiate AF are also responsible , via transitional AF, for onset of the great majority of AFL episodes. This background is of prime importance when considering the accumulated literature evaluating the incidence of AF late after AFL ablation. This incidence is clearly time-dependent with reported rates of 17-22\% at 6 months, increasing to 50\% at 2 years and 63\% at 4 years. 10,11 The most consistently identified risk factor for the development of post-ablation AF is documented pre-ablation AF, the prevalence of which varies according to the intensity of monitoring, 10-14 Other identified risk factors have included left ventricular (LV) systolic dysfunction, 12,14 significant mitral regurgitation, 10 left atrial (LA) enlargement, 11,15 and the failure of multiple antiarrhyth-mic drugs (AADs). 14 All are associated with LA remodeling and an elevated risk of incident AF regardless of AFL abla-tion. Importantly, the incidence of AF after AFL ablation is also proportional to the intensity of monitoring. In a small study of patients who had loop recorders implanted after flutter ablation, 55\% developed new AF within the first year of follow-up. 16 It seems probable that the variability in the reported incidence of post-ablation AF is related in large part to varying intensities of monitoring. In this issue of the Journal, Brembilla-Perrot and colleagues 17 further explore the incidence of and risk factors for AF following ablation of AFL. They present a large single-center series of 1,121 consecutive patients undergoing catheter ablation of CTI-dependent AFL, with data retrospectively extracted by chart review. A history of AF before AFL ablation was present in 31.8\% of patients, but the nature of pre-ablation monitoring to determine this is not described. It is probable that the real AF incidence before ablation was much higher. Follow-up was continued for a mean of 2.1 Â± 2.7 years, and included ECG and 24-hour Holter monitoring at 1 month but thereafter only at annual intervals or for investigation of symptoms. Using this approach, new AF was observed during follow-up in 19.3\% of patients without pre-ablation AF, but ongoing AF was only detected in 31.5\% of patients who did have pre-ablation AF. The study thus observed a fall in the overall AF incidence post-ablation (23.2\%) compared with pre-ablation (31.8\%), with a particularly marked fall in the group with AF before AFL ablation. This result should be viewed in the context of the limited post-ablation monitoring performed. Nevertheless, the ongoing involvement with the healthcare system remained significant with 8\% developing permanent AF, 7\% requiring electrical cardioversion, 7\% atrio-ventricular node ablation and 15\% pacemaker implantation. These data certainly make it difficult to argue that AFL ablation in this population provides a definitive result. Only AF history and female gender were significant pre-dictors of AF occurrence post-ablation. Other established markers of AF risk such as age, hypertension, diabetes and various forms of structural heart disease were not associated with post-ablation AF in this study. Importantly, at the time of ablation 50.5\% had a CHADS 2 score 1 and although only 2 strokes occurred during follow-up both were in patients who were not anti-coagulated and who had AF recurrence.},
  keywords = {ðŸ”´,atrial flutter,clinical: catheter ablation},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Walters_Kalman_2014_Development of atrial fibrillation after atrial flutter ablation.pdf}
}

@article{Wang2014b,
  title = {Social Support Moderates Stress Effects on Depression},
  author = {Wang, Xingmin and Cai, Lin and Qian, Jing and Peng, Jiaxi},
  date = {2014},
  journaltitle = {International Journal of Mental Health Systems},
  volume = {8},
  number = {1},
  publisher = {{BioMed Central Ltd.}},
  issn = {17524458},
  doi = {10.1186/1752-4458-8-41},
  abstract = {This study examined the moderator effect of social support on the relationship between stress and depression of university students. A total of 632 undergraduate students completed the measures of perceived stress, perceived social support, and depression. Hierarchical regression analysis showed that social support moderated the association between stress and depression. Undergraduate students with high stress reported higher scores in depression than those with low stress with low social support level. However, the impact of stress on depression was much smaller in the high social support group compared with that in the low social support group.},
  keywords = {ðŸ”´,Depression,Moderating effect,Social support,Stress,University students},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Wang et al_2014_Social support moderates stress effects on depression.pdf}
}

@article{Wang2023,
  title = {Genetic {{Susceptibility}} to {{Atrial Fibrillation Identified}} via {{Deep Learning}} of 12-{{Lead Electrocardiograms}}},
  author = {Wang, Xin and Khurshid, Shaan and Choi, Seung Hoan and Friedman, Samuel and Weng, Lu-Chen and Reeder, Christopher and Pirruccello, James P. and Singh, Pulkit and Lau, Emily S. and Venn, Rachael and Diamant, Nate and Di Achille, Paolo and Philippakis, Anthony and Anderson, Christopher D. and Ho, Jennifer E. and Ellinor, Patrick T. and Batra, Puneet and Lubitz, Steven A.},
  date = {2023},
  journaltitle = {Circulation: Genomic and Precision Medicine},
  volume = {0},
  number = {0},
  pages = {e003808},
  doi = {10.1161/CIRCGEN.122.003808},
  url = {https://www.ahajournals.org/doi/abs/10.1161/CIRCGEN.122.003808},
  urldate = {2023-06-09},
  abstract = {BACKGROUND: Artificial intelligence (AI) models applied to 12-lead ECG waveforms can predict atrial fibrillation (AF), a heritable and morbid arrhythmia. However, the factors forming the basis of risk predictions from AI models are usually not well understood. We hypothesized that there might be a genetic basis for an AI algorithm for predicting the 5-year risk of new-onset AF using 12-lead ECGs (ECG-AI)-based risk estimates. METHODS: We applied a validated ECG-AI model for predicting incident AF to ECGs from 39 986 UK Biobank participants without AF. We then performed a genome-wide association study (GWAS) of the predicted AF risk and compared it with an AF GWAS and a GWAS of risk estimates from a clinical variable model. RESULTS: In the ECG-AI GWAS, we identified 3 signals (P{$<$}5Ã—10âˆ’8) at established AF susceptibility loci marked by the sarcomeric gene TTN and sodium channel genes SCN5A and SCN10A. We also identified 2 novel loci near the genes VGLL2 and EXT1. In contrast, the clinical variable model prediction GWAS indicated a different genetic profile. In genetic correlation analysis, the prediction from the ECG-AI model was estimated to have a higher correlation with AF than that from the clinical variable model. CONCLUSIONS: Predicted AF risk from an ECG-AI model is influenced by genetic variation implicating sarcomeric, ion channel and body height pathways. ECG-AI models may identify individuals at risk for disease via specific biological pathways.},
  keywords = {ðŸ”´,algorithm,artificial intelligence,atrial fibrillation,morbidity,risk factor},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Wang et al_Genetic Susceptibility to Atrial Fibrillation Identified via Deep Learning of.pdf;/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Wang et al_Genetic Susceptibility to Atrial Fibrillation Identified via Deep Learning of2.pdf}
}

@article{Wei2014,
  title = {Depressive Symptoms Are Associated with Mental Stress-Induced Myocardial Ischemia after Acute Myocardial Infarction},
  author = {Wei, Jingkai and Pimple, Pratik and Shah, Amit J. and Rooks, Cherie and Bremner, J. Douglas and Nye, Jonathon A. and Ibeanu, Ijeoma and Murrah, Nancy and Shallenberger, Lucy and Raggi, Paolo and Vaccarino, Viola},
  editor = {Hayley, Shawn},
  date = {2014-07-25},
  journaltitle = {PLoS ONE},
  volume = {9},
  number = {7},
  eprint = {25061993},
  eprinttype = {pmid},
  pages = {e102986},
  issn = {19326203},
  doi = {10.1371/journal.pone.0102986},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/25061993},
  urldate = {2018-11-25},
  abstract = {OBJECTIVES: Depression is an adverse prognostic factor after an acute myocardial infarction (MI), and an increased propensity toward emotionally-driven myocardial ischemia may play a role. We aimed to examine the association between depressive symptoms and mental stress-induced myocardial ischemia in young survivors of an MI.\textbackslash n\textbackslash nMETHODS: We studied 98 patients (49 women and 49 men) age 38-60 years who were hospitalized for acute MI in the previous 6 months. Patients underwent myocardial perfusion imaging at rest, after mental stress (speech task), and after exercise or pharmacological stress. A summed difference score (SDS), obtained with observer-independent software, was used to quantify myocardial ischemia under both stress conditions. The Beck Depression Inventory-II (BDI-II) was used to measure depressive symptoms, which were analyzed as overall score, and as separate somatic and cognitive depressive symptom scores.\textbackslash n\textbackslash nRESULTS: There was a significant positive association between depressive symptoms and SDS with mental stress, denoting more ischemia. After adjustment for demographic and lifestyle factors, disease severity and medications, each incremental depressive symptom was associated with 0.14 points higher SDS. When somatic and cognitive depressive symptoms were examined separately, both somatic [Î² = 0.17, 95\% CI: (0.04, 0.30), p = 0.01] and cognitive symptoms [Î² = 0.31, 95\% CI: (0.07, 0.56), p = 0.01] were significantly associated with mental stress-induced ischemia. Depressive symptoms were not associated with ischemia induced by exercise or pharmacological stress.\textbackslash n\textbackslash nCONCLUSION: Among young post-MI patients, higher levels of both cognitive and somatic depressive symptoms are associated with a higher propensity to develop myocardial ischemia with mental stress, but not with physical (exercise or pharmacological) stress.},
  isbn = {0009-7322},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Wei et al_2014_Depressive symptoms are associated with mental stress-induced myocardial.PDF}
}

@article{Williams2000,
  title = {Anger Proneness Predicts Coronary Heart Disease Risk: {{Prospective}} Analysis from the Atherosclerosis Risk in Communities ({{ARIC}}) Study},
  author = {Williams, Janice E and Paton, Catherine C and Siegler, Ilene C and Eigenbrodt, Marsha L and Nieto, F. Javier and Tyroler, Herman A},
  date = {2000},
  journaltitle = {Circulation},
  volume = {101},
  number = {17},
  pages = {2034--2039},
  issn = {00097322},
  doi = {10.1161/01.CIR.101.17.2034},
  url = {http://www.circulationaha.org},
  urldate = {2019-06-03},
  abstract = {BACKGROUND: Increased research attention is being paid to the negative impact of anger on coronary heart disease (CHD). METHODS AND RESULTS: This study examined prospectively the association between trait anger and the risk of combined CHD (acute myocardial infarction [MI]/fatal CHD, silent MI, or cardiac revascularization procedures) and of "hard" events (acute MI/fatal CHD). Participants were 12 986 black and white men and womenenrolled in the Atherosclerosis Risk In Communities study. In the entire cohort, individuals with high trait anger, compared with their low anger counterparts, were at increased risk of CHD in both event categories. The multivariate-adjusted hazard ratio (HR) (95\% CI) was 1.54 (95\% CI 1.10 to 2.16) for combined CHD and 1.75 (95\% CI 1.17 to 2.64) for "hard" events. Heterogeneity of effect was observed by hypertensive status. Among normotensive individuals, the risk of combined CHD and of "hard" events increased monotonically with increasing levels of trait anger. The multivariate-adjusted HR of CHD for high versus low anger was 2.20 (95\% CI 1.36 to 3.55) and for moderate versus low anger was 1.32 (95\% CI 0.94 to 1.84). For "hard" events, the multivariate-adjusted HRs were 2.69 (95\% CI 1.48 to 4.90) and 1.35 (95\% CI 0.87 to 2.10), respectively. No statistically significant association between trait anger and incident CHD risk was observed among hypertensive individuals. CONCLUSIONS: Proneness to anger places normotensive middle-aged men and women at significant risk for CHD morbidity and death independent of the established biological risk factors.},
  keywords = {ðŸ”´,Coronary disease,Epidemiology,Stress}
}

@article{Wineinger2019,
  title = {Identification of Paroxysmal Atrial Fibrillation Subtypes in over 13,000 Individuals},
  author = {Wineinger, Nathan E. and Barrett, Paddy M. and Zhang, Yunyue and Irfanullah, Ikram and Muse, Evan D. and Steinhubl, Steven R. and Topol, Eric J.},
  date = {2019-01},
  journaltitle = {Heart Rhythm},
  shortjournal = {Heart Rhythm},
  volume = {16},
  number = {1},
  eprint = {30118885},
  eprinttype = {pmid},
  pages = {26--30},
  issn = {1556-3871},
  doi = {10.1016/j.hrthm.2018.08.012},
  abstract = {BACKGROUND: Paroxysmal atrial fibrillation (PAF) is broadly defined despite high variability in the occurrence and duration of PAF episodes. OBJECTIVE: The purpose of this study was to identify rhythm patterns in a large cohort of individuals with PAF who wore an ambulatory single-lead electrocardiogram (ECG) patch sensor as part of standard clinical care. METHODS: We performed a retrospective analysis of longitudinal rhythm data obtained from 13,293 individuals with PAF. RESULTS: In this study, 7934 men and 5359 women with PAF wore an ambulatory single-lead ECG patch sensor for 11.4 days on average, experiencing 1,041,504 PAF episodes. The median daily rate of PAF was 1.21 episodes per day (interquartile range [IQR] 0.31-4.99), and the median maximum duration per individual was 7.5 hours (IQR 2.4-18.6 hours). There was an inverse relationship between the duration of PAF episodes and the frequency in which they occurred, which became pronounced at moderate and high overall burdens of AF. This produced a spectrum of PAF flanked by 2 distinct subtypes of the disease: the staccato subtype, characterized by many, short AF episodes; and the legato subtype, characterized by fewer, longer episodes. Longer but less frequent episodes became more common with increasing age. Only 49.4\% of individuals experienced an episode in the first 24 hours of monitoring, increasing to 89.7\% after 1 week of monitoring. CONCLUSION: We identified subtypes of the disease that we labeled staccato and legato. Although further study is required, these subtypes may result from differing elements of pathophysiology and disease progression, and may confer differing stroke risks.},
  langid = {english},
  pmcid = {PMC6800237},
  keywords = {ðŸ”´,Adult,Aged,Atrial Fibrillation,Atrial fibrillation burden,Digital medicine,Disease Progression,{Electrocardiography, Ambulatory},Female,Follow-Up Studies,Heart Conduction System,Heart Rate,Humans,Male,Middle Aged,Mobile health,Paroxysmal atrial fibrillation,Retrospective Studies,Single-lead ECG patch sensor},
  file = {/Users/asshah4/projects/zotero/storage/U6RN8MGA/Wineinger et al. - 2019 - Identification of paroxysmal atrial fibrillation s.pdf}
}

@article{Yannopoulos2019,
  title = {The {{Evolving Role}} of the {{Cardiac Catheterization Laboratory}} in the {{Management}} of {{Patients With Out-of-Hospital Cardiac Arrest}}: {{A Scientific Statement From}} the {{American Heart Association}}},
  author = {Yannopoulos, Demetris and Bartos, Jason A. and Aufderheide, Tom P. and Callaway, Clifton W. and Deo, Rajat and Garcia, Santiago and Halperin, Henry R. and Kern, Karl B. and Kudenchuk, Peter J. and Neumar, Robert W. and Raveendran, Ganesh},
  date = {2019-03-19},
  journaltitle = {Circulation},
  volume = {139},
  number = {12},
  eprint = {30760026},
  eprinttype = {pmid},
  pages = {e530-e552},
  publisher = {{NLM (Medline)}},
  issn = {15244539},
  doi = {10.1161/CIR.0000000000000630},
  url = {http://ahajournals.org},
  urldate = {2020-08-26},
  abstract = {Coronary artery disease is prevalent in different causes of out-of-hospital cardiac arrest (OHCA), especially in individuals presenting with shockable rhythms of ventricular fibrillation/pulseless ventricular tachycardia (VF/pVT). The purpose of this report is to review the known prevalence and potential importance of coronary artery disease in patients with OHCA and to describe the emerging paradigm of treatment with advanced perfusion/reperfusion techniques and their potential benefits on the basis of available evidence. Although randomized clinical trials are planned or ongoing, current scientific evidence rests principally on observational case series with their potential confounding selection bias. Among patients resuscitated from VF/pVT OHCA with ST-segment elevation on their postresuscitation ECG, the prevalence of coronary artery disease has been shown to be 70\% to 85\%. More than 90\% of these patients have had successful percutaneous coronary intervention. Conversely, among patients resuscitated from VF/pVT OHCA without ST-segment elevation on their postresuscitation ECG, the prevalence of coronary artery disease has been shown to be 25\% to 50\%. For these patients, early access to the cardiac catheterization laboratory is associated with a 10\% to 15\% absolute higher functionally favorable survival rate compared with more conservative approaches of late or no access to the cardiac catheterization laboratory. In patients with VF/pVT OHCA refractory to standard treatment, a new treatment paradigm is also emerging that uses venoarterial extracorporeal membrane oxygenation to facilitate return of normal perfusion and to support further resuscitation efforts, including coronary angiography and percutaneous coronary intervention. The burden of coronary artery disease is high in this patient population, presumably causative in most patients. The strategy of venoarterial extracorporeal membrane oxygenation, coronary angiography, and percutaneous coronary intervention has resulted in functionally favorable survival rates ranging from 9\% to 45\% in observational studies in this patient population. Patients with VF/pVT should be considered at the highest severity in the continuum of acute coronary syndromes. These patients have a significant burden of coronary artery disease and acute coronary thrombotic events. Evidence from randomized trials will further define optimal clinical practice.},
  keywords = {ðŸ”´,AHA Scientific Statements,cardiac catheterization,laboratories,out-of-hospital cardiac arrest,percutaneous coronary intervention,tachycardia,ventricular,ventricular fibrillation},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Yannopoulos et al_2019_The Evolving Role of the Cardiac Catheterization Laboratory in the Management.pdf}
}

@article{Yeboah2016,
  title = {Utility of {{Nontraditional Risk Markers}} in {{Atherosclerotic Cardiovascular Disease Risk Assessment}}},
  author = {Yeboah, Joseph and Young, Rebekah and McClelland, Robyn L. and Delaney, Joseph C. and Polonsky, Tamar S. and Dawood, Farah Z. and Blaha, Michael J. and Miedema, Michael D. and Sibley, Christopher T. and Carr, J. Jeffrey and Burke, Gregory L. and Goff, David C. and Psaty, Bruce M. and Greenland, Philip and Herrington, David M.},
  date = {2016-01-19},
  journaltitle = {Journal of the American College of Cardiology},
  volume = {67},
  number = {2},
  eprint = {26791059},
  eprinttype = {pmid},
  pages = {139--147},
  publisher = {{Elsevier USA}},
  issn = {15583597},
  doi = {10.1016/j.jacc.2015.10.058},
  url = {https://www.jacc.org/doi/10.1016/j.jacc.2015.10.058},
  urldate = {2022-08-12},
  abstract = {Background The improvement in discrimination gained by adding nontraditional cardiovascular risk markers cited in the 2013 American College of Cardiology/American Heart Association cholesterol guidelines to the atherosclerotic cardiovascular disease (ASCVD) risk estimator (pooled cohort equation [PCE]) is untested. Objectives This study assessed the predictive accuracy and improvement in reclassification gained by the addition of the coronary artery calcium (CAC) score, the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) levels, and family history (FH) of ASCVD to the PCE in participants of MESA (Multi-Ethnic Study of Atherosclerosis). Methods The PCE was calibrated (cPCE) and used for this analysis. The Cox proportional hazards survival model, Harrell's C statistics, and net reclassification improvement analyses were used. ASCVD was defined as myocardial infarction, coronary heart disease-related death, or fatal or nonfatal stroke. Results Of 6,814 MESA participants not prescribed statins at baseline, 5,185 had complete data and were included in this analysis. Their mean age was 61 years; 53.1\% were women, 9.8\% had diabetes, and 13.6\% were current smokers. After 10 years of follow-up, 320 (6.2\%) ASCVD events occurred. CAC score, ABI, and FH were independent predictors of ASCVD events in the multivariable Cox models. CAC score modestly improved the Harrell's C statistic (0.74 vs. 0.76; p = 0.04); ABI, hsCRP levels, and FH produced no improvement in Harrell's C statistic when added to the cPCE. Conclusions CAC score, ABI, and FH were independent predictors of ASCVD events. CAC score modestly improved the discriminative ability of the cPCE compared with other nontraditional risk markers.},
  keywords = {ðŸ”´,coronary artery calcium,high-sensitivity C-reactive protein,Key Words ankle-brachial index,pooled cohort equation},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Yeboah et al_2016_Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular.pdf}
}

@article{Yeragani2002,
  title = {Major Depression with Ischemic Heart Disease: {{Effects}} of Paroxetine and Nortriptyline on Long-Term Heart Rate Variability Measures},
  author = {Yeragani, Vikram K and Pesce, Vanessa and Jayaraman, Anusha and Roose, Steven and V.K., Yeragani and V., Pesce and A., Jayaraman and S., Roose},
  date = {2002-09-01},
  journaltitle = {Biological psychiatry},
  volume = {52},
  number = {5},
  eprint = {12242058},
  eprinttype = {pmid},
  pages = {418--29},
  issn = {0006-3223},
  url = {http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L35266733%5Cnhttp://dx.doi.org/10.1016/S0006-3223(02)01394-X%5Cnhttp://sfx.library.uu.nl/utrecht?sid=EMBASE&issn=00063223&id=doi:10.1016%2FS0006-3223%2802%2901394-X&atitle=Major+depr},
  abstract = {Background: Studies have linked depression to sudden death and serious cardiovascular events in patients with preexisting cardiac illness. Recent studies have shown decreased vagal function in cardiac patients with depression and depressed patients without cardiac illness. Methods: We compared 20-hour, sleeping, and awake heart period variability measures using spectral analysis, fractal dimension, and symbolic dynamics in two patient groups with major depression and ischemic heart disease (mean age 59-60 years) before and after 6 weeks of paroxetine or nortriptyline treatment. Results: Spectral measures showed decreases in awake and sleeping total power (TP: 0.0-0.5 Hz), ultra low frequency power (ULF: 0-0.0033 Hz), very low frequency power (VLF: 0.0033-0.04 Hz), and low-frequency power (LF: 0.04-0.15 Hz) for nortriptyline condition and a decrease in high-frequency power (HF: 0.15-0.5 Hz) for the awake condition in patients who received nortriptyline. A measure of nonlinear complexity, WC-100, significantly increased after paroxetine during the awake condition. Conclusions: These findings suggest that nortriptyline has stronger vagolytic effects on cardiac autonomic function compared with paroxetine, which is in agreement with previous clinical and preclinical reports. Paroxetine may have some cardio-protective effects, especially in cardiac patients. Â© 2002 Society of Biological Psychiatry.},
  keywords = {ðŸ”´,adult,aged,article,awake,cardiovascular mortality,clinical trial,controlled clinical trial,controlled study,depression,disease association,double blind procedure,drug blood level,drug effect,electrocardiogram,fractal analysis,heart protection,heart rate variability,hemodynamic monitoring,human,ischemic heart disease,major clinical study,Major depression,nonlinear,nortriptyline,paroxetine,priority journal,sleep,sleep waking cycle,spectral analysis,symbolic dynamics,treatment outcome,vagus tone},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/Yeragani et al_2002_Major depression with ischemic heart disease.pdf}
}

@article{Yusuf2004,
  title = {Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (the {{INTERHEART}} Study): {{Case-control}} Study},
  author = {Yusuf, Prof Salim and Hawken, Steven and Ã”unpuu, Stephanie and Dans, Tony and Avezum, Alvaro and Lanas, Fernando and McQueen, Matthew and Budaj, Andrzej and Pais, Prem and Varigos, John and Lisheng, Liu},
  date = {2004-09-11},
  journaltitle = {Lancet},
  volume = {364},
  number = {9438},
  eprint = {15364185},
  eprinttype = {pmid},
  pages = {937--952},
  publisher = {{Elsevier}},
  issn = {01406736},
  doi = {10.1016/S0140-6736(04)17018-9},
  url = {http://www.thelancet.com/article/S0140673604170189/fulltext},
  urldate = {2022-08-12},
  abstract = {Background Although more than 80\% of the global burden of cardiovascular disease occurs in low-income and middle-income countries, knowledge of the importance of risk factors is largely derived from developed countries. Therefore, the effect of such factors on risk of coronary heart disease in most regions of the world is unknown. Methods We established a standardised case-control study of acute myocardial infarction in 52 countries, representing every inhabited continent. 15 152 cases and 14 820 controls were enrolled. The relation of smoking, history of hypertension or diabetes, waist/hip ratio, dietary patterns, physical activity, consumption of alcohol, blood apolipoproteins (Apo), and psychosocial factors to myocardial infarction are reported here. Odds ratios and their 99\% CIs for the association of risk factors to myocardial infarction and their population attributable risks (PAR) were calculated. Findings Smoking (odds ratio 2Â·87 for current vs never, PAR 35Â·7\% for current and former vs never), raised ApoB/ApoA1 ratio (3Â·25 for top vs lowest quintile, PAR 49Â·2\% for top four quintiles vs lowest quintile), history of hypertension (1Â·91, PAR 17Â·9\%), diabetes (2Â·37, PAR 9Â·9\%), abdominal obesity (1Â·12 for top vs lowest tertile and 1Â·62 for middle vs lowest tertile, PAR 20Â·1\% for top two tertiles vs lowest tertile), psychosocial factors (2Â·67, PAR 32Â·5\%), daily consumption of fruits and vegetables (0Â·70, PAR 13Â·7\% for lack of daily consumption), regular alcohol consumption (0Â·91, PAR 6Â·7\%), and regular physical activity (0Â·86, PAR 12Â·2\%), were all significantly related to acute myocardial infarction (p{$<$}0Â·0001 for all risk factors and p=0Â·03 for alcohol). These associations were noted in men and women, old and young, and in all regions of the world. Collectively, these nine risk factors accounted for 90\% of the PAR in men and 94\% in women. Interpretation Abnormal lipids, smoking, hypertension, diabetes, abdominal obesity, psychosocial factors, consumption of fruits, vegetables, and alcohol, and regular physical activity account for most of the risk of myocardial infarction worldwide in both sexes and at all ages in all regions. This finding suggests that approaches to prevention can be based on similar principles worldwide and have the potential to prevent most premature cases of myocardial infarction.},
  keywords = {ðŸ”´}
}

@article{ZekiAlHazzouri2018c,
  title = {Heart {{Rate Variability}} and {{Cognitive Function}} in {{Middle-Age Adults}}: {{The Coronary Artery Risk Development}} in {{Young Adults}}},
  author = {Zeki Al Hazzouri, Adina and Elfassy, Tali and Carnethon, Mercedes R and Lloyd-Jones, Donald M and Yaffe, Kristine},
  date = {2018},
  journaltitle = {American Journal of Hypertension},
  volume = {31},
  number = {1},
  eprint = {28985245},
  eprinttype = {pmid},
  pages = {27--34},
  issn = {19417225},
  doi = {10.1093/ajh/hpx125},
  abstract = {BACKGROUND Low heart rate variability (HRV), a marker of cardiac autonomic dysfunction, has been associated with major risk factors of cognitive impairment. Yet, the direct association of HRV with cognitive function remains relatively unexplored, particularly in midlife. METHODS In 2005, 2 measures of short-term HRV, the SD of normal-to-normal intervals (SDNN) and the root mean square of successive differences (RMSSD), were calculated for participants of the Coronary Artery Risk Development in Young Adults study, and then categorized into quartiles. Five years later, 3 cognitive tests were administered for verbal memory ("Rey Auditory-Verbal Learning Test", RAVLT, range 0-15), processing speed ("Digit Symbol Substitution Test", DSST, range 0-133), and executive function ("Stroop interference"). RESULTS Two thousand one hundred and eighteen participants (57.7\% female, 42.2\% Black) with a mean baseline age of 45.3 years were included in this analysis. In demographic-adjusted models, compared to participants with quartile 1 SDNN (lowest quartile), participants in the upper quartiles of SDNN scored better on the DSST (quartile 4: Î² = 1.83 points better, P = 0.03; and quartile 3: Î² = 1.95 points better, P = 0.03) and on the stroop (quartile 3: Î² = 1.19 points better, P {$<$} 0.05; and quartile2: Î² = 1.44 points better, P = 0.02). After adjusting for behavioral and cardiovascular risk factors, higher quartile SDNN remained significantly associated with better stroop score (quartile 3: Î² = 1.21 points better, P = 0.04; and quartile 2: Î² = 1.72 points better, P {$<$} 0.01) but not with DSST. There was no association between quartile of RMSSD and cognitive function, from fully adjusted models. CONCLUSIONS Our findings suggest that higher quartile SDDN is associated with better executive function in midlife, above, and beyond cardiovascular risk factors.},
  keywords = {ðŸ”´}
}

@article{ZÃ¶ller2013,
  title = {High Familial Risk of Atrial Fibrillation/Atrial Flutter in Multiplex Families: A Nationwide Family Study in {{Sweden}}.},
  author = {ZÃ¶ller, Bengt and Ohlsson, Henrik and Sundquist, Jan and Sundquist, Kristina},
  date = {2013},
  journaltitle = {Journal of the American Heart Association},
  volume = {2},
  number = {1},
  eprint = {23525409},
  eprinttype = {pmid},
  issn = {20479980},
  doi = {10.1161/JAHA.112.003384},
  abstract = {Although the heritability of atrial fibrillation/atrial flutter (AF/AFl) has been determined, the familial risk in multiplex families is unclear. The main aim of this nationwide study was to determine the familial risk of AF/AFl in multiplex families. We examined the familial risk of AF/AFl in the entire Swedish population. We linked Multigeneration Register data on individuals aged 0 to 76 years with Hospital Discharge Register data for 1987-2008 and Outpatient Register data for 2001-2008 to compare AF/AFl risk among relatives of all 300 586 individuals with AF/AFl with that among relatives of unaffected individuals. We used conditional logistic regression to investigate differences in exposure between cases and controls. Parents (odds ratio [OR] 1.95 [95\% CI 1.89 to 2.00]) and siblings (OR=3.08 [3.00 to 3.16]) of cases had higher odds of AF/AFl than did parents and siblings of controls. AF/AFl ORs were increased in both sexes. For 2\% of cases, both parents had AF/AFl, compared with only 0.7\% of controls (OR=3.60 [3.30 to 3.92]). Moreover, 3\% of cases had â‰¥2 siblings with AF/AFl, compared with 1\% of controls (OR=5.72 [5.28 to 6.19]). In premature cases (diagnosed at age {$<$}50 years), the ORs were 5.04 (4.36 to 5.82) and 8.51 (6.49 to 11.15) for AF/AFl in both parents and AF/AFl in â‰¥2 siblings, respectively. The overall spouse OR was 1.16 (1.13 to 1.19). Family history of AF/AFl increases the odds of AF/AFl in first-degree relatives. High familial risks were observed in multiplex families.},
  keywords = {ðŸ”´},
  file = {/Users/asshah4/Library/CloudStorage/OneDrive-UniversityofIllinoisChicago/articles/ZÃ¶ller et al_2013_High familial risk of atrial fibrillation-atrial flutter in multiplex families.pdf}
}
